Patent Grant
11844691
Some applications of the present invention relate in general to valve replacement. More specifically, some applications of the present invention relate to prosthetic cardiac valves and techniques for implantation thereof.
Ischemic heart disease causes regurgitation of a heart valve by the combination of ischemic dysfunction of the papillary muscles, and the dilatation of the ventricle that is present in ischemic heart disease, with the subsequent displacement of the papillary muscles and the dilatation of the valve annulus.
Dilation of the annulus of the valve prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium.
For some applications of the invention, tissue anchors coupled to tethers are transluminally anchored to ventricular tissue of a native valve. A prosthetic valve component, such as a prosthetic valve assembly, a prosthetic valve body, or a support, is transluminally slid along a guide member coupled to the tethers, and is anchored to the tethers.
For some applications, a prosthetic valve assembly comprises (1) a valve body shaped to define a lumen therethrough, and a valve member disposed within the lumen, (2) an upstream support configured to be placed against an upstream surface of a native heart valve, and (2) a flexible sheet that couples the upstream support to the valve body.
For some applications, the prosthetic valve assembly comprises eyelets to facilitate sliding along the guide member.
For some applications, the prosthetic valve assembly has a compressed delivery state in which the valve body and the upstream support are articulatably coupled to each other by the sheet. For such applications, a delivery tool houses the prosthetic valve assembly such that the valve body and upstream support are articulatable with respect to each other during transluminal delivery.
For some applications, the prosthetic valve assembly comprises tethers that, when tensioned, move the valve body closer to the support. For such applications, the assembly typically comprises tissue-engaging elements that protrude from the valve body, and the tethers are tensioned to sandwich tissue of the native valve between the tissue-engaging elements and the support.
For some applications, one or more forces is measured during implantation, and distributed among various anchoring elements. For some such applications, an intracorporeal spring is used that is extracorporeally observable using imaging techniques. For some such applications, the spring facilitates force distribution.
For some applications, a prosthetic valve assembly comprises a flexible sheet forms a pocket between the sheet and a frame of the assembly, and facilitates sealing between the assembly and tissue of the native valve.
For some applications of the invention, tissue anchors coupled to longitudinal members that are reversibly couplable to wires are transluminally advanced to the ventricle downstream of a native heart valve, and are anchored there. A prosthetic valve support comprising an upstream support portion is slid, in a compressed delivery configuration, over the wires and part of each longitudinal member, and into an atrium upstream of the native valve where it is deployed (e.g., expanded) and placed against an upstream surface (e.g., an atrial surface) of the native valve. A locking member is also slid over the wires and part of each longitudinal member, and locks to the longitudinal member, thereby securing the prosthetic valve support against the upstream surface of the native valve. A prosthetic valve is subsequently transluminally advanced to the native valve, and is implanted by coupling the prosthetic valve to leaflets of the native valve and to the prosthetic valve support.
For some applications of the invention, a tubular member is slidable over the wire and the longitudinal member, and when disposed over the wire and the long member, inhibits decoupling of the wire from the longitudinal member. For such applications, the prosthetic valve support and the locking member are typically slidable over the tubular member.
For some applications of the invention, a control rod, reversibly coupled to the locking member, is slid over the tubular member so as to push the locking member and the prosthetic valve support over the tubular member. For some such applications, the control rod is used to lock the locking member to the longitudinal member.
There is therefore provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including:
In an application, the upstream support is coupled to the valve body only via the sheet.
In an application:
In an application, the sheet provides fluid communication between the opening and the lumen.
In an application, the sheet is not attached to the inner perimeter of the second frame.
In an application, the sheet is not attached to an upstream end of the valve body.
In an application, the sheet is generally annular when the valve body is in the expanded state thereof and the upstream support is in the expanded state thereof.
In an application, the sheet is generally frustoconical when the valve body is in the expanded state thereof and the upstream support is in the expanded state thereof.
In an application, the sheet is attached to the inner perimeter of the second frame.
In an application, the sheet is circumferentially attached to the second frame at a radius that is greater than a radius of the inner perimeter.
In an application, the sheet is circumferentially attached to the second frame at the outer perimeter of the second frame.
In an application, the sheet is attached to an upstream end of the valve body.
In an application, the first frame is generally cylindrical in both the compressed state thereof and the expanded state thereof.
In an application, the second frame is generally cylindrical in the compressed state thereof.
In an application, the valve body includes at least one downstream anchor, configured such that, in the expanded configuration of the valve body, the anchor protrudes radially outward from the first frame.
In an application, the apparatus further includes at least one tensioning element, coupled to the valve body and to the upstream support, a length of the tensioning element between the valve body and the upstream portion being adjustable such that a distance between the first frame and the second frame is adjustable.
In an application, the at least one tensioning element includes a tether.
In an application, the at least one tensioning element is coupled to the first frame, and slidably coupled to the second frame.
In an application, the valve body, the upstream support and the sheet together define a prosthetic valve assembly, the prosthetic valve assembly:
In an application, the apparatus further includes a delivery tool:
In an application:
In an application, the eyelets are pivotably coupled to the valve body.
In an application, the delivery tool further includes at least two reference-force tubes, each reference-force tube configured (1) to be slidable over a respective one of the guide members, and (2) to apply a distally-directed force to the prosthetic valve assembly.
In an application, in the compressed state of the prosthetic valve assembly, each reference-force tube extends distally (1) through a lumen defined by the second frame of the upstream support, (2) through the sheet, and (3) along an outside of at least part of the valve body.
In an application, the apparatus further includes at least two locking members, each locking member:
In an application, the apparatus further includes the at least two guide members:
In an application, the apparatus is configured such that, for each respective guide member and locking member, while (1) the tubular member is disposed within the locking member, (2) the distal portion of the pull-wire and the proximal portion of the tether are disposed within the lumen of the tubular member, and (3) the tissue anchor is coupled to the ventricular tissue:
In an application, at least one housing selected from the group consisting of: the first housing and the second housing has a lateral wall that is shaped to define at least two slits, the eyelets being configured to protrude radially outward from the delivery tool via the slits.
In an application, each slit of the at least one selected housing is continuous with the orifice of the at least one selected housing.
In an application, the eyelets are coupled to and protrude radially outward from the valve body.
In an application, the eyelets are pivotably coupled to the valve body.
In an application:
In an application, the delivery tool further includes a housing-control rod that extends through the first housing and is coupled to the second housing such that a first portion of the housing-control rod is disposed within the first housing, a second portion of the housing-control rod is disposed within the second housing, and a third portion of the housing-control rod (1) is disposed within the second articulation zone, and (2) is more flexible than at least one portion of the housing-control rod selected from the group consisting of: the first portion and the second portion.
In an application:
In an application, the second housing orifice faces the first housing orifice.
In an application:
In an application, the prosthesis-control rod is reversibly couplable to the prosthetic valve assembly by being reversibly couplable to the valve body.
In an application, at least part of the second housing-control rod is disposed within and slidable through the prosthesis-control rod, and at least part of the prosthesis-control rod is disposed within and slidable through the first housing-control rod.
In an application, the outer perimeter of the second frame has a third diameter that is greater than the second diameter.
In an application, the inner perimeter has a fourth diameter that is greater than the second diameter.
In an application, when the valve body is in the expanded state thereof and the upstream support is in the expanded state thereof, a gap is defined between the first frame and the second frame, the sheet spanning the gap.
In an application, no metallic structure is disposed within the gap.
In an application, the sheet is configured to inhibit expansion of the second frame.
In an application, the apparatus is configured such that when the second frame expands from the compressed state thereof toward the expanded state thereof, the sheet retains the second frame in a generally frustoconical shape by inhibiting expansion of at least the outer perimeter of the second frame.
In an application, the sheet extends over at least part of the second frame to serve as a covering of the upstream support.
In an application, the covering defines a tissue-contacting surface of the upstream support.
In an application, the sheet extends over at least part of the first frame to serve as a covering of the valve body.
In an application, the covering is disposed on an inner surface of the first frame.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including:
In an application, the spring is shaped to define a repeating pattern.
In an application, the spring is pre-loaded.
In an application, the spring is a constant-force spring.
In an application, the spring is configured to facilitate extracorporeal fluoroscopic observation of a state of the spring.
In an application, the spring is coupled to a plurality of radiopaque markers such that a juxtaposition of the markers changes as the state of the spring changes, the juxtaposition of the markers being extracorporeally fluoroscopically observable.
In an application, the spring is coupled to at least one radiopaque marker, and the apparatus further includes an intracorporeal reference, a juxtaposition between the radiopaque marker and the intracorporeal reference being extracorporeally fluoroscopically observable.
In an application, the intracorporeal reference includes a scale including a plurality of radiopaque markers.
In an application, the plurality of radiopaque markers includes a first plurality of radiopaque markers, and the at least one radiopaque marker includes a second plurality of radiopaque markers.
In an application, the spring is configured to provide distinct indication that is observable using fluoroscopy, when the spring is experiencing a force that is within a margin force from a target force.
In an application, the spring is configured to provide the distinct indication when the spring experiences a force that is above 300 g force.
In an application, the spring is configured to provide the distinct indication when the spring experiences a force that is above 400 g force.
In an application, the spring is configured to provide the distinct indication when the spring experiences a force that is about 500 g force.
In an application, the spring is coupled to the prosthetic valve, and is intracorporeally lockable to the tether subsequently to anchoring of the tissue anchor to the ventricular muscle tissue.
In an application, the spring is slidable along at least part of the tether, and is intracorporeally couplable to the tether by inhibiting the sliding.
In an application, the prosthetic valve includes a generally cylindrical valve body having an upstream end, and the spring includes an elastically-deformable appendage that protrudes laterally from the valve body.
In an application:
In an application, the prosthetic valve includes:
In an application, the prosthetic valve is couplable to the upstream support intracorporeally by being expanded within an opening defined by the upstream support while the upstream support is disposed against the upstream surface.
In an application, the apparatus is configured such that the coupling of the prosthetic valve to the upstream support couples the tether to the prosthetic valve.
In an application, the apparatus is configured to sandwich a portion of the native valve between the tissue-engaging legs and the upstream support by providing a space having a height between the tissue-engaging legs and the upstream support.
In an application, the apparatus is configured to facilitate altering the height without altering a force on the spring.
In an application, the apparatus is configured such that altering the height automatically alters a force on the spring.
In an application, the apparatus is configured to facilitate altering the height by moving the valve body through the opening defined by the upstream support.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native heart valve of a subject, the apparatus including:
In an application, the second longitudinal position is closer to the downstream end of the valve body than is the first longitudinal position.
In an application, the first aperture is larger than the second aperture.
In an application, the sheet is attached to the upstream support at an outer perimeter of the upstream support.
In an application, the sheet assumes a frustoconical shape.
In an application, the sheet assumes a funnel shape.
In an application, the apparatus is provided with the inner perimeter of the upstream support pre-coupled to the valve body at the first longitudinal position of the valve body.
In an application, the apparatus is configured such that the inner perimeter of the upstream support is intracorporeally couplable to the valve body at the first longitudinal position of the valve body.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native heart valve disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
In an application, the apparatus further includes at least one tether, a first portion of the tether being coupled to the valve body and a second portion of the tether being coupled to the upstream support, such that tensioning of at least a portion of the tether reduces the gap.
In an application, the apparatus is configured such that tensioning of at least the portion of the tether rumples the sheet.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native heart valve disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
In an application, the valve body includes:
In an application, the frame is separated from the upstream element by a gap, and the conduit spans the gap.
There is further provided, in accordance with an application of the present invention, apparatus, for use with a guide member that extends into a subject, the apparatus including:
In an application, the implant is configured to be implanted by being intracorporeally locked to the guide member.
In an application, the implant has a compressed state and an expanded state, is configured to be housed by the housing while in the compressed state, and is configured to automatically expand toward the expanded state when removed from the housing.
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the method including:
In an application, measuring the force includes measuring the force using an extracorporeal force meter.
In an application, measuring the force includes observing a shape of the tissue-engaging legs using imaging.
In an application, applying the tension includes applying the tension while applying the force.
In an application, locking the second portion to the selected component includes locking the second portion to the prosthetic valve.
In an application, locking the second portion to the selected component includes locking the second portion to the upstream support.
In an application, locking the second portion includes locking the second portion when the observed shape indicates that the spring is experiencing between 400 g force and 600 g force.
In an application, locking the second portion includes locking the second portion subsequently to applying the tension, and applying the force includes applying the force subsequently to locking the second portion.
In an application:
In an application, facilitating holding includes locking the second portion of the first tether and the second portion of the second tether to the selected at least one component, at least in part responsively to a ratio between tension in the first tether and tension in the second tether, the ratio being derived from the observed shape of the first spring and the observed shape of the second spring.
In an application, locking includes locking the second portion to the at least one component at least in part responsively to the observed shape.
In an application, locking includes locking the second portion to the at least one component at least in part responsively to the measured force.
In an application, applying the force includes moving the valve body in an upstream direction through an opening defined by the upstream support, and the method further includes coupling the prosthetic valve to the upstream support by expanding the valve body within the opening.
In an application, coupling the prosthetic valve to the upstream support includes coupling the prosthetic valve to the upstream support at least in part responsively to the measured force.
There is further provided, in accordance with an application of the present invention, a method, including:
There is further provided, in accordance with an application of the present invention, a method, for use with a native valve of a heart of a subject, the method including:
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the method including:
In an application, tensioning the tether coupled to the upstream support includes tensioning a tether that is coupled to a valve body coupled to the upstream support.
In an application, before the tensioning, the upstream support is generally flat annular, and changing the shape includes making the support assume a frustoconical shape.
In an application, before the tensioning, the upstream support is frustoconical, and changing the shape includes changing a slant of the frustoconical shape.
There is further provided, in accordance with an application of the present invention, apparatus for use with a valve of a heart of a subject, the apparatus including:
In an application, the anchor manipulator is slidably coupled to the catheter such that a distal end of the anchor manipulator is slidable distally no more than a pre-determined distance from the longitudinal site.
In an application, the apparatus further includes an implant, intracorporeally lockable to the tether.
In an application, the apparatus further includes a guide member, reversibly couplable to the tether, and the implant is intracorporeally slidable along the guide member toward the tether and the implant.
In an application, the tether has exactly one locking site at which the implant is lockable to the tether.
In an application, the exactly one locking site is disposed at a pre-determined distance from the anchor that is pre-determined at least in part dependently on a distance between the longitudinal site and a distal end of the catheter.
There is further provided, in accordance with an application of the present invention, a method, including:
There is further provided, in accordance with an application of the present invention, apparatus, for implantation at a native valve of a heart of a subject, the native valve being disposed between an atrium and a ventricle of the heart, the apparatus including:
In an application, the at least one valve member is coupled to the downstream portion of the valve body.
In an application, the native valve includes a plurality of native leaflets, and the downstream portion of the valve body is configured to be coupled to the native leaflets.
In an application, the apparatus further includes a plurality of clips, configured to facilitate the coupling of the downstream portion of the valve body to the native leaflets.
In an application, each clip:
In an application, the clips are coupled to the downstream portion of the valve body, and the downstream portion of the valve body is configured to be coupled to the native leaflets by the clips being coupled to the native leaflets.
In an application, each clip of the plurality of clips is articulatably coupled to the downstream portion of the valve body.
In an application, the native valve includes an annulus having an upstream surface, and the apparatus further includes a prosthetic valve support:
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the native valve having a plurality of leaflets that meet at a plurality of commissures, the apparatus including:
In an application, the longitudinal member is flexible.
In an application, the longitudinal member includes a suture.
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the native valve having a plurality of leaflets that meet at a first commissure and at a second commissure, the method including:
In an application, anchoring, placing, and securing include anchoring, securing, and placing without the use of cardiopulmonary bypass.
In an application, anchoring to the first site and anchoring to the second site include anchoring to myocardium.
In an application, placing the upstream support portion against the upstream surface includes sliding the upstream support portion over at least part of the first longitudinal member.
In an application, coupling the upstream support portion to the first longitudinal member and to the second longitudinal member includes coupling the upstream support portion to the first longitudinal member in the atrium of the heart of the subject, and coupling the upstream support portion to the second longitudinal member includes coupling the upstream support portion to the second longitudinal member in the atrium of the heart of the subject.
In an application, the leaflets move in response to beating of the heart of the subject, and securing the upstream support portion includes securing the upstream support portion without eliminating the movement of the native leaflets.
In an application, coupling the upstream support portion to the first longitudinal member includes coupling the upstream support portion to the first longitudinal member such that a length of the portion of the first longitudinal member is greater than 1 cm.
In an application, the method further includes:
In an application, sliding the at least first tubular member includes sliding at least part of the at least first tubular member through a channel defined by a locking member, and coupling the upstream support portion to the respective longitudinal member includes locking the locking member to the respective longitudinal member by narrowing at least a portion of the channel.
In an application:
In an application:
In an application, sliding the at least first tubular member off of the portion of the wire includes sliding the at least first tubular member off of the portion of the wire by applying less than 500 g of pulling force to the at least first tubular member.
In an application, applying less than 500 g of pulling force to the at least first tubular member includes applying less than 300 g of pulling force to the at least first tubular member.
In an application, the method further includes, subsequently to securing the upstream support portion, coupling a prosthetic valve to the prosthetic valve support.
In an application, the upstream support portion has an inner edge that defines an opening through the upstream support portion, and coupling the prosthetic valve to the prosthetic valve support includes placing at least a portion of the prosthetic valve within the opening, and expanding at least the portion of the prosthetic valve such that at least the portion of the prosthetic valve applies a radially-expansive force against the inner edge of the upstream support portion.
In an application, the prosthetic valve includes one or more tissue-engaging elements, each of the one or more tissue-engaging elements including at least two arms, and the method further includes, subsequent to securing the upstream support portion, coupling the prosthetic valve to at least one of the leaflets by sandwiching the at least one of the leaflets between the at least clip arms of the one or more tissue-engaging elements.
In an application, coupling the prosthetic valve to the at least one of the leaflets includes coupling the prosthetic valve to the at least one of the leaflets before coupling the prosthetic valve to the prosthetic valve support.
In an application:
In an application:
In an application, applying the force to the first arm using the delivery tube includes pushing on the first arm by sliding the delivery tube over at least part of the prosthetic valve.
There is further provided, in accordance with an application of the present invention, apparatus for use with a body of a subject, the apparatus including:
In an application, the portion of the second longitudinal member is configured, when (1) the portion of the second longitudinal member is coupled to the first longitudinal member, and (2) the portion of the second longitudinal member is disposed outside of the lumen of the tubular member, to be decouplable from the first longitudinal member by the second longitudinal member being pulled away from the first longitudinal member.
In an application, at least one longitudinal member selected from the group consisting of: the first longitudinal member and the second longitudinal member, is flexible.
In an application, the tubular member is more rigid than the first longitudinal member.
In an application, the tubular member fits snugly over at least the portion of the second longitudinal member.
In an application, the first implantable member includes a tissue anchor, configured to be anchored to a tissue of the subject.
In an application, the apparatus further includes a second implantable member, slidable over the tubular member, and couplable to the first longitudinal member while the portion of the second longitudinal member is coupled to the first longitudinal member.
In an application, the portion of the second longitudinal member is reversibly couplable to the first longitudinal member at a first site of the first longitudinal member, and the second implantable member is couplable to the first longitudinal member at a second site of the first longitudinal member that is distal to the first site of the longitudinal member.
In an application, the apparatus further includes a locking member having an unlocked state and a locked state, and configured to be slid over the tubular member in the unlocked state and to be locked to the first longitudinal member by being transitioned to the locked state.
In an application, the locking member is configured to facilitate coupling of the second implantable member to the first longitudinal member.
In an application, the locking member is configured to be coupled to the first longitudinal member at least 1 cm away from the first implantable member.
There is further provided, in accordance with an application of the present invention, apparatus for use at a native valve of a heart of a subject, the apparatus including:
In an application, the locking member is configured to be locked to the longitudinal member at a site of the longitudinal member that is distal to a site of the longitudinal member to which the portion of the wire is reversibly couplable.
In an application, the tubular member is configured to be slid out of the locking member before the locking member is locked to the longitudinal member.
In an application, the apparatus further includes a control rod, slidable over the tubular member, the locking member being reversibly coupled to a control rod, the control rod being configured to restrain the locking member in an unlocked configuration thereof, and to facilitate locking of the locking member by ceasing to restrain the locking member in the unlocked configuration.
In an application, the control rod is configured to decouple from the locking member when the control rod ceases to restrain the locking member in the unlocked configuration thereof.
In an application, the control rod is configured to cease to restrain the locking member in the unlocked configuration thereof by the control rod being rotated with respect to the locking member.
In an application:
The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
Reference is made to
Reference is now made to
State A of
State B of
For some applications, subsequent to anchoring each tissue anchor 48 to the tissue, a testing pulling force of known magnitude is applied to the anchor (e.g., by applying the pulling force to anchor manipulator 54), and movement of the tissue anchor in response to the pulling force is observed using imaging (e.g., fluoroscopy). The observed movement may be used to confirm successful and/or stable anchoring (e.g., relatively little movement may indicate firm anchoring in firm tissue) or to determine sub-optimal anchoring (e.g., relatively large movement may indicate weak anchoring and/or anchoring in weak tissue). Thus, at least in part responsively to the observed movement, the operating physician may decouple manipulator 54 from anchor 48, or may de-anchor the anchor from the tissue using the manipulator.
State C of
Typically, and as shown in
State D of
Reference is now made to
Prosthetic valve support 42 comprises an annular upstream support portion 43 which, in the delivery configuration of the prosthetic valve support, is generally cylindrical, and which, once the prosthetic valve is deployed and expands to an uncompressed configuration thereof, is generally annular. For some applications, upstream support portion 43 is generally frustoconical in the uncompressed configuration thereof. Typically, a distal end of upstream support portion 43 in the compressed, cylindrical configuration, defines an inner perimeter of the upstream support portion in the uncompressed configuration, the inner perimeter defining an opening through the upstream support portion.
State A of
State B of
Typically, prosthetic valve support 42 (e.g., upstream support portion 43 thereof) is provided with one or more (e.g., two) control filaments 88 reversibly coupled thereto. Typically, filaments 88 are coupled to upstream support portion 43 at sites that are disposed opposite each other around the generally annular shape of the upstream support portion, and disposed evenly between holes 82. That is, in the expanded configuration of upstream support portion 43, a straight line between holes 82 is typically perpendicular to a straight line between the sites at which filaments 88 are coupled to the upstream support portion. It should be noted that other numbers and arrangements of control filaments may also be used. Typically, each control filament 88 (1) comprises two portions of a loop of filament that passes through upstream support portion 43, loops around a downstream surface of the upstream support portion (i.e., the surface that is placed in contact with the annulus of the native valve), and passes back through the upstream support portion, and (2) is decouplable from the upstream support portion by releasing a first end of the filament and pulling a second end, thereby unthreading and/or unlooping the control filament from the upstream support portion.
Control filaments 88 facilitate some manipulation of prosthetic valve support 42 following deployment from delivery tube 80. Typically, control rods 86 further facilitate such manipulation. State C of
Reference is now made to
For some applications, longitudinal member 102 and pull-wire 104 are coupled via complementary screw threads. For example, longitudinal member 102 may comprise, or be coupled to, a screw at a proximal end thereof, and pull-wire 104 may comprise, or be coupled to, a socket at a distal end thereof. For some applications, tubular member 100 is used to decouple (e.g., unscrew) pull-wire 104 from longitudinal member 102.
Tubular member 100 is typically more rigid than pull-wire 104 and/or longitudinal member 102 (although it is still sufficiently flexible to be transluminally delivered). This rigidity reduces a likelihood of twisting, kinking, snagging, and/or other undesirable phenomenon or interactions within the transluminal delivery system (e.g., within sheath 46, catheter 50, and/or anchor-delivery tube 52). For some applications tubular member 100 has a smoother surface than does pull-wire 104 or longitudinal member 102. For some applications, tubular member 100, which is necessarily wider than pull-wire 104 and/or longitudinal member 102, is also more visible using imaging techniques such as fluoroscopy. This advantageously allows an operating physician to monitor the intracorporeal juxtaposition of the tubular members and, if necessary, to intervene, such as by revolving the tubular members (e.g., proximal ends thereof) around each other.
As described hereinabove, control rods 86 are used to push prosthetic valve support 42 toward the annulus of valve 10 by sliding the control rod over a respective guide member 56 (i.e., over the tubular member 100 of the respective guide member). Each control rod 86 is reversibly coupled at a distal end thereof to a respective locking member 110 that, in an unlocked state thereof, is slidable over guide member 56. Thereby, the pushing of prosthetic valve support 42 is typically performed by pushing with both control rod 86 and locking member 110. State A of
State B of
Subsequently, and as shown in state C of
Typically, anchors 48 and longitudinal members 102 are configured to withstand a pulling force of at least 500 g, so as to withstand forces within the beating heart. The apparatus is typically configured such that a pulling force required to pull tubular member 100 proximally, is less than 500 g, such as less than 300 g. For some applications, such a configuration is achieved at least in part by reducing friction between tubular member 100 and pull-wire 104, such as by thermally treating the pull-wire 104.
Subsequently, control rod 86, tubular member 100, and pull-wire 104 are pulled proximally, as shown in state D of
It is to be noted that, as shown in
Reference is now made to
Prosthetic valve 44 further comprises one or more tissue-engaging elements 124. Typically, and as shown, valve 44 comprises two tissue-engaging elements 124 coupled to valve body 122 at sites that are on opposite sides of the circumference of the valve body. Each tissue-engaging element 124 typically comprises two arms 126 (e.g., a first clip arm 126a and a second clip arm 126b). For some applications, and as shown, each arm 126 defines an arc that is coupled to valve body 122 at the base of the arc. For example, and as shown, each arm 126 may comprise a single arc of the same shape-memory material as the frame of valve body 122. For some applications, one or both arms 126 of each tissue-engaging element 124 may be covered in a covering, such as a fabric.
When valve 44 is in the compressed state thereof within delivery tube 120, arms 126 are held against valve body 122 with a tip 127 of each arm disposed proximally to a site at which that arm is coupled to the valve body. Each tissue-engaging element 124 is configured such that a tip 127a of arm 126a is disposed distal to a tip 127b of arm 126b. For example, arm 126a may be shorter than arm 126b. Alternatively or additionally, arm 126a may be coupled to valve body 122 at a site that is distal to a site at which arm 126b is coupled to the valve body.
Prosthetic valve 44, within delivery tube 120, is advanced distally between leaflets 14 of native valve 10, and the prosthetic valve is progressively advanced distally out of a distal end of the delivery tube, as shown in states A-B of
Subsequently, and as shown in state D of
Typically, the force is applied by moving delivery tube 120 distally with respect to the prosthetic valve (e.g., sliding the delivery tube over at least part of the prosthetic valve), so as to push the arm, as shown in state C of
Subsequently, delivery tube 120 is pulled further proximally with respect to prosthetic valve 44, such that tip 127b of second arm 126b of each tissue-engaging element 124 becomes exposed from the delivery tube, and each arm 126b responsively deflects radially outward from valve body 122, toward a pres-set position (state A of
Subsequently, prosthetic valve 44 is fully deployed by a proximal end of the prosthetic valve (e.g., valve body 122 thereof) being exposed from delivery tube 120 (e.g., by further withdrawing the delivery tube proximally with respect to the prosthetic valve)(state C of
For some applications, and as shown in state B of
It is to be noted that, for some applications, each tissue-engaging element 124 comprises only one arm 126. For some such applications, the one arm 126 comprises and/or functions like first arm 126a described herein. For some such applications, the one arm 126 is configured to couple to the leaflet by sandwiching a portion of the leaflet between the one arm and valve body 122. For some such applications, the one arm 126 is configured, when the prosthetic valve is pulled proximally as shown in state B of
State D of
Reference is again made to
Reference is again made to
Because prosthetic valve support 42 is typically implantable without eliminating functioning of the native leaflets, for some applications, the prosthetic valve support is implantable without the use of cardiopulmonary bypass. For some applications, prosthetic valve 44 is also implantable without the use of cardiopulmonary bypass.
Reference is made to
Reference is made to
Typically, prosthetic valve support 42 is provided in the compressed state thereof, within delivery tube 80, e.g., as a unit 140, coupled to a distal end of a controller 142 that is used to move the unit transluminally (e.g., within sheath 46). Unit 140 comprises (e.g., is provided having) one or more introducer tubes 144, each introducer tube being shaped to define a lumen therethrough, and having an open distal end 143 and an open proximal end 145. Distal end 143 of each tube is disposed outside a distal end of support 42 and/or tube 80, and proximal end 145 of each tube is disposed outside a proximal end of the support and/or tube 80. Each introducer tube 144 passes (1) from the distal end thereof, (2) through a respective hole 82 in upstream support portion 43 from the downstream surface of the support portion (which defines an outer surface of the support portion in the compressed state thereof) to an upstream surface of the support portion (which defines an inner surface of the support portion in the compressed state thereof), and (3) to the proximal end thereof.
As shown in
Reference is made to
Locking member 110 is typically controllable using a holding member 112 that inhibits (e.g., prevents) the locking member from locking, such as by inhibiting movement of locking bar 164. As described hereinabove, each control rod 86, used to push prosthetic valve support 42 toward the annulus of valve 10, is reversibly coupled at a distal end thereof to a respective locking member 110, such that the pushing is typically performed by pushing with control rod 86 and locking member 110. For some applications, and as shown in
In the unlocked state in which locking member 110 is advanced over guide member 56 toward upstream support portion 43 and the annulus of the native valve, the ends of locking bar 164 are disposed in holding region 170 of each slit 168, and the locking bar is thereby inhibited from moving distally and locking the locking member (
As described hereinabove, tubular member 100 is typically withdrawn from locking member 110 before the locking member is locked, and the locking member is locked to longitudinal member 102, e.g., by locking bar 164 sandwiching longitudinal member 102 against the inner surface of the channel of the locking member (e.g., effectively narrowing the channel at the site of the locking bar). Movement of the ends of locking bar 164 into and through release region 172 also decouples control rod 86 from the locking member, allowing the control rod to be removed from the body of the subject (typically along with tubular member 100)(
It is to be noted that locking member 110 thereby (1) when unlocked, facilitates sliding therethrough of a relatively wide element, tubular member 100, and (2) when locked, locks to a relatively narrow element, longitudinal member 102. To facilitate this, between the locked and unlocked states, locking bar 164 thereby moves a sufficient distance across the channel defined by locking member 110. That is, locking bar 164 moves a larger distance than would be necessary to lock a similar locking member that does not facilitate, in the unlocked state thereof, sliding therethrough of a tubular member that is wider than the longitudinal element.
Reference is again made to
Reference is made to
Typically, first anchor 48a is delivered and anchored as described hereinabove with reference to
Reference is made to
Unit 182 comprises (e.g., is provided having) one or more introducer tubes 184, each introducer tube being shaped to define a lumen therethrough, and having an open distal end 183. Distal end 183 of each tube is disposed outside a distal end of support 42 and/or tube 80, and each introducer tube 184 extends out of a proximal end of the support and/or tube 80. Similarly to unit 140 described with reference to
A locking member 190 is disposed over each introducer tube 184, such that the introduction of guide member 56 through the introducer tube also introduces the guide member through the locking member. Locking member 190 is slidable over guide member 56 (e.g., over tubular member 100 thereof), and is configured to lock to longitudinal member 102. Typically, locking member 190 is identical to locking member 110, described hereinabove, except that locking member 190 is configured (e.g., dimensioned) to be slidable also over introducer tube 184. Each locking member 190 is disposed at the distal end of a respective tubular control rod 192, which is typically identical to control rod 86, described hereinabove, except that control rod 192 is configured (e.g., dimensioned) to be slidable also over introducer tube 184.
The use of system 180, including introducer tubes 184, advantageously (1) removes the requirement for two separate introductions of proximal end 57 of guide member 56 (i.e., through an introducer tube and subsequently through a locking member and control rod); and (2) facilitates control rods 192 (and locking members 190) being present in the atrium of the subject during expansion of prosthetic valve support 42, thereby reducing an interval between the expansion of the prosthetic valve support and pressing of the prosthetic valve support against the annulus of the native valve.
Reference is made to
Sheet 214 may be a fabric, a film, and/or another sheet-like structure, and may comprise a natural material, a polymer, a biomaterial, and/or any other suitable material. Typically, sheet 214 comprises polyester, PTFE, and/or pericardial tissue.
For some applications, and as shown in
For some applications, in such an expanded and unconstrained state, sheet 214 is generally frustoconical or funnel-shaped, and upstream end 218 of frame 206 is disposed below the plane defined by support 210. (For some such frustoconical or funnel-shaped arrangements, the sheet may also be considered to be annular.)
For some applications, in such an expanded and unconstrained state, sheet 214 is generally tubular, upstream end 218 of frame 206 is disposed below the plane defined by support 210. For such applications, diameter d3 is typically generally equal to diameter d1.
Typically, one or both of frames 206 and 212 is covered on at least one side by a covering 220. For some applications, sheet 214 comprises a portion of covering 220, e.g., the sheet is defined by a portion of the covering that is disposed between frames 206 and 212. For some applications, and as shown in
A valve member 205 (e.g., comprising one or more prosthetic leaflets; shown in
At least two eyelets 222 are disposed on an outer surface of body 204 (i.e., protrude radially outward from body 204). Typically, eyelets 222 are pivotably coupled to body 204, e.g., such that the eyelets can pivot (e.g., rotate) in both directions by at least 5 degrees (e.g., more than 5 degrees and/or less than 90 degrees, such as between 5 and 90 degrees, e.g., between 5 and 60 degrees, such as between 5 and 45 degrees). For some applications, the eyelets can pivot in a plane parallel to a plane defined by a tangent of the valve body at the site to which the eyelet is coupled, as shown in the blowup box. Alternatively or additionally, the eyelets can pivot in a plane that is orthogonal to the plane defined by the tangent, e.g., such that the eyelets can point toward and/or away from the valve body. For some applications, eyelets 222 are sutured to body 204. Eyelets 222 are arranged in at least one pair; each eyelet of the pair being disposed on the opposite side of body 206 from the other eyelet of the pair.
In the delivery configuration of system 200, assembly 202 is in a compressed state thereof, in which prosthetic valve body 204 (in a compressed state thereof) is generally cylindrical, and upstream support 210 (in a compressed state thereof) is also generally cylindrical. Typically, in the delivery configuration of system 200, sheet 214 is also generally cylindrical. Assembly 202, in the compressed configuration thereof, (1) has a central longitudinal axis, at one zone (e.g., at one end) of which body 204 is disposed, and at another zone (e.g., the other end) of which support 210 is disposed, and (2) defines an articulation zone 236 in which (a) at least part of sheet 214 is disposed, and (b) neither frame 206 of body 204 nor frame 212 of support 210 is disposed, and about which body 204 and support 210 are articulatable with respect to each other.
In the delivery configuration of system 200, at least part of support 210 is disposed within housing 232 (which maintains the at least part of the support in the compressed state thereof), and at least part of body 204 is disposed within housing 234 (which maintains the at least part of the support in the compressed state thereof). Housing 232 defines an orifice 233 through which support 210 is introducible into the housing, and removable from the housing. Housing 234 defines an orifice 235 that faces orifice 233, and through which body 204 is introducible into the housing, and removable from the housing. In the delivery configuration, eyelets 222 protrude radially outward beyond the surface of delivery tool 230 (e.g., beyond a lateral wall of housing 234). Typically, housing 234 (e.g., the lateral wall thereof) is shaped to define a respective slit 237 for each eyelet, through which the eyelet protrudes beyond the surface of the housing. Each slit 237 is continuous with (i.e., is in communication with) orifice 235 such that, as described hereinbelow, during deployment of valve body 204, eyelet 222 can slide out of the slit at the orifice.
In the delivery configuration of system 200, tool 230 is in a contracted state, in which housing 232 is disposed at a distance d4 from housing 234 (e.g., orifice 233 is disposed at distance d4 from orifice 235). Distance d4 is typically greater than 1.5 mm and/or less than 30 mm, such as between 1.5 mm and 30 mm (e.g., between 10 and 15 mm). In this state, at least part of sheet 214 is exposed between the housings. The at least part of sheet 214 (and thereby of articulation zone 236) that is exposed between housings 232 and 234 facilitates articulation of housing 234 containing body 204 with respect to housing 232 containing support 210, and thereby defines an articulation zone 238 of system 200 in the delivery configuration thereof. Typically at least part of control rod assembly 240 is flexible, so as to facilitate articulation at articulation zone 238. For example, although assembly 240 as a whole is typically sufficiently flexible so as to facilitate its transluminal delivery to the heart, control rods 244 and 246 may be more flexible than control rod 240 (e.g., more flexible than required for transluminal delivery to the heart alone), so as to facilitate articulation at articulation zone 238. For some such applications, respective portions of control rods 244 and 246 that are disposed within articulation zone 238 when tool 230 is in the contracted state (
Control rod assembly 240 comprises (1) a first housing-control rod 242, coupled to first housing 232, (2) a second housing-control rod 244, coupled to second housing 234, and (3) a prosthesis-control rod 246, coupled to a mount 248 that is reversibly couplable to valve assembly 202, e.g., via a plurality of recesses 250 in the mount which receive respective portions of assembly 202. Typically, assembly 202 is couplable to mount 248 by valve body 204 being coupled to the mount, and further typically by a plurality of protrusions 252 of frame 206 being disposed within respective recesses 250. Housing 234 retains this coupling by inhibiting body 204 from expanding radially away from mount 248.
Typically, at least part of second housing-control rod 244 is disposed within and slidable through prosthesis-control rod 246, and at least part of the prosthesis-control rod is disposed within and slidable through first housing-control rod 242 (e.g., coaxially).
System 200 (e.g., tool 230 thereof) further comprises at least two flexible reference-force tubes 260, which extend, (a) from a proximal end of the system (e.g., from an extracorporeal portion of the system, such as from a handle of tool 230), (b) through a proximal end of housing 232, (c) through a lumen 254 defined by support 210 in the compressed state thereof, (d) through sheet 214, (e) along the outside of at least part of body 204, and typically (f) until a distal portion of body 204. A locking member 262 is disposed between each eyelet 222 and a respective tube 260. Typically, locking members 262 are not directly coupled to body 204, but are instead each held in position between eyelet 222 and tube 260 by a guide member 256 being disposed through the eyelet, the tube, and the locking member. For some applications, locking member 262 is integral with eyelet 222 (e.g., eyelet 222 is configured to and/or shaped to define locking member 262).
For some applications, guide members 256 are identical to guide members 56, described hereinabove. Guide members 256 are described in more detail hereinbelow.
Reference is now made to
A guide member 256 is coupled to each tissue anchor (e.g., the tissue anchors are provided pre-coupled to the guide members), such that after anchoring of the tissue anchors, each guide member extends from the anchor, out of the body of the subject, e.g., as described hereinabove with respect to guide member 56, mutatis mutandis. A proximal end of each guide member 256 is introduced through a respective eyelet 222, locking member 262, and reference-force tube 260, such that system 200 appears as shown in
System 200 (e.g., assembly 202 within delivery tool 230) is subsequently advanced along guide members 256 and via sheath 46 to left atrium 6 (
It is to be noted that, due to the described articulation, a distance d5 between a proximal end of housing 232 and a distal end of housing 234 may be greater than for a similar system that does not articulate. For example, distance d5 may be greater than a distance d6 along an atrioventricular axis between (a) a height on the atrioventricular axis of the upstream surface of native valve 10, and (b) a height on the atrioventricular axis of the transseptal entry point into left atrium 6 (e.g., the fossa ovalis). For some applications, distance d5 may be greater than the overall height of left atrium 6. Distance d5 is typically greater than 25 mm and/or less than 100 mm, such as between 25 mm and 100 mm (e.g., 35-60 mm, such as 40-50 mm).
Reference is made to
When protrusions 252 of frame 206 become withdrawn from housing 234, the portion of valve body 204 coupled to the mount expands (e.g., automatically), thereby disengaging the protrusions from recesses 250 of mount 248, and decoupling the valve body from the mount (
During the withdrawal of valve body 204 from housing 234, eyelets 222 typically slide through slits 237, and out of the slits at orifice 235.
For some applications, support 210 is deployed from housing 232 before valve body 204 is deployed from housing 234.
Subsequently, tension is applied to guide members 256 while an opposing reference force is provided to assembly 202 by tubes 260, thereby reducing a length of each guide member 256 that is disposed between eyelet 222 and its respective tissue anchor 48 (
For some applications this tensioning moves valve body 204 at least slightly distally into ventricle 8, such that sheet 214 becomes at least slightly frustoconical (e.g., as shown in
For some applications, tensioning is performed before deployment of support 210 from housing 232.
Each guide member 256 typically comprises a tether 282 (e.g., a longitudinal member), a pull-wire 284, and a tubular member 280 in which the pull-wire and the tether are disposed. A distal portion of pull-wire 284 is reversibly coupled to a proximal portion of tether 282, and tubular member 280 fits snugly over at least the distal portion of the pull-wire and the proximal portion of the tether so as to inhibit the pull-wire from becoming decoupled from the tether (e.g., to maintain a state of coupling therebetween). For some applications, and as shown, the reversible coupling is provided by pull-wire 284 and tether 282 defining respective mating surfaces. For some applications, the reversible coupling is provided as described hereinabove for guide member 56.
When each guide member 256 (e.g., the tether 282 thereof) is tensioned, the guide member is withdrawn proximally until at least part of tether 282 (within tubular member 280) is disposed within locking member 262 (e.g., at least until the proximal portion of the tether has passed through the locking member;
Reference is now made to
Typically, locking member 262 is biased (e.g., shape-set) to assume a locked state, and while tubular member 280 is disposed within the locking member, the tubular member inhibits locking of the locking member to tether 282 (or to pull-wire 284), and the removal of the tubular member from within the locking member facilitates automatic locking of the locking member to the tether (i.e., transitioning of the locking member into a locked state). Tubular member 280 is slidable through locking member 262 despite such biasing of the locking member, e.g., due to (a) the tubular member having a smooth surface, and/or (b) the tubular member retaining locking elements 263 of the locking member at an angle alpha_1 with respect to the tubular member, which is shallower than an angle alpha_2 with respect to tether 282 that the locking elements assume when the tubular element is withdrawn (compare
Typically, tether 282 defines a plurality of nodules 286, which facilitate locking of locking member 262 to the tether. For some applications, locking elements 263 and nodules 286 function as a ratchet. For some such applications, subsequently to transitioning of locking member 262 into the locked state thereof, one-way movement of tether 282 through the locking member is possible, thereby facilitating further increase, but not reduction, of tension.
Reference is now made to
Typically, tubular member 280 and pull-wire 284 are decoupled from tether 282 by withdrawing the tubular member further proximally, such that the distal portion of pull-wire 284 and the proximal portion of tether 282 are exposed from the tubular member (state A of
Regurgitation through these holes is typically minimal or absent due to their small size. The holes may be slit-like (rather than punched holes), such that in the absence of reference-force tubes 260 the holes become generally closed. Additionally, coaptation of leaflets 14 and tissue growth over the holes may further facilitate sealing. Alternatively or additionally, the holes may be defined by tubular protrusions 215 that extend from sheet 214 (shown in the “optional” box,
The positioning of prosthetic valve assembly 202 at the native valve typically results in leaflets 14 of the native valve coapting around valve body 204, thereby providing sealing that inhibits (e.g., prevents) perivalvular leakage.
The positioning of prosthetic valve assembly typically also places sheet 214 in contact with the annulus and/or leaflets of the native valve. In general, a prosthetic valve implanted at a native valve encounters forces due to beating of the heart and/or the resulting flow of blood. Small movements (e.g., oscillations) resulting from these forces may inhibit tissue growth (e.g., fibrosis) that would otherwise facilitate sealing between the prosthetic valve and the native valve. For some applications, such movements are reduced (e.g., dampened) at sites at which the contact between assembly 202 and the surrounding tissue is provided by sheet 214, e.g., due to flexibility of the sheet. Thereby sheet 214 typically provides stabilized (e.g., more constant) contact with tissue than would a less flexible structure in the same position; this is hypothesized to improve tissue growth and thereby sealing. Furthermore, sheet 214 itself may be configured to promote tissue growth thereon, e.g., due to surface treatments and/or impregnation, and/or structure, such as weave and/or porosity, thereby further facilitating sealing.
Reference is made to
Sheet 314 is not attached to inner perimeter 311 of frame 312, but rather is circumferentially attached to frame 312 at a radius that is greater than that of the inner perimeter. For example, sheet 314 may be attached to frame 312 at outer perimeter 313. Sheet 314 is also not attached to an upstream end 307 of valve body 304. Thereby a pocket region 316 is defined between sheet 314 and at least inner perimeter 311, in which sheet 314 is not attached to frame 312 or frame 306.
In the compressed state (
Sheet 354 is not attached to inner perimeter 351 of frame 352, but rather is circumferentially attached to frame 352 at a radius that is greater than that of the inner perimeter. For example, sheet 354 may be attached to frame 352 at outer perimeter 353. Sheet 354 is also not attached to an upstream end 347 of valve body 344. Thereby a pocket region 356 is defined between sheet 354 and at least inner perimeter 351, in which sheet 354 is not attached to frame 352 or frame 346.
Frame 352 is configured such that when the frame is in the compressed state, the frame has a generally cylindrical shape that defines a lumen therethrough, inner perimeter 351 defines an upstream end of the frame (e.g., of the cylindrical shape of the frame), and outer perimeter 353 defines a downstream end. Therefore, when frame 352 expands, the downstream end of the frame expands radially outward more than does the upstream end of the frame. In the compressed state (
Sheet 394 is not attached to inner perimeter 391 of frame 392, but rather is circumferentially attached to frame 392 at a radius that is greater than that of the inner perimeter. For example, sheet 394 may be attached to frame 392 at outer perimeter 393. Sheet 394 is also not attached to an upstream end 387 of valve body 384. Thereby a pocket region 396 is defined between sheet 394 and at least inner perimeter 391, in which sheet 394 is not attached to frame 392 or frame 386.
Assembly 382 is configured such that, in the compressed state thereof (
Sheet 414 is not attached to inner perimeter 411 of frame 412, but rather is circumferentially attached to frame 412 at a radius that is greater than that of the inner perimeter. For example, sheet 414 may be attached to frame 412 at outer perimeter 413. Sheet 414 is also not attached to an upstream end 407 of valve body 404. Thereby a pocket region 416 is defined between sheet 414 and at least inner perimeter 411, in which sheet 414 is not attached to frame 412 or frame 406.
Assembly 402 is configured such that, in the compressed state thereof (
Frame 426 of valve body 424 has an upstream end 427 and a downstream end 429. In the expanded state, in the absence of external forces, an outer perimeter 433 of second frame 432 of upstream support 430 is disposed closer to downstream end 429 than is an inner perimeter 431 of the second frame. For example, upstream support 430 may define a frustum, the larger base of which is disposed closer to downstream end 429 (and closer to a ventricular end of an atrioventricular axis) than is the smaller base of the frustum. For some applications, the assembly is thus configured such that, when placed at the native valve, outer perimeter 433 of the upstream support contacts the upstream surface of the native valve (e.g., the valve annulus), and the inner perimeter of the upstream support does not (
Sheet 434 is not attached to inner perimeter 431 of frame 432, but rather is circumferentially attached to frame 432 at a radius that is greater than that of the inner perimeter. For example, sheet 434 may be attached to frame 432 at outer perimeter 433. Sheet 434 is also not attached to upstream end 427 of valve body 424. Thereby a pocket region 436 is defined between sheet 434 and at least inner perimeter 431, in which sheet 434 is not attached to frame 432 or frame 426.
For some such applications, such a configuration provides a spring functionality that allows valve body 424 to move along an atrioventricular axis while outer perimeter 433 and/or portions of sheet 434 remain in contact with tissue (
For some applications, a compressed state of assembly 422 is as described for one or more of the prosthetic valve assemblies described with reference to
For some applications, assembly 422 is implanted as described for one or more of the prosthetic valve assemblies described with respect to
Reference is again made to
Reference is again made to
As described hereinabove, the respective pocket region of each assembly 302, 342, 382, 402 and 422 is defined by the manner in which the sheet of the assembly is coupled to the frames of the assembly. When the assembly is in the expanded state thereof, the sheet is typically frustoconical and/or funnel-shaped. This shape is defined by a lateral wall (i.e., the sheet itself), and first and second apertures (at either end of the shape), the first aperture being larger than the second aperture. A portion of the sheet that defines the first aperture is circumferentially attached to the frame of the upstream support at a radius that is greater than a radius of the inner perimeter of the support. A portion of the sheet that defines the second aperture is circumferentially attached to the frame of the valve body at a longitudinal site that is closer to a downstream end of the valve body than is the longitudinal site at which the upstream support is coupled to the valve body.
For some applications, the sheet extends radially past the radius at which it is coupled to the upstream support. As described hereinabove, for some applications the sheet is coupled to the upstream support at an outer perimeter of the upstream support. For some applications, the sheet extends radially past the outer perimeter of the upstream support.
Reference is made to
The boxes on the right-hand side of
The left-hand side of
Tool 460 comprises a pull-wire-coupling element 462, configured to be coupled to the proximal portion of pull-wire 284 (e.g., to a grip 464 of the pull-wire), and a reference-force-tube-coupling element 466, configured to be coupled to the proximal portion of reference-force tube 260 (e.g., to a grip 468 of the tubular member). Coupling elements 462 and 466 are coupled to each other via an adjustment member 470 that facilitates adjustment of a distance between the coupling elements. Adjustment member 470 may comprise screw threads, a ratchet mechanism, or any other suitable adjustment mechanism.
Pull-wire-coupling element 462 is coupled to the proximal portion of pull-wire 284 (e.g., to a grip 464 of the pull-wire), and reference-force-tube-coupling element 466 is coupled to the proximal portion of reference-force tube 260 (e.g., to a grip 468 of the tubular member), typically subsequently to delivery of prosthetic valve assembly 202 to the native valve (
Subsequently, adjustment member 470 is used (e.g., actuated) so as to change (e.g., increase) the distance between coupling elements 462 and 466 (
When a desired tensile state of tether 282 has been achieved (e.g., an absolute value and/or a value relative to other detected forces, such as the tensile state of the other tether 282), the tension is fixed, and pull-wire 284 is decoupled from tether 282 (
For some applications, this is performed by one continuous movement of tubular member 280. For some applications, visual and/or tactile indicators allow the operating physician to lock locking member 262 to tether 282 without decoupling pull-wire 284 from the tether. This may advantageously allow the physician to further increase the tension on the tether (e.g., by using the ratchet functionality described with reference to
Although tool 460 is described hereinabove for facilitating implantation of assembly 202, the tool may also be used, mutatis mutandis, in combination with other systems described herein, such as system 40 described hereinabove and/or assembly 552 described hereinbelow (e.g., for tensioning tethers 582 thereof).
Reference is now made to
Each spring 484 is disposed outside of valve body 204, typically laterally outside the valve body, and further typically between eyelet 222 and locking member 262 (e.g., coupling the eyelet to the locking member). For example, and as shown, spring 484 may have a longitudinal axis that is generally parallel with lumen 208 of the valve body. When reference-force tube 260 provides the reference force to locking member 262 during tensioning of guide member 256 (e.g., tether 282 thereof), the reference force is transferred via spring 484. Typically spring 484 serves as a compression spring, such that increasing tension on guide member 256 (e.g., the tether 282 thereof) compresses the spring.
For some applications, spring 484 provides an indication of a state of the spring that is observable and recognizable using imaging techniques (e.g., fluoroscopy). That is, spring 484 is configured to change shape in response to a force applied to it, in a manner that is observable and recognizable using fluoroscopy. This functionality therefore provides intracorporeal measurement of tension on tether 282 (in a manner that is itself observable extracorporeally). It is hypothesized that for some applications, this intracorporeal measurement advantageously detects the tension with reduced interference (e.g., noise) that may be present in extracorporeal measurement techniques. For example, for some applications, extracorporeal measurement of the tension by extracorporeally measuring tension on pull-wire 284 (e.g., tension with respect to reference-force tube 280) may be inhibited by interference by inherent elasticity of the pull-wire and other elements of the system, and by friction between elements of the system.
For some applications, the shape of spring 484 alone provides the tension indication. For such applications, spring 484 may be coated with a radiopaque material such as tantalum. For some applications, spring 484 has (e.g., comprises and/or is coupled to) one or more radiopaque markers 486, and the juxtaposition of the markers facilitates extracorporeal detection of the shape of the spring. For example, when spring 484 serves as a compression spring, a reduction of a distance d11 (compare d11 to d11′) between adjacent markers 486 indicates an increase in tension on tether 282.
For some applications, an intracorporeal reference (e.g., a scale) 488 is provided, to facilitate identification of shape change of spring 484 (e.g., to facilitate quantification of the shape change by (1) comparing the position of markers 486 to reference 488, and/or (2) comparing the juxtaposition of markers 486 to the juxtaposition of elements of the scale. For example, and as shown in
For some applications, spring 484 also alters the relationship between (a) changes in the length of tether 282 disposed between eyelet 222 and anchor 48 and (b) tension on the tether. For example, for system 200 described hereinabove (i.e., in the absence of spring 484), starting with slack on tether 282 between the eyelet and the anchor, as the length of the tether between the eyelet and the anchor is reduced, tension on tether 282 may remain constant and low despite the reduction in the length of the tether, until the tether encounters resistance provided by tissue anchor 48, at which point tension increases relatively quickly for every unit reduction in length. For system 480 (i.e., using spring 484), the relationship between (a) the length of tether 282 disposed between the eyelet and the anchor, and (b) the tension on the tether, is smoother (e.g., the transition between before and after resistance from the anchor is encountered is smoother). That is, spring 484 absorbs some of the applied tensile force and in exchange provides additional length to the tether. This is hypothesized to advantageously provide more flexibility to the operating physician to adjust the length of tether 282 disposed between the eyelet and the anchor, with reduced changes to tension on the tether.
For some applications, spring 484 is configured so as to provide a desired tension (e.g., a desired resistance) over a range of lengths of tether 282 (e.g., over a range of compression states of the spring). That is, the spring constant of the spring is sufficiently low that a change in resistance is minimized per unit length change. For example, the spring constant may be less than 50 g/mm.
For some applications, the desired tension is above 300 g force and/or below 700 g force, e.g., above 400 g force, and/or below 600 g force, such as between 400 g force and 600 g force, e.g., about 500 g force. For example, a desired target tether tension may be 500 g force, and spring 484 may be configured to provide, over a range of compression states of the spring, resistance that results in a tether tension that is within a margin tension (e.g., within 200 g force, such as within 100 g force) of the target force.
For some applications, spring 484 is configured to provide a distinct indication, observable using fluoroscopy, when the spring experiences a force that is within a margin force (i.e., a force that corresponds to being within the margin tension). For example, spring 484 may undergo (e.g., suddenly undergo) a more obvious shape change when such a force is experienced.
For some applications, spring 484 is configured to act as a constant-force spring or similar, so as to facilitate the behavior described above. For some applications, spring 484 is pre-loaded (e.g., pre-tensioned or pre-compressed).
Reference is made to
Each spring 504 is disposed outside of valve body 204, typically laterally outside the valve body, and further typically is disposed functionally between locking member 262 and anchor 48 (e.g., between locking member 262 and eyelet 222, or between eyelet 222 and anchor 48. For some applications, and as shown, spring 504 is a cantilever spring, and may be defined by a protrusion of frame 206 that extends away (e.g., laterally away) from valve body 204. That is, spring 504 may comprise an elastically-deformable appendage. For some applications, the protrusion is shaped to define a loop 506 that provides spring 504 with constant-force-spring functionality.
Typically, spring 504 provides similar functionality to spring 484, described hereinabove, mutatis mutandis. For example, for some applications, spring 504 provides an indication of a state of the spring that is observable and recognizable using fluoroscopy. That is, spring 504 is configured to change shape in response to a force applied to it, in a manner that is detectable and recognizable using fluoroscopy. For some applications, spring 504 also alters the relationship between (a) the length of tether 282 disposed between eyelet 222 and anchor 48 and (b) tension on the tether, e.g., as described hereinabove with reference to spring 484, mutatis mutandis.
Reference is made to
For illustrative purposes, springs 520 and 530 are shown being used with system 200 (e.g., with prosthetic valve assembly 202), described hereinabove. However it is to be noted that the techniques described with reference to
Typically, springs 520 and 530 provide similar functionality to springs 484 and 504, described hereinabove, mutatis mutandis. For example, for some applications, springs 520 and 530 provide an indication of a state of the spring that is observable and recognizable using fluoroscopy. That is, the springs are configured to change shape in response to a force applied to them, in a manner that is detectable and recognizable using fluoroscopy. For some applications, springs 520 and 530 also alter the relationship between (a) the length of tether 282 disposed between eyelet 222 and anchor 48 and (b) tension on the tether, e.g., as described hereinabove with reference to springs 484 and 504, mutatis mutandis.
Reference is again made to
Reference is made to
Housing 706 is advanced through native valve 10 and into ventricle 8, and valve body 702 is partly advanced out of the housing, and automatically expands toward an expanded state (
Typically system 700 is used for implantation of valve body 702 at a native valve at which a prosthetic valve support (e.g., an upstream support) has already been delivered, and to which the valve body is intracorporeally coupled (e.g., as described elsewhere herein). For example, and as shown in
Pulling housing 706 and valve body 702 proximally (i.e., atrially) while tissue-engaging elements 714 are protruding pushes the tissue-engaging elements against leaflets 14, reducing a height of a gap between the tissue-engaging elements and support 42, and sandwiching the leaflets against the support (
For some applications, alternatively or additionally to using extracorporeal force detector 716, the force encountered by tissue-engaging elements 714 is observed using fluoroscopy (e.g., by observing a shape and/or position of the tissue-engaging elements). For such applications, the tissue-engaging elements are typically configured to facilitate such observation, as described herein for various springs. For some applications, elements 714 are configured (e.g., shaped) to define a loop, e.g., as described hereinabove for springs 504, mutatis mutandis.
For some applications, valve body 702 is coupled via tethers to tissue anchors that are anchored to ventricular muscle tissue, as described elsewhere herein. For some such applications, a spring couples the valve body to each tissue anchor (e.g., as described with reference to
It is to be noted that the above technique may be used for prosthetic valve assemblies in which the valve body is pre-coupled to the upstream support, mutatis mutandis. For such applications, the proximal pulling force is not a sandwiching force, but rather is a testing force, typically used in combination with another testing force, e.g., as described hereinbelow, e.g., with reference to
Reference is made to
(1) Extracorporeal detection of tension on tethers (box 722). This is described, for example, with reference to force detector 472 of tool 460 of
(2) Extracorporeal detection of atrially-directed force of valve-mounted tissue-engaging elements against tissue (e.g., leaflets or annulus) of the native valve (box 742). This is described, for example, with reference to
(3) Extracorporeal detection of sandwiching force (box 720). That is, extracorporeal detection of the force of tissue-engaging elements coupled to the valve body against the native valve tissue and/or the upstream support. This is described, for example, (a) with reference to
(4) Intracorporeal detection (observed using imaging) of tension on tethers (724). This is described, for example, with reference to the springs described with reference to
(5) Intracorporeal detection (observed using imaging) of atrially-directed force of valve-mounted tissue-engaging elements against tissue (e.g., leaflets or annulus) of the native valve (box 744). This is described, for example, with reference to
(6) Intracorporeal detection (observed using imaging) of sandwiching force (box 726). This is described, for example, with reference to one or more of the springs described with reference to
(7) Intracorporeal detection (observed using imaging) of ventricularly-directed force of the upstream support against the native annulus (box 728). For some applications, this is achieved by using imaging (e.g., fluoroscopy) to extracorporeally observe intracorporeal changes in the shape of the upstream support (e.g., changes described with reference to
It is hypothesized that combining two or more of the force-measurement techniques described herein may provide synergistic benefits when implanting an implant (e.g., a prosthetic valve assembly, prosthetic valve body, and/or prosthetic valve support), so as to facilitate controlled implantation (box 730). The ability to control various forces that secure the implant allows, inter alia, the forces to be spread as desired by the operating physician. For example, it may be desirable:
It is to be noted that the example combinations provided hereinabove are intended to be illustrative, and not limiting.
As described hereinabove, it may be desirable to that tension on a given tether is optimized. For example, it may be desirable that tension on the given tether to be maximized within a tension range that is known to be supported by (1) the tissue anchor to which the tether is coupled, and (2) the tissue to which the tissue anchor is anchored. For some applications, subsequently to anchoring the tissue anchor, the operating physician applies a testing pulling force to the tissue anchor. The testing pulling force is used to confirm that the anchored tissue anchor is capable of supporting an overload tension that is greater than an expected tension that it is expected that the anchor will encounter during operation. The expected tension may be determined at least in part based on possible ventricular blood pressure and the cross-sectional area of the lumen of the valve body.
For some applications, the testing pulling force is applied (e.g., via the tether or via the anchor manipulator), and movement of the tissue anchor is observed using imaging, e.g., as described with reference to
For some applications, the testing pulling force is applied by applying tension to the tether, and the tension is measured using intracorporeal springs and fluoroscopy, as described hereinabove, mutatis mutandis. It is to be noted that, for such applications, the same technique is used (1) to confirm that the anchored tissue anchor is capable of supporting the overload tension, and (2) to facilitate the application of the tension (e.g., the anchoring tension) that will be fixed when the locking member is locked to the tether.
As described hereinabove, it may be desirable that, during operation of the valve, resistance to a force that pushes the valve body in an atrial direction (e.g., during ventricular systole) is optimally balanced between the various anchoring elements. For some applications, the following technique is used:
(1) Anchor at least one tissue anchor coupled to a respective at least one tether (e.g., within guide members).
(2) Advance a valve body that comprises at least one tissue-engaging element (e.g., a tissue-engaging leg) over at least part of the tether (e.g., by advancing over a guide member), such that a length of the tether is disposed between the valve body and the tissue anchor. Examples of such tissue-engaging elements are described with reference to
(3) Apply a first tension to the tether (measured intracorporeally or extracorporeally).
(4) Apply proximal pulling force to the valve body such that the tissue-engaging element applies force against tissue of the native valve, such as leaflets and/or annulus. This pulling typically automatically increases the tension on the tether.
(5) While applying the proximal pulling force, intracorporeally and/or extracorporeally measure (a) force of tissue-engaging element against tissue, and (b) tension on the tether (e.g., the change in tension on the tether caused by the proximal pulling.
(6) At least in part based on measurements (a) and (b) of step 5, adjust the length of the tether disposed between the valve body and the tissue anchor, and/or lock the valve body to the tether (i.e., fix the length of the tether disposed between the valve body and the tissue anchor).
It is hypothesized that the above technique provides a prediction of the force distribution between the various anchoring elements that will exist during operation of the prosthetic valve assembly (e.g., during the lifetime thereof). For example, the technique provides a prediction of force distribution between the ventricular anchors and the valve-mounted tissue-engaging elements if/when atrially-directed force increases (e.g., as will be encountered during ventricular systole and/or increases in systemic blood pressure). Based on this indication, the technique facilitates adjustment of this distribution, via adjustment of the length of tethers disposed between the valve body and the tissue anchors.
Reference is made to
Assembly 552 comprises one or more tissue-engaging elements 580 (e.g., legs) that protrude radially outward from valve body 554 so as to define a diameter d15, which is greater than diameter d13. Typically, and as shown in
For some applications, except for (1) the presence of tissue-engaging elements 580 and tethers 582, and (2) the absence of eyelets 222, assembly 552 is identical to (e.g., comprises the same components as, and/or has identical functionality to) assembly 202, described hereinabove. Identically-named components of system 202 and system 552 are typically identical in structure and/or function.
For some applications, assembly 202 comprises tissue-engaging elements 580 and/or tethers 582. For some applications, assembly 552 comprises eyelets 222 and/or locking members 262 for sliding over and locking to guide members.
Both support 560 of assembly 552 and support 210 of assembly 202 may be flat annular (e.g., as shown for support 210) or frustoconical (as shown for support 560).
Subsequently, upstream support 560 is deployed, e.g., by a delivery housing 584 thereof being retracted (state B of
Subsequently, tethers 582 are tensioned so as to draw support 560 and body 554 closer to each other, thereby reducing the total height of assembly 552 to height d18, and reducing the distance between the distal end of frame 562 and the proximal-most part of frame 554 to a distance d19 (state C of
Tensioning of tethers 582 may be accomplished by any suitable technique. For some applications, the tensioning is performed using control rods 86 and locking members 110, e.g., as described with reference to
For some applications, assembly 552 has a compressed state (e.g., for transluminal delivery) in which the assembly defines an articulation zone between frames 556 and 562, e.g., as described hereinabove for assembly 202, mutatis mutandis.
For some application, one or more of the techniques described hereinabove may be used to (1) control applied to tethers 582, and/or (2) facilitate intracorporeal measurement of tension on the tethers (and optionally fluoroscopic detection of that measurement). For example, assembly 552 may comprise a tension spring midway along each tether 582, and/or may comprise a compression spring at the coupling point of support 560 and the tether (e.g., between the support and a locking member 262 configured to lock a respective tether to the support). Alternatively or additionally, for applications in which the tensioning is performed using reference-force tubes and locking members (e.g., as described with reference to
Reference is made to
For some applications, and as shown in
Tubular valve body 604 typically comprises a frame 614, such as a stent-like wire frame. As shown in
Typically, prosthetic valve 603 comprises an expandable prosthetic valve, and is deployed such that it (1) expands within the opening defined by upstream support portion 620 and/or the opening defined by stabilizing member 622, (2) applies a radially-expansive force against the upstream support portion and/or the stabilizing member, and (3) thereby becomes coupled thereto. Typically, and as shown in
For some applications, prosthetic valve 603 may be used in combination with other apparatus and techniques described herein. For example, valve body 604 may be substituted for another valve body described herein, mutatis mutandis, including valve bodies that are described herein as being intracorporeally coupled to an upstream support, and valve bodies that are described herein as being provided pre-coupled to an upstream support (either directly, or via a flexible sheet).
Reference is again made to
As described hereinabove, prosthetic valve 603 typically comprises a covering 616. Covering 616 has (i) a first portion 700 that entirely covers an outer surface of the downstream row 689 of downstream cells, and (ii) a second portion 702 that partially covers an outer surface of the upstream row 687 of downstream cells such that outer surfaces of the peaks 695 of the upstream row 687 of downstream cells are disposed upstream of an upstream end 704 of second portion 702 of covering 616.
For some applications, frame 614 is shaped to define exactly four rows of cells 1R, 2R, 3R, and 4R.
As shown, each cell defines a window 706, and each row of cells defines respective junctions 708 between adjacent cells. Upstream end 704 of second portion 702 of covering 616 spans a respective window 706a of each cell of the upstream row 687 of downstream cells at a longitudinal level 710 of frame 614 that is at junctions 708 between the adjacent cells, such that for each window 706 of each cell of the upstream row 687 of downstream cells:
Typically, covering 616 extends in the upstream direction, from a downstream perimeter 722 of the frame. A third portion 730 of covering 616 lines an inner surface 732 of frame 614 and extends around the downstream end 619 of frame 614 to meet the first portion 700 of covering 616. The upstream row 684 of upstream cells defines respective spaces 734 between respective junctions 708 of the ascending struts 691 and descending struts 693 at peaks 695 of upstream row 684 of upstream cells. An upstream end 736 of third portion 730 of covering 616 spans the respective spaces 734 between the respective junctions 708 of the ascending struts 691 and descending struts 693 at the peaks 695 of the upstream row 684 of upstream cells.
As shown in
Reference is made to
A tissue anchor 48 is advanced through catheter 644 using an anchor manipulator 650, and anchored to tissue at the ventricular site at which distal end 645 is disposed. Typically, little or none of anchor 48 or manipulator 650 becomes exposed from distal end 645 during anchoring.
Length d21 of system 660 is typically shorter than length d20 of system 640, and in contrast to system 640, for system 660, catheter 664 is not configured for distal end 665 to be placed against ventricular tissue. Rather, an anchor manipulator 670 advances tissue anchor 48 through catheter 664, out of the distal end 665, and toward a ventricular site at which it anchors the tissue anchor. Typically, anchor manipulator 670 is slidably coupled to catheter 664 such that a distal end of the anchor manipulator is slidable distally no more than a pre-determined distance d22 from longitudinal site 668 (and thereby no more than a pre-determined distance from distal end 665 of catheter 664). Anchor manipulator 670 is thereby used to anchor anchor 48 at a ventricular site that is disposed at a distance from the atrial surface (e.g., from a portion of the atrial surface that element 666 abuts) that is generally equal to d22. Typically, anchor manipulator 670 (or at least a distal portion 672 thereof that is exposable from distal end 665 of catheter 664) is steerable independently of catheter 664.
It is to be noted that, for systems 640 and 660, the distance from the atrial surface at which anchor 48 is anchored is generally equal, but not necessarily exactly equal, to d20 or d22. For example, anchor 48 may be anchored at a site that is closer to another portion of the atrial surface than to the portion of the atrial surface that the obstructing element abuts. Alternatively or additionally, curvature of the catheter and/or the anchor manipulator may result in a direct distance between the atrial surface and the tissue anchor being smaller than d20 or d22.
Typically, anchor 48 is coupled to a tether, guide member, and/or other longitudinal member (e.g., as described hereinabove with reference to other systems). When the anchor driver is decoupled from the anchor and withdrawn proximally, the tether extends proximally from the anchor (e.g., out of the body of the subject) so that an implant, such as a prosthetic valve, prosthetic valve support, and/or a prosthetic valve assembly (e.g., those described hereinabove) may be advanced therealong and/or locked thereto, e.g., as described hereinabove for other systems, mutatis mutandis. Because the distance between the tissue anchor and the atrial surface is known, for some applications the tether coupled to the tissue anchor may comprise fewer locking sites for locking to the implant, a relatively shorter locking site, and/or only one locking site. It is hypothesized that this may provide the possibility of using simpler, smaller and/or more effective mechanisms to lock the implant to the tether.
Reference is again made to
Although each of the prosthetic valve assemblies is shown implanted in a generally symmetrical state, it is to be noted that for some applications this characteristic of the sheet facilitates asymmetrical implantation. For example, the assembly may better conform to the native anatomy, and/or one tether of assembly 552 may be tensioned more than another so as to alter the anchoring, sealing, and/or flow characteristics of the assembly, e.g., in response to the native anatomy.
For some applications it may be advantageous for the valve body to be disposed at a particular rotational orientation within ventricle 8, and for the upstream support to be disposed at a particular rotational orientation within atrium 6. For example, for prosthetic valve assemblies such as assembly 202 that are tethered to ventricular anchors, it may be advantageous for each eyelet to be aligned with a respective anchor, and for the point at which each guide members passes through the upstream support to be aligned with a respective commissure. Alternatively or additionally, the upstream support may be geometrically asymmetric, and a particular rotational orientation with respect to atrial tissue may be advantageous. (Examples of such upstream supports are described in PCT patent application publication WO/2013/021374 to Gross et. al, which is incorporated herein by reference.) Alternatively or additionally, the upstream support may be asymmetric with respect to rigidity (i.e., some regions of the support may be more rigid than others). Alternatively or additionally, it may be advantageous to place the holes in sheet 214 through which tubes 260 pass in a particular rotational orientation with respect to the native valve.
For some applications, the sheet facilitates implantation of the upstream support in a different rotational position to its valve body, e.g., by twisting. For example, the upstream support may be implanted at more than 5 degrees (e.g., more than 10 degrees, such as more than 20 degrees) rotational offset with respect to the valve body.
Reference is again made to
For applications in which the first frame of the valve body is coupled to the second frame of the upstream support by the sheet, a gap typically exists between the first frame and the second frame. For some such applications, no metallic structure is disposed within the gap.
For some applications (including some applications in which the first and second frames are coupled independently of the sheet), the flexible sheet comprises, in addition to the sheet-like structure, one or more flexible longitudinal members, such as metallic or polymer wires (e.g., embedded within or attached to a surface of the sheet-like structure). These flexible longitudinal members may provide a small amount of rigidity to the sheet without detracting from the general nature of the sheet. For example, the flexible longitudinal members may facilitate opening of the sheet during deployment of the prosthetic valve assembly.
It is to be noted that for applications in which the first and second frames are coupled by the sheet, even when the sheet comprises flexible longitudinal members that are metallic wires, the frame of the valve body and the frame of the upstream support are typically distinct from each other, and can be considered to be coupled to each other by the sheet (e.g., generally only by the sheet).
For some applications, within the total height of the prosthetic valve assembly, a distance exists within which no rigid and/or metallic structure is disposed. For example, for assembly 552, typically no rigid and/or metallic structure is disposed within distance d17 and/or distance d19. It is to be noted that a similar distance exists for assembly 202 between frames 210 and 206 (e.g., when implanted; see
Reference is again made to
It will be understood that, although the terms “first, “second,” etc. may be used in the present application (including the specification and the claims) to describe various elements and/or directions, these terms should not be limiting. These terms are only used to distinguish one element and/or direction from another. Thus, a “first” element described herein could also be termed a “second” element without departing from the teachings of the present disclosure.
As used in the present application, including in the claims, a “central longitudinal axis” of a structure (e.g., an elongate structure) is the set of all centroids of transverse cross-sectional sections of the structure along the structure. Thus the cross-sectional sections are locally perpendicular to the central longitudinal axis, which runs along the structure. (If the structure is circular in cross-section, the centroids correspond with the centers of the circular cross-sectional sections.)
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application is a continuation of U.S. patent application Ser. No. 16/802,353 to Hammer et al., filed Feb. 26, 2020, and entitled “Prosthetic valve and upstream support therefor” (now U.S. Pat. No. 11,135,059), which is a continuation of U.S. patent application Ser. No. 15/872,501 to Hammer et al., filed Jan. 16, 2018, and entitled “Prosthetic valve and upstream support therefor” (now U.S. Pat. No. 10,631,982), which is a continuation of U.S. patent application Ser. No. 14/763,004 to Hammer et al., filed Jul. 23, 2015, and entitled “Ventricularly-anchored prosthetic valves,” which published as US 2015/0351906, which is a national phase of PCT/IL2014/050087 to Hammer et al., filed Jan. 23, 2014, and entitled “Ventricularly-anchored prosthetic valves,” which published as WO 2014/115149, and which claims priority from U.S. provisional patent application 61/756,049 to HaCohen et al., filed Jan. 24, 2013, and entitled “Ventricularly-anchored prosthetic valve support”; and U.S. provisional patent application 61/756,034 to HaCohen et al., filed Jan. 24, 2013, and entitled “Tissue-engaging elements”, and is related to: US patent application publication 2012/0022639 to Hacohen et al., filed Jul. 21, 2010 (now U.S. Pat. No. 9,132,009); US patent application publication 2012/0022640 to Gross et al., filed Feb. 24, 2011 (now U.S. Pat. No. 8,992,604); U.S. patent application Ser. No. 13/811,308 to Gross et al., filed Jan. 21, 2013, which published as US 2013/0172992 (now U.S. Pat. No. 9,017,399); U.S. patent application Ser. No. 13/412,814 to Gross et al., filed Mar. 6, 2012, which published as US 2013/0035759 (now U.S. Pat. No. 8,852,272); PCT patent application IL2012/000292 to Gross et al., filed Aug. 5, 2012, which published as WO/2013/021374; PCT patent application IL2012/000293 to Gross et al., filed Aug. 5, 2012, which published as WO/2013/021375; and U.S. patent application Ser. No. 14/161,921 to HaCohen et al., entitled “Anchoring of prosthetic valve supports”, filed on Jan. 23, 2014 (now U.S. Pat. No. 9,681,952), all of which are incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3604488 | Wishart et al. | Sep 1971 | A |
| 3656185 | Carpentier | Apr 1972 | A |
| 3840018 | Heifetz | Oct 1974 | A |
| 3874388 | King et al. | Apr 1975 | A |
| 3898701 | La Russa | Aug 1975 | A |
| 4042979 | Angell | Aug 1977 | A |
| 4118805 | Reimels | Oct 1978 | A |
| 4214349 | Munch | Jul 1980 | A |
| 4222126 | Boretos et al. | Sep 1980 | A |
| 4261342 | Aranguren | Apr 1981 | A |
| 4275469 | Gabbay | Jun 1981 | A |
| 4340091 | Skelton et al. | Jul 1982 | A |
| 4423525 | Vallana et al. | Jan 1984 | A |
| 4434828 | Trincia | Mar 1984 | A |
| 4473928 | Johnson | Oct 1984 | A |
| 4602911 | Ahmadi et al. | Jul 1986 | A |
| 4625727 | Leiboff | Dec 1986 | A |
| 4712549 | Peters et al. | Dec 1987 | A |
| 4778468 | Hunt et al. | Oct 1988 | A |
| 4853986 | Allen | Aug 1989 | A |
| 4892541 | Alonso | Jan 1990 | A |
| 4917698 | Carpenter et al. | Apr 1990 | A |
| 4961738 | Mackin | Oct 1990 | A |
| 4972494 | White et al. | Nov 1990 | A |
| 4994077 | Dobben | Feb 1991 | A |
| 5061277 | Carpentier et al. | Oct 1991 | A |
| 5078739 | Martin | Jan 1992 | A |
| 5104407 | Lam et al. | Apr 1992 | A |
| 5108420 | Marks | Apr 1992 | A |
| 5201757 | Heyn et al. | Apr 1993 | A |
| 5201880 | Wright | Apr 1993 | A |
| 5258008 | Wilk | Nov 1993 | A |
| 5300034 | Behnke | Apr 1994 | A |
| 5306296 | Wright et al. | Apr 1994 | A |
| 5314473 | Godin | May 1994 | A |
| 5325845 | Adair | Jul 1994 | A |
| 5332402 | Teitelbaum | Jul 1994 | A |
| 5397351 | Pavcnik et al. | Mar 1995 | A |
| 5405378 | Strecker | Apr 1995 | A |
| 5443500 | Sigwart | Aug 1995 | A |
| 5450860 | O'Connor | Sep 1995 | A |
| 5473812 | Morris et al. | Dec 1995 | A |
| 5477856 | Lundquist | Dec 1995 | A |
| 5593424 | Northrup, III | Jan 1997 | A |
| 5601572 | Middleman et al. | Feb 1997 | A |
| 5607444 | Lam | Mar 1997 | A |
| 5607470 | Milo | Mar 1997 | A |
| 5626609 | Zvenyatsky et al. | May 1997 | A |
| 5647857 | Anderson et al. | Jul 1997 | A |
| 5669919 | Sanders et al. | Sep 1997 | A |
| 5674279 | Wright et al. | Oct 1997 | A |
| 5683402 | Cosgrove et al. | Nov 1997 | A |
| 5702397 | Goble et al. | Dec 1997 | A |
| 5702398 | Tarabishy | Dec 1997 | A |
| 5709695 | Northrup, III | Jan 1998 | A |
| 5713948 | Uflacker | Feb 1998 | A |
| 5716370 | Williamson et al. | Feb 1998 | A |
| 5716397 | Myers | Feb 1998 | A |
| 5716417 | Girard et al. | Feb 1998 | A |
| 5728116 | Rosenman | Mar 1998 | A |
| 5730150 | Peppel et al. | Mar 1998 | A |
| 5741297 | Simon | Apr 1998 | A |
| 5749371 | Zadini et al. | May 1998 | A |
| 5765682 | Bley et al. | Jun 1998 | A |
| 5776140 | Cottone | Jul 1998 | A |
| 5810882 | Bolduc | Sep 1998 | A |
| 5824066 | Gross | Oct 1998 | A |
| 5830221 | Stein et al. | Nov 1998 | A |
| 5843120 | Israel et al. | Dec 1998 | A |
| 5855614 | Stevens et al. | Jan 1999 | A |
| 5868777 | Lam | Feb 1999 | A |
| 5873906 | Lau et al. | Feb 1999 | A |
| 5876373 | Giba et al. | Mar 1999 | A |
| 5935098 | Blaisdell et al. | Aug 1999 | A |
| 5954766 | Zadno-Azizi et al. | Sep 1999 | A |
| 5957949 | Leonhardt et al. | Sep 1999 | A |
| 5957953 | DiPoto et al. | Sep 1999 | A |
| 5961440 | Schweich et al. | Oct 1999 | A |
| 5961539 | Northrup, III et al. | Oct 1999 | A |
| 5980565 | Jayaraman | Nov 1999 | A |
| 5984959 | Robertson | Nov 1999 | A |
| 6010530 | Goicoechea | Jan 2000 | A |
| 6019787 | Richard et al. | Feb 2000 | A |
| 6042554 | Rosenman | Mar 2000 | A |
| 6042607 | Williamson, IV | Mar 2000 | A |
| 6045497 | Schweich et al. | Apr 2000 | A |
| 6050936 | Schweich et al. | Apr 2000 | A |
| 6059715 | Schweich et al. | May 2000 | A |
| 6059827 | Fenton | May 2000 | A |
| 6074401 | Gardiner et al. | Jun 2000 | A |
| 6074417 | Peredo | Jun 2000 | A |
| 6102945 | Campbell | Aug 2000 | A |
| 6106550 | Magovern | Aug 2000 | A |
| 6110200 | Hinnenkamp | Aug 2000 | A |
| 6113612 | Swanson et al. | Sep 2000 | A |
| 6120534 | Ruiz | Sep 2000 | A |
| 6126686 | Badylak et al. | Oct 2000 | A |
| 6143024 | Campbell et al. | Nov 2000 | A |
| 6152937 | Peterson et al. | Nov 2000 | A |
| 6159240 | Sparer | Dec 2000 | A |
| 6165119 | Schweich et al. | Dec 2000 | A |
| 6165183 | Kuehn et al. | Dec 2000 | A |
| 6165210 | Lau et al. | Dec 2000 | A |
| 6174332 | Loch | Jan 2001 | B1 |
| 6183411 | Mortier et al. | Feb 2001 | B1 |
| 6187020 | Zegdi et al. | Feb 2001 | B1 |
| 6187040 | Wright | Feb 2001 | B1 |
| 6193686 | Estrada et al. | Feb 2001 | B1 |
| 6193745 | Fogarty et al. | Feb 2001 | B1 |
| 6315784 | Djurovic | Feb 2001 | B1 |
| 6217610 | Carpentier et al. | Apr 2001 | B1 |
| 6231602 | Carpentier et al. | May 2001 | B1 |
| 6251092 | Qin et al. | Jun 2001 | B1 |
| 6254609 | Vrba et al. | Jul 2001 | B1 |
| 6264700 | Kilcoyne et al. | Jul 2001 | B1 |
| 6287339 | Vasquez et al. | Sep 2001 | B1 |
| 6296656 | Bodluc et al. | Oct 2001 | B1 |
| 6312465 | Griffin et al. | Nov 2001 | B1 |
| 6319281 | Patel | Nov 2001 | B1 |
| 6332893 | Mortier et al. | Dec 2001 | B1 |
| 6334873 | Lane et al. | Jan 2002 | B1 |
| 6346074 | Roth | Feb 2002 | B1 |
| 6350278 | Lenker et al. | Feb 2002 | B1 |
| 6352561 | Leopold et al. | Mar 2002 | B1 |
| 6391036 | Berg et al. | May 2002 | B1 |
| 6402780 | Williamson, IV | Jun 2002 | B2 |
| 6406420 | McCarthy et al. | Jun 2002 | B1 |
| 6406493 | Tu et al. | Jun 2002 | B1 |
| 6409755 | Vrba | Jun 2002 | B1 |
| 6419696 | Ortiz et al. | Jul 2002 | B1 |
| 6428550 | Vargas et al. | Aug 2002 | B1 |
| 6440164 | Dimatteo et al. | Aug 2002 | B1 |
| 6451054 | Stevens | Sep 2002 | B1 |
| 6454799 | Schreck | Sep 2002 | B1 |
| 6458153 | Bailey et al. | Oct 2002 | B1 |
| 6461366 | Seguin | Oct 2002 | B1 |
| 6470892 | Forsell | Oct 2002 | B1 |
| 6478807 | Foreman et al. | Nov 2002 | B1 |
| 6482228 | Norred | Nov 2002 | B1 |
| 6491711 | Durcan | Dec 2002 | B1 |
| 6503274 | Howanec et al. | Jan 2003 | B1 |
| 6511491 | Grudem et al. | Jan 2003 | B2 |
| 6524338 | Gundry | Feb 2003 | B1 |
| 6530952 | Vesely | Mar 2003 | B2 |
| 6533772 | Sherts et al. | Mar 2003 | B1 |
| 6537314 | Langberg et al. | Mar 2003 | B2 |
| 6540782 | Snyders | Apr 2003 | B1 |
| 6547801 | Dargent et al. | Apr 2003 | B1 |
| 6551350 | Thornton et al. | Apr 2003 | B1 |
| 6554845 | Fleenor et al. | Apr 2003 | B1 |
| 6558396 | Inoue | May 2003 | B1 |
| 6558418 | Carpentier et al. | May 2003 | B2 |
| 6564805 | Garrison et al. | May 2003 | B2 |
| 6565603 | Cox | May 2003 | B2 |
| 6569196 | Vesely | May 2003 | B1 |
| 6569198 | Wilson et al. | May 2003 | B1 |
| 6579297 | Bicek et al. | Jun 2003 | B2 |
| 6582464 | Gabbay | Jun 2003 | B2 |
| 6589160 | Schweich et al. | Jul 2003 | B2 |
| 6602263 | Swanson et al. | Aug 2003 | B1 |
| 6602288 | Cosgrove et al. | Aug 2003 | B1 |
| 6602289 | Colvin et al. | Aug 2003 | B1 |
| 6613078 | Barone | Sep 2003 | B1 |
| 6613079 | Wolinsky et al. | Sep 2003 | B1 |
| 6616675 | Evard et al. | Sep 2003 | B1 |
| 6619291 | Hlavka et al. | Sep 2003 | B2 |
| 6626899 | Houser et al. | Sep 2003 | B2 |
| 6626917 | Craig | Sep 2003 | B1 |
| 6626930 | Allen et al. | Sep 2003 | B1 |
| 6629534 | St. Goar et al. | Oct 2003 | B1 |
| 6629921 | Schweich et al. | Oct 2003 | B1 |
| 6651671 | Donlon et al. | Nov 2003 | B1 |
| 6652556 | VanTassel et al. | Nov 2003 | B1 |
| 6669724 | Park et al. | Dec 2003 | B2 |
| 6682558 | Tu et al. | Jan 2004 | B2 |
| 6689125 | Keith et al. | Feb 2004 | B1 |
| 6689164 | Seguin | Feb 2004 | B1 |
| 6695866 | Kuehn et al. | Feb 2004 | B1 |
| 6699256 | Logan et al. | Mar 2004 | B1 |
| 6702826 | Liddicoat et al. | Mar 2004 | B2 |
| 6702846 | Mikus et al. | Mar 2004 | B2 |
| 6706065 | Langberg et al. | Mar 2004 | B2 |
| 6709456 | Langberg et al. | Mar 2004 | B2 |
| 6711444 | Koblish | Mar 2004 | B2 |
| 6716244 | Klaco | Apr 2004 | B2 |
| 6718985 | Hlavka et al. | Apr 2004 | B2 |
| 6719781 | Kim | Apr 2004 | B1 |
| 6719786 | Ryan et al. | Apr 2004 | B2 |
| 6719788 | Cox | Apr 2004 | B2 |
| 6723038 | Schroeder et al. | Apr 2004 | B1 |
| 6726716 | Marquez | Apr 2004 | B2 |
| 6726717 | Alfieri et al. | Apr 2004 | B2 |
| 6730118 | Spenser et al. | May 2004 | B2 |
| 6730121 | Ortiz et al. | May 2004 | B2 |
| 6733525 | Yang et al. | May 2004 | B2 |
| 6749630 | McCarthy et al. | Jun 2004 | B2 |
| 6752813 | Goldfarb et al. | Jun 2004 | B2 |
| 6764310 | Ichihashi et al. | Jul 2004 | B1 |
| 6764510 | Vidlund et al. | Jul 2004 | B2 |
| 6764514 | Li et al. | Jul 2004 | B1 |
| 6764518 | Godin | Jul 2004 | B2 |
| 6767362 | Schreck | Jul 2004 | B2 |
| 6770083 | Seguin | Aug 2004 | B2 |
| 6786924 | Ryan et al. | Sep 2004 | B2 |
| 6786925 | Schoon et al. | Sep 2004 | B1 |
| 6790231 | Liddicoat et al. | Sep 2004 | B2 |
| 6797001 | Mathis et al. | Sep 2004 | B2 |
| 6797002 | Spence et al. | Sep 2004 | B2 |
| 6802319 | Stevens et al. | Oct 2004 | B2 |
| 6805710 | Bolling et al. | Oct 2004 | B2 |
| 6805711 | Quijano et al. | Oct 2004 | B2 |
| 6821297 | Snyders | Nov 2004 | B2 |
| 6830585 | Artof et al. | Dec 2004 | B1 |
| 6830638 | Boylan et al. | Dec 2004 | B2 |
| 6855126 | Flinchbaugh | Feb 2005 | B2 |
| 6858039 | McCarthy | Feb 2005 | B2 |
| 6884250 | Monassevitch et al. | Apr 2005 | B2 |
| 6884257 | Cox | Apr 2005 | B1 |
| 6893459 | Macoviak | May 2005 | B1 |
| 6893460 | Spenser et al. | May 2005 | B2 |
| 6908482 | McCarthy et al. | Jun 2005 | B2 |
| 6918917 | Nguyen et al. | Jul 2005 | B1 |
| 6926715 | Hauck et al. | Aug 2005 | B1 |
| 6926730 | Nguyen et al. | Aug 2005 | B1 |
| 6951571 | Srivastava | Oct 2005 | B1 |
| 6960217 | Bolduc | Nov 2005 | B2 |
| 6964684 | Ortiz et al. | Nov 2005 | B2 |
| 6964686 | Gordon | Nov 2005 | B2 |
| 6974476 | McGuckin et al. | Dec 2005 | B2 |
| 6976995 | Mathis et al. | Dec 2005 | B2 |
| 6986775 | Morales et al. | Jan 2006 | B2 |
| 6989028 | Lashinski et al. | Jan 2006 | B2 |
| 6997951 | Solem et al. | Feb 2006 | B2 |
| 7004176 | Lau | Feb 2006 | B2 |
| 7011669 | Kimblad | Mar 2006 | B2 |
| 7011681 | Vesely | Mar 2006 | B2 |
| 7011682 | Lashinski et al. | Mar 2006 | B2 |
| 7018406 | Seguin et al. | Mar 2006 | B2 |
| 7037334 | Hlavka et al. | May 2006 | B1 |
| 7041132 | Quijano et al. | May 2006 | B2 |
| 7074236 | Rabkin et al. | Jul 2006 | B2 |
| 7077850 | Kortenbach | Jul 2006 | B2 |
| 7077861 | Spence | Jul 2006 | B2 |
| 7077862 | Vidlund et al. | Jul 2006 | B2 |
| 7087064 | Hyde | Aug 2006 | B1 |
| 7101336 | Miller | Sep 2006 | B2 |
| 7101395 | Tremulis et al. | Sep 2006 | B2 |
| 7101396 | Artof et al. | Sep 2006 | B2 |
| 7112207 | Allen et al. | Sep 2006 | B2 |
| 7118595 | Ryan et al. | Oct 2006 | B2 |
| 7125421 | Tremulis et al. | Oct 2006 | B2 |
| 7137184 | Schreck | Nov 2006 | B2 |
| 7150737 | Purdy et al. | Dec 2006 | B2 |
| 7159593 | McCarthy et al. | Jan 2007 | B2 |
| 7166127 | Spence et al. | Jan 2007 | B2 |
| 7169187 | Datta et al. | Jan 2007 | B2 |
| 7172625 | Shu et al. | Feb 2007 | B2 |
| 7175656 | Khairkhahan | Feb 2007 | B2 |
| 7175660 | Cartledge et al. | Feb 2007 | B2 |
| 7186262 | Saadat | Mar 2007 | B2 |
| 7186264 | Liddicoat et al. | Mar 2007 | B2 |
| 7189199 | McCarthy et al. | Mar 2007 | B2 |
| 7192443 | Solem et al. | Mar 2007 | B2 |
| 7198646 | Figulla et al. | Apr 2007 | B2 |
| 7201772 | Schwammenthal | Apr 2007 | B2 |
| 7220277 | Arru et al. | May 2007 | B2 |
| 7226467 | Lucatero et al. | Jun 2007 | B2 |
| 7226477 | Cox | Jun 2007 | B2 |
| 7226647 | Kasperchik et al. | Jun 2007 | B2 |
| 7229452 | Kayan | Jun 2007 | B2 |
| 7238191 | Bachmann | Jul 2007 | B2 |
| 7261686 | Couvillon, Jr. | Aug 2007 | B2 |
| 7288097 | Seguin | Oct 2007 | B2 |
| 7288111 | Holloway et al. | Oct 2007 | B1 |
| 7294148 | McCarthy | Nov 2007 | B2 |
| 7297150 | Cartledge et al. | Nov 2007 | B2 |
| 7311728 | Solem et al. | Dec 2007 | B2 |
| 7311729 | Mathis et al. | Dec 2007 | B2 |
| 7314485 | Mathis | Jan 2008 | B2 |
| 7316710 | Cheng et al. | Jan 2008 | B1 |
| 7316716 | Egan | Jan 2008 | B2 |
| 7329279 | Haug et al. | Feb 2008 | B2 |
| 7329280 | Bolling et al. | Feb 2008 | B2 |
| 7335213 | Hyde et al. | Feb 2008 | B1 |
| 7351256 | Hojeibane et al. | Apr 2008 | B2 |
| 7361190 | Shoulian et al. | Apr 2008 | B2 |
| 7364588 | Mathis et al. | Apr 2008 | B2 |
| 7374571 | Pease et al. | May 2008 | B2 |
| 7374573 | Gabbay | May 2008 | B2 |
| 7377938 | Sarac et al. | May 2008 | B2 |
| 7377941 | Rhee et al. | May 2008 | B2 |
| 7381218 | Schreck | Jun 2008 | B2 |
| 7381219 | Salahieh et al. | Jun 2008 | B2 |
| 7390329 | Westra et al. | Jun 2008 | B2 |
| 7404824 | Webler et al. | Jul 2008 | B1 |
| 7422603 | Lane | Sep 2008 | B2 |
| 7429269 | Schwammenthal | Sep 2008 | B2 |
| 7431692 | Zollinger et al. | Oct 2008 | B2 |
| 7442204 | Schwammenthal | Oct 2008 | B2 |
| 7442207 | Rafiee | Oct 2008 | B2 |
| 7445630 | Lashinski et al. | Nov 2008 | B2 |
| 7452376 | Lim et al. | Nov 2008 | B2 |
| 7455677 | Vargas et al. | Nov 2008 | B2 |
| 7455688 | Furst et al. | Nov 2008 | B2 |
| 7455690 | Cartledge et al. | Nov 2008 | B2 |
| 7462162 | Phan et al. | Dec 2008 | B2 |
| 7481838 | Carpentier et al. | Jan 2009 | B2 |
| 7485142 | Milo | Feb 2009 | B2 |
| 7500989 | Solem et al. | Mar 2009 | B2 |
| 7507252 | Lashinski et al. | Mar 2009 | B2 |
| 7510575 | Spenser et al. | Mar 2009 | B2 |
| 7510577 | Moaddeb et al. | Mar 2009 | B2 |
| 7513909 | Lane et al. | Apr 2009 | B2 |
| 7524331 | Birdsall | Apr 2009 | B2 |
| 7527646 | Rahdert et al. | May 2009 | B2 |
| 7527647 | Spence | May 2009 | B2 |
| 7530995 | Quijano et al. | May 2009 | B2 |
| 7549983 | Roue et al. | Jun 2009 | B2 |
| 7556632 | Zadno | Jul 2009 | B2 |
| 7556646 | Yang et al. | Jul 2009 | B2 |
| 7559936 | Levine | Jul 2009 | B2 |
| 7562660 | Saadat | Jul 2009 | B2 |
| 7563267 | Goldfarb et al. | Jul 2009 | B2 |
| 7563273 | Goldfarb et al. | Jul 2009 | B2 |
| 7569062 | Kuehn et al. | Aug 2009 | B1 |
| 7582111 | Krolik et al. | Sep 2009 | B2 |
| 7585321 | Cribier | Sep 2009 | B2 |
| 7588582 | Starksen et al. | Sep 2009 | B2 |
| 7591826 | Alferness et al. | Sep 2009 | B2 |
| 7597711 | Drews et al. | Oct 2009 | B2 |
| 7604646 | Goldfarb et al. | Oct 2009 | B2 |
| 7608091 | Goldfarb et al. | Oct 2009 | B2 |
| 7608103 | McCarthy | Oct 2009 | B2 |
| 7611534 | Kapadia et al. | Nov 2009 | B2 |
| 7618449 | Tremulis et al. | Nov 2009 | B2 |
| 7621948 | Hermann et al. | Nov 2009 | B2 |
| 7625403 | Krivoruchko | Dec 2009 | B2 |
| 7632302 | Vreeman et al. | Dec 2009 | B2 |
| 7632303 | Stalker et al. | Dec 2009 | B1 |
| 7635329 | Goldfarb et al. | Dec 2009 | B2 |
| 7635386 | Gammie | Dec 2009 | B1 |
| 7648528 | Styrc | Jan 2010 | B2 |
| 7655015 | Goldfarb et al. | Feb 2010 | B2 |
| 7666204 | Thornton et al. | Feb 2010 | B2 |
| 7682319 | Martin | Mar 2010 | B2 |
| 7682369 | Seguin | Mar 2010 | B2 |
| 7682380 | Thornton et al. | Mar 2010 | B2 |
| 7686822 | Shayani | Mar 2010 | B2 |
| 7699892 | Rafiee et al. | Apr 2010 | B2 |
| 7704269 | St. Goar et al. | Apr 2010 | B2 |
| 7704277 | Zakay et al. | Apr 2010 | B2 |
| 7708775 | Rowe et al. | May 2010 | B2 |
| 7717952 | Case et al. | May 2010 | B2 |
| 7717955 | Lane et al. | May 2010 | B2 |
| 7722666 | Lafontaine | May 2010 | B2 |
| 7731741 | Eidenschink | Jun 2010 | B2 |
| 7731742 | Schlick et al. | Jun 2010 | B2 |
| 7736388 | Goldfarb et al. | Jun 2010 | B2 |
| 7748389 | Salahieh et al. | Jul 2010 | B2 |
| 7753922 | Starksen | Jul 2010 | B2 |
| 7753924 | Starksen et al. | Jul 2010 | B2 |
| 7753949 | Lamphere et al. | Jul 2010 | B2 |
| 7758595 | Allen et al. | Jul 2010 | B2 |
| 7758632 | Hojeibane et al. | Jul 2010 | B2 |
| 7758640 | Vesely | Jul 2010 | B2 |
| 7771467 | Svensson | Aug 2010 | B2 |
| 7771469 | Liddicoat | Aug 2010 | B2 |
| 7776080 | Bei et al. | Aug 2010 | B2 |
| 7776083 | Vesely | Aug 2010 | B2 |
| 7780726 | Seguin | Aug 2010 | B2 |
| 7785341 | Forster et al. | Aug 2010 | B2 |
| 7799069 | Bailey et al. | Sep 2010 | B2 |
| 7803181 | Furst et al. | Sep 2010 | B2 |
| 7811296 | Goldfarb et al. | Oct 2010 | B2 |
| 7811316 | Kalmann et al. | Oct 2010 | B2 |
| 7824442 | Salahieh et al. | Nov 2010 | B2 |
| 7837645 | Bessler et al. | Nov 2010 | B2 |
| 7837727 | Goetz et al. | Nov 2010 | B2 |
| 7842081 | Yadin | Nov 2010 | B2 |
| 7850725 | Vardi et al. | Dec 2010 | B2 |
| 7871368 | Zollinger et al. | Jan 2011 | B2 |
| 7871432 | Bergin | Jan 2011 | B2 |
| 7871433 | Lattouf | Jan 2011 | B2 |
| 7871436 | Ryan et al. | Jan 2011 | B2 |
| 7887583 | Macoviak | Feb 2011 | B2 |
| 7892281 | Seguin et al. | Feb 2011 | B2 |
| 7896915 | Guyenot et al. | Mar 2011 | B2 |
| 7914544 | Nguyen et al. | Mar 2011 | B2 |
| 7914569 | Nguyen et al. | Mar 2011 | B2 |
| 7927370 | Webler et al. | Apr 2011 | B2 |
| 7927371 | Navia et al. | Apr 2011 | B2 |
| 7942927 | Kaye et al. | May 2011 | B2 |
| 7947072 | Yang et al. | May 2011 | B2 |
| 7947075 | Goetz et al. | May 2011 | B2 |
| 7951195 | Antonsson et al. | May 2011 | B2 |
| 7955375 | Agnew | Jun 2011 | B2 |
| 7955377 | Melsheimer | Jun 2011 | B2 |
| 7955384 | Rafiee et al. | Jun 2011 | B2 |
| 7959666 | Salahieh et al. | Jun 2011 | B2 |
| 7959672 | Salahieh et al. | Jun 2011 | B2 |
| 7967833 | Sterman et al. | Jun 2011 | B2 |
| 7967857 | Lane | Jun 2011 | B2 |
| 7981151 | Rowe | Jul 2011 | B2 |
| 7981153 | Fogarty et al. | Jul 2011 | B2 |
| 7988725 | Gross et al. | Aug 2011 | B2 |
| 7992567 | Hirotsuka et al. | Aug 2011 | B2 |
| 7993368 | Gambale et al. | Aug 2011 | B2 |
| 7993393 | Carpentier et al. | Aug 2011 | B2 |
| 7993397 | Lashinski | Aug 2011 | B2 |
| 8002825 | Letac et al. | Aug 2011 | B2 |
| 8002826 | Seguin | Aug 2011 | B2 |
| 8012201 | Lashinski et al. | Sep 2011 | B2 |
| 8016877 | Seguin et al. | Sep 2011 | B2 |
| 8016882 | Macoviak | Sep 2011 | B2 |
| 8021420 | Dolan | Sep 2011 | B2 |
| 8021421 | Fogarty et al. | Sep 2011 | B2 |
| 8025695 | Fogarty et al. | Sep 2011 | B2 |
| 8029518 | Goldfarb et al. | Oct 2011 | B2 |
| 8029557 | Sobrino-Serrano et al. | Oct 2011 | B2 |
| 8029564 | Johnson et al. | Oct 2011 | B2 |
| 8034103 | Burriesci | Oct 2011 | B2 |
| 8034104 | Carpentier et al. | Oct 2011 | B2 |
| 8038720 | Wallace et al. | Oct 2011 | B2 |
| 8043360 | McNamara et al. | Oct 2011 | B2 |
| 8048138 | Sulivan et al. | Nov 2011 | B2 |
| 8048140 | Purdy | Nov 2011 | B2 |
| 8048153 | Salahieh et al. | Nov 2011 | B2 |
| 8052592 | Goldfarb et al. | Nov 2011 | B2 |
| 8052741 | Bruszewski et al. | Nov 2011 | B2 |
| 8052749 | Salahieh et al. | Nov 2011 | B2 |
| 8057493 | Goldfarb et al. | Nov 2011 | B2 |
| 8057532 | Hoffman | Nov 2011 | B2 |
| 8057540 | Letac et al. | Nov 2011 | B2 |
| 8062355 | Figulla et al. | Nov 2011 | B2 |
| 8062359 | Marquez et al. | Nov 2011 | B2 |
| 8070708 | Rottenberg et al. | Dec 2011 | B2 |
| 8070800 | Lock et al. | Dec 2011 | B2 |
| 8070802 | Lamphere et al. | Dec 2011 | B2 |
| 8070804 | Hyde | Dec 2011 | B2 |
| 8070805 | Vidlund | Dec 2011 | B2 |
| 8075611 | Milwee et al. | Dec 2011 | B2 |
| 8075616 | Solem | Dec 2011 | B2 |
| 8080054 | Rowe | Dec 2011 | B2 |
| 8083793 | Lane et al. | Dec 2011 | B2 |
| D652927 | Braido et al. | Jan 2012 | S |
| D653341 | Braido et al. | Jan 2012 | S |
| 8092518 | Schreck | Jan 2012 | B2 |
| 8092520 | Quadri | Jan 2012 | B2 |
| 8092521 | Figulla et al. | Jan 2012 | B2 |
| 8100964 | Spence | Jan 2012 | B2 |
| 8105377 | Liddicoat | Jan 2012 | B2 |
| 8109996 | Stacchino et al. | Feb 2012 | B2 |
| 8118866 | Herrmann et al. | Feb 2012 | B2 |
| 8123800 | McCarthy | Feb 2012 | B2 |
| 8123801 | Milo | Feb 2012 | B2 |
| 8323334 | Deem et al. | Feb 2012 | B2 |
| 8133270 | Kheradvar et al. | Mar 2012 | B2 |
| 8136218 | Millwee et al. | Mar 2012 | B2 |
| 8137398 | Tuval et al. | Mar 2012 | B2 |
| 8142492 | Forster et al. | Mar 2012 | B2 |
| 8142493 | Spence et al. | Mar 2012 | B2 |
| 8142494 | Rahdert et al. | Mar 2012 | B2 |
| 8142495 | Hasenkam et al. | Mar 2012 | B2 |
| 8142496 | Berreklouw | Mar 2012 | B2 |
| 8142497 | Friedman | Mar 2012 | B2 |
| 8147504 | Ino et al. | Apr 2012 | B2 |
| 8147542 | Maisano et al. | Apr 2012 | B2 |
| 8152844 | Rao | Apr 2012 | B2 |
| 8157852 | Bloom et al. | Apr 2012 | B2 |
| 8157853 | Laske et al. | Apr 2012 | B2 |
| 8157860 | McNamara et al. | Apr 2012 | B2 |
| 8163008 | Wilson et al. | Apr 2012 | B2 |
| 8163013 | Machold et al. | Apr 2012 | B2 |
| 8163014 | Lane et al. | Apr 2012 | B2 |
| D660433 | Braido et al. | May 2012 | S |
| D660967 | Braido et al. | May 2012 | S |
| 8167894 | Miles et al. | May 2012 | B2 |
| 8167932 | Bourang et al. | May 2012 | B2 |
| 8167935 | McGuckin, Jr. et al. | May 2012 | B2 |
| 8172896 | McNamara et al. | May 2012 | B2 |
| 8172898 | Alferness et al. | May 2012 | B2 |
| 8177836 | Lee et al. | May 2012 | B2 |
| 8182528 | Salahieh et al. | May 2012 | B2 |
| 8187299 | Goldfarb et al. | May 2012 | B2 |
| 8187324 | Webler et al. | May 2012 | B2 |
| 8202315 | Hlavka et al. | Jun 2012 | B2 |
| 8206439 | Gomez-Duran | Jun 2012 | B2 |
| 8211169 | Lane et al. | Jul 2012 | B2 |
| 8216256 | Raschdorf, Jr. et al. | Jul 2012 | B2 |
| 8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
| 8221492 | Case et al. | Jul 2012 | B2 |
| 8221493 | Boyle et al. | Jul 2012 | B2 |
| 8226710 | Nguyen et al. | Jul 2012 | B2 |
| 8226711 | Mortier et al. | Jul 2012 | B2 |
| 8231670 | Salahieh et al. | Jul 2012 | B2 |
| 8231671 | Kim | Jul 2012 | B2 |
| 8236045 | Benichou et al. | Aug 2012 | B2 |
| 8236049 | Rowe et al. | Aug 2012 | B2 |
| 8241351 | Cabiri | Aug 2012 | B2 |
| 8252042 | McNamara et al. | Aug 2012 | B2 |
| 8252050 | Maisano et al. | Aug 2012 | B2 |
| 8252051 | Chau et al. | Aug 2012 | B2 |
| 8252052 | Salahieh et al. | Aug 2012 | B2 |
| 8257390 | Carley et al. | Sep 2012 | B2 |
| 8262725 | Subramanian | Sep 2012 | B2 |
| 8267988 | Hamer et al. | Sep 2012 | B2 |
| 8277501 | Chalekian et al. | Oct 2012 | B2 |
| 8277502 | Miller et al. | Oct 2012 | B2 |
| 8287584 | Salahieh et al. | Oct 2012 | B2 |
| 8287591 | Keidar et al. | Oct 2012 | B2 |
| 8298280 | Yadin et al. | Oct 2012 | B2 |
| 8303608 | Goldfarb et al. | Nov 2012 | B2 |
| 8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
| 8308798 | Pintor et al. | Nov 2012 | B2 |
| 8317853 | Agnew | Nov 2012 | B2 |
| 8317855 | Gregorich et al. | Nov 2012 | B2 |
| 8323335 | Rowe et al. | Dec 2012 | B2 |
| 8328868 | Paul et al. | Dec 2012 | B2 |
| 8333777 | Schaller et al. | Dec 2012 | B2 |
| 8337541 | Quadri et al. | Dec 2012 | B2 |
| 8343173 | Starksen et al. | Jan 2013 | B2 |
| 8343174 | Goldfarb et al. | Jan 2013 | B2 |
| 8343213 | Salahieh et al. | Jan 2013 | B2 |
| 8348999 | Kheradvar et al. | Jan 2013 | B2 |
| 8349002 | Milo | Jan 2013 | B2 |
| 8353956 | Miller et al. | Jan 2013 | B2 |
| 8357195 | Kuehn | Jan 2013 | B2 |
| 8361144 | Fish et al. | Jan 2013 | B2 |
| 8366767 | Zhang | Feb 2013 | B2 |
| 8372140 | Hoffman et al. | Feb 2013 | B2 |
| 8377119 | Drews et al. | Feb 2013 | B2 |
| 8382829 | Call et al. | Feb 2013 | B1 |
| 8388680 | Starksen et al. | Mar 2013 | B2 |
| 8393517 | Milo | Mar 2013 | B2 |
| 8398708 | Meiri et al. | Mar 2013 | B2 |
| 8403981 | Forster et al. | Mar 2013 | B2 |
| 8403983 | Quadri et al. | Mar 2013 | B2 |
| 8408214 | Spenser | Apr 2013 | B2 |
| 8414644 | Quadri et al. | Apr 2013 | B2 |
| 8425593 | Braido et al. | Apr 2013 | B2 |
| 8430926 | Kirson | Apr 2013 | B2 |
| 8430934 | Das | Apr 2013 | B2 |
| 8444689 | Zhang | May 2013 | B2 |
| 8449599 | Chau et al. | May 2013 | B2 |
| 8449625 | Campbell et al. | May 2013 | B2 |
| 8454686 | Alkhatib | Jun 2013 | B2 |
| 8460365 | Haverkost et al. | Jun 2013 | B2 |
| 8460370 | Zakay et al. | Jun 2013 | B2 |
| 8460371 | Hlavka et al. | Jun 2013 | B2 |
| 8474460 | Barrett et al. | Jul 2013 | B2 |
| 8475491 | Milo | Jul 2013 | B2 |
| 8480732 | Subramanian | Jul 2013 | B2 |
| 8500800 | Maisano et al. | Aug 2013 | B2 |
| 8500821 | Sobrino-Serrano et al. | Aug 2013 | B2 |
| 8512400 | Tran et al. | Aug 2013 | B2 |
| 8518107 | Tsukashima et al. | Aug 2013 | B2 |
| 8523881 | Cabiri et al. | Sep 2013 | B2 |
| 8523940 | Richardson et al. | Sep 2013 | B2 |
| 8529431 | Baker et al. | Sep 2013 | B2 |
| 8539662 | Stacchino et al. | Sep 2013 | B2 |
| 8540767 | Zhang | Sep 2013 | B2 |
| 8545544 | Spenser et al. | Oct 2013 | B2 |
| 8545553 | Zipory et al. | Oct 2013 | B2 |
| 8551160 | Figulla et al. | Oct 2013 | B2 |
| 8551161 | Dolan | Oct 2013 | B2 |
| 8562672 | Bonhoeffer et al. | Oct 2013 | B2 |
| 8568475 | Nguyen et al. | Oct 2013 | B2 |
| 8579964 | Lane et al. | Nov 2013 | B2 |
| 8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
| 8585755 | Chau et al. | Nov 2013 | B2 |
| 8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
| 8591460 | Wilson et al. | Nov 2013 | B2 |
| 8591570 | Revuelta et al. | Nov 2013 | B2 |
| 8591576 | Hasenkam et al. | Nov 2013 | B2 |
| 8608797 | Gross et al. | Dec 2013 | B2 |
| 8623075 | Murray et al. | Jan 2014 | B2 |
| 8623080 | Fogarty et al. | Jan 2014 | B2 |
| 8628569 | Benichou et al. | Jan 2014 | B2 |
| 8628570 | Seguin | Jan 2014 | B2 |
| 8628571 | Hacohen et al. | Jan 2014 | B1 |
| 8641727 | Starksen et al. | Feb 2014 | B2 |
| 8652202 | Alon et al. | Feb 2014 | B2 |
| 8652203 | Quadri et al. | Feb 2014 | B2 |
| 8652204 | Quill et al. | Feb 2014 | B2 |
| 8657872 | Seguin | Feb 2014 | B2 |
| 8663322 | Keranen | Mar 2014 | B2 |
| 8673020 | Sobrino-Serrano et al. | Mar 2014 | B2 |
| 8679174 | Ottma et al. | Mar 2014 | B2 |
| 8685086 | Navia et al. | Apr 2014 | B2 |
| 8690939 | Miller et al. | Apr 2014 | B2 |
| 8696742 | Pintor et al. | Apr 2014 | B2 |
| 8715342 | Zipory et al. | May 2014 | B2 |
| 8728097 | Sugimoto et al. | May 2014 | B1 |
| 8728155 | Montorfano et al. | May 2014 | B2 |
| 8734467 | Miller et al. | May 2014 | B2 |
| 8734507 | Keranen | May 2014 | B2 |
| 8740920 | Goldfarb et al. | Jun 2014 | B2 |
| 8747460 | Tuval et al. | Jun 2014 | B2 |
| 8771345 | Tuval et al. | Jul 2014 | B2 |
| 8778021 | Cartledge | Jul 2014 | B2 |
| 8784472 | Eidenschink | Jul 2014 | B2 |
| 8784479 | Antonsson et al. | Jul 2014 | B2 |
| 8784481 | Alkhatib et al. | Jul 2014 | B2 |
| 8790367 | Nguyen et al. | Jul 2014 | B2 |
| 8790394 | Miller et al. | Jul 2014 | B2 |
| 8795298 | Hernlund et al. | Aug 2014 | B2 |
| 8795355 | Alkhatib | Aug 2014 | B2 |
| 8795356 | Quadri et al. | Aug 2014 | B2 |
| 8795357 | Yohanan et al. | Aug 2014 | B2 |
| 8801776 | House et al. | Aug 2014 | B2 |
| 8808366 | Braido et al. | Aug 2014 | B2 |
| 8808368 | Maisano et al. | Aug 2014 | B2 |
| 8808371 | Cartledge | Aug 2014 | B2 |
| 8840663 | Salahieh et al. | Sep 2014 | B2 |
| 8840664 | Karapetian et al. | Sep 2014 | B2 |
| 8845717 | Khairkhahan et al. | Sep 2014 | B2 |
| 8845722 | Gabbay | Sep 2014 | B2 |
| 8845723 | Spence et al. | Sep 2014 | B2 |
| 8852261 | White | Oct 2014 | B2 |
| 8852272 | Gross et al. | Oct 2014 | B2 |
| 8858623 | Miller et al. | Oct 2014 | B2 |
| 8864822 | Spence et al. | Oct 2014 | B2 |
| 8870948 | Erzberger et al. | Oct 2014 | B1 |
| 8870949 | Rowe | Oct 2014 | B2 |
| 8870950 | Hacohen | Oct 2014 | B2 |
| 8876800 | Behan | Nov 2014 | B2 |
| 8888843 | Khairkhahan et al. | Nov 2014 | B2 |
| 8894702 | Quadri et al. | Nov 2014 | B2 |
| 8900294 | Paniagua et al. | Dec 2014 | B2 |
| 8900295 | Migliazza et al. | Dec 2014 | B2 |
| 8906083 | Obermiller et al. | Dec 2014 | B2 |
| 8911455 | Quadri et al. | Dec 2014 | B2 |
| 8911461 | Traynor et al. | Dec 2014 | B2 |
| 8911489 | Ben-Muvhar | Dec 2014 | B2 |
| 8911493 | Rowe et al. | Dec 2014 | B2 |
| 8911494 | Hammer et al. | Dec 2014 | B2 |
| 8926695 | Gross et al. | Jan 2015 | B2 |
| 8926696 | Cabiri et al. | Jan 2015 | B2 |
| 8926697 | Gross et al. | Jan 2015 | B2 |
| 8932343 | Alkhatib et al. | Jan 2015 | B2 |
| 8932348 | Solem et al. | Jan 2015 | B2 |
| 8940042 | Miller et al. | Jan 2015 | B2 |
| 8940044 | Hammer et al. | Jan 2015 | B2 |
| 8945177 | Dell et al. | Feb 2015 | B2 |
| 8945211 | Sugimoto | Feb 2015 | B2 |
| 8951285 | Sugimoto et al. | Feb 2015 | B2 |
| 8951286 | Sugimoto et al. | Feb 2015 | B2 |
| 8961595 | Alkhatib | Feb 2015 | B2 |
| 8979922 | Jayasinghe et al. | Mar 2015 | B2 |
| 8986370 | Annest | Mar 2015 | B2 |
| 8986373 | Chau et al. | Mar 2015 | B2 |
| 8986375 | Garde et al. | Mar 2015 | B2 |
| 8992599 | Thubrikar et al. | Mar 2015 | B2 |
| 8992604 | Gross et al. | Mar 2015 | B2 |
| 8992608 | Haug et al. | Mar 2015 | B2 |
| 8998982 | Richter et al. | Apr 2015 | B2 |
| 9005273 | Salahieh et al. | Apr 2015 | B2 |
| 9011468 | Ketai et al. | Apr 2015 | B2 |
| 9011520 | Miller et al. | Apr 2015 | B2 |
| 9011527 | Li et al. | Apr 2015 | B2 |
| 9011530 | Reich et al. | Apr 2015 | B2 |
| 9017399 | Gross et al. | Apr 2015 | B2 |
| D730520 | Braido et al. | May 2015 | S |
| D730521 | Braido et al. | May 2015 | S |
| 9023100 | Quadri et al. | May 2015 | B2 |
| 9034032 | McLean et al. | May 2015 | B2 |
| 9034033 | McLean et al. | May 2015 | B2 |
| 9039757 | McLean et al. | May 2015 | B2 |
| D732666 | Nguyen et al. | Jun 2015 | S |
| 9050188 | Schweich et al. | Jun 2015 | B2 |
| 9060858 | Thornton et al. | Jun 2015 | B2 |
| 9072603 | Tuval et al. | Jul 2015 | B2 |
| 9084676 | Chau et al. | Jul 2015 | B2 |
| 9095434 | Rowe | Aug 2015 | B2 |
| 9119719 | Zipory et al. | Sep 2015 | B2 |
| 9125632 | Loulmet et al. | Sep 2015 | B2 |
| 9125738 | Figulla et al. | Sep 2015 | B2 |
| 9125740 | Morriss et al. | Sep 2015 | B2 |
| 9132006 | Spenser et al. | Sep 2015 | B2 |
| 9132009 | Hacohen et al. | Sep 2015 | B2 |
| 9138312 | Tuval et al. | Sep 2015 | B2 |
| 9155619 | Liu et al. | Oct 2015 | B2 |
| 9173646 | Fabro | Nov 2015 | B2 |
| 9173659 | Bodewadt et al. | Nov 2015 | B2 |
| 9173738 | Murray et al. | Nov 2015 | B2 |
| 9180005 | Lashinski et al. | Nov 2015 | B1 |
| 9192472 | Gross et al. | Nov 2015 | B2 |
| 9220594 | Braido et al. | Dec 2015 | B2 |
| 9226820 | Braido et al. | Jan 2016 | B2 |
| 9226825 | Starksen et al. | Jan 2016 | B2 |
| 9226839 | Kariniemi et al. | Jan 2016 | B1 |
| 9232995 | Kovalsky et al. | Jan 2016 | B2 |
| 9241790 | Lane et al. | Jan 2016 | B2 |
| 9241791 | Braido et al. | Jan 2016 | B2 |
| 9241792 | Benichou et al. | Jan 2016 | B2 |
| 9241794 | Braido et al. | Jan 2016 | B2 |
| 9248014 | Lane et al. | Feb 2016 | B2 |
| 9265608 | Miller et al. | Feb 2016 | B2 |
| 9277994 | Miller et al. | Mar 2016 | B2 |
| 9289290 | Alkhatib et al. | Mar 2016 | B2 |
| 9289291 | Gorman et al. | Mar 2016 | B2 |
| 9295550 | Nguyen et al. | Mar 2016 | B2 |
| 9295551 | Straubinger et al. | Mar 2016 | B2 |
| 9295552 | McLean et al. | Mar 2016 | B2 |
| 9301836 | Buchbinder et al. | Apr 2016 | B2 |
| 9308087 | Lane et al. | Apr 2016 | B2 |
| 9320591 | Bolduc | Apr 2016 | B2 |
| D755384 | Pesce et al. | May 2016 | S |
| 9326852 | Spenser | May 2016 | B2 |
| 9326876 | Acosta et al. | May 2016 | B2 |
| 9345573 | Nyuli et al. | May 2016 | B2 |
| 9351830 | Gross et al. | May 2016 | B2 |
| 9387078 | Gross et al. | Jul 2016 | B2 |
| 9393110 | Levi et al. | Jul 2016 | B2 |
| 9421098 | Gifford et al. | Aug 2016 | B2 |
| 9427303 | Liddy et al. | Aug 2016 | B2 |
| 9427316 | Schweich, Jr. et al. | Aug 2016 | B2 |
| 9439757 | Wallace et al. | Sep 2016 | B2 |
| 9463102 | Kelly | Oct 2016 | B2 |
| 9474599 | Keränen | Oct 2016 | B2 |
| 9474638 | Robinson et al. | Oct 2016 | B2 |
| 9480559 | Vidlund et al. | Nov 2016 | B2 |
| 9492273 | Wallace et al. | Nov 2016 | B2 |
| 9498314 | Behan | Nov 2016 | B2 |
| 9498332 | Hacohen et al. | Nov 2016 | B2 |
| 9510947 | Straubinger et al. | Dec 2016 | B2 |
| 9532870 | Cooper et al. | Jan 2017 | B2 |
| 9554897 | Lane et al. | Jan 2017 | B2 |
| 9554899 | Granada et al. | Jan 2017 | B2 |
| 9561103 | Granada et al. | Feb 2017 | B2 |
| 9566152 | Schweich et al. | Feb 2017 | B2 |
| 9597182 | Straubinger et al. | Mar 2017 | B2 |
| 9629716 | Seguin | Apr 2017 | B2 |
| 9662203 | Sheahan et al. | May 2017 | B2 |
| 9681952 | Hacohen et al. | Jun 2017 | B2 |
| 9717591 | Chau et al. | Aug 2017 | B2 |
| 9743932 | Amplatz et al. | Aug 2017 | B2 |
| 9763657 | Hacohen et al. | Sep 2017 | B2 |
| 9763817 | Roeder | Sep 2017 | B2 |
| 9770256 | Cohen et al. | Sep 2017 | B2 |
| D800908 | Hariton et al. | Oct 2017 | S |
| 9788941 | Hacohen | Oct 2017 | B2 |
| 9895226 | Harari et al. | Feb 2018 | B1 |
| 9974651 | Hariton et al. | May 2018 | B2 |
| 9987132 | Hariton et al. | Jun 2018 | B1 |
| 9993360 | Shalev et al. | Jun 2018 | B2 |
| 10010414 | Cooper et al. | Jul 2018 | B2 |
| 10045845 | Hacohen et al. | Aug 2018 | B2 |
| 10076415 | Metchik et al. | Sep 2018 | B1 |
| 10098732 | Hariton et al. | Oct 2018 | B1 |
| 10105222 | Metchik et al. | Oct 2018 | B1 |
| 10111751 | Metchik et al. | Oct 2018 | B1 |
| 10123873 | Metchik et al. | Nov 2018 | B1 |
| 10130475 | Metchik et al. | Nov 2018 | B1 |
| 10136993 | Metchik et al. | Nov 2018 | B1 |
| 10143552 | Wallace et al. | Dec 2018 | B2 |
| 10149761 | Granada et al. | Dec 2018 | B2 |
| 10154903 | Albitov et al. | Dec 2018 | B2 |
| 10154906 | Granada et al. | Dec 2018 | B2 |
| 10159570 | Metchik et al. | Dec 2018 | B1 |
| 10182908 | Tubishevitz et al. | Jan 2019 | B2 |
| 10206668 | Mcgoldrick et al. | Feb 2019 | B2 |
| 10226341 | Gross et al. | Mar 2019 | B2 |
| 10231831 | Hacohen | Mar 2019 | B2 |
| 10231837 | Metchik et al. | Mar 2019 | B1 |
| 10238493 | Metchik et al. | Mar 2019 | B1 |
| 10245143 | Gross et al. | Apr 2019 | B2 |
| 10245144 | Metchik et al. | Apr 2019 | B1 |
| 10258471 | Lutter et al. | Apr 2019 | B2 |
| 10292816 | Raanani et al. | May 2019 | B2 |
| 10299927 | McLean et al. | May 2019 | B2 |
| 10321995 | Christianson et al. | Jun 2019 | B1 |
| 10322020 | Lam et al. | Jun 2019 | B2 |
| 10327895 | Lozonschi et al. | Jun 2019 | B2 |
| 10335278 | McLean et al. | Jul 2019 | B2 |
| 10376361 | Gross et al. | Aug 2019 | B2 |
| 10390952 | Hariton et al. | Aug 2019 | B2 |
| 10426614 | Hariton et al. | Oct 2019 | B2 |
| 10449047 | Hariton et al. | Oct 2019 | B2 |
| 10456256 | Braido et al. | Oct 2019 | B2 |
| 10492908 | Hammer et al. | Dec 2019 | B2 |
| 10507108 | Delgado et al. | Dec 2019 | B2 |
| 10507109 | Metchik et al. | Dec 2019 | B2 |
| 10512456 | Hacohen et al. | Dec 2019 | B2 |
| 10517719 | Miller et al. | Dec 2019 | B2 |
| 10524792 | Hernandez et al. | Jan 2020 | B2 |
| 10524910 | Hammer et al. | Jan 2020 | B2 |
| 10531866 | Hariton et al. | Jan 2020 | B2 |
| 10531872 | Hacohen et al. | Jan 2020 | B2 |
| 10537426 | Iamberger et al. | Jan 2020 | B2 |
| 10548726 | Hacohen et al. | Feb 2020 | B2 |
| 10548731 | Lashinski et al. | Feb 2020 | B2 |
| 10575948 | Iamberger et al. | Mar 2020 | B2 |
| 10595992 | Chambers | Mar 2020 | B2 |
| 10595997 | Metchik et al. | Mar 2020 | B2 |
| 10610358 | Vidlund et al. | Apr 2020 | B2 |
| 10610359 | Hacohen | Apr 2020 | B2 |
| 10631871 | Goldfarb et al. | Apr 2020 | B2 |
| 10631982 | Hammer et al. | Apr 2020 | B2 |
| 10646342 | Marr et al. | May 2020 | B1 |
| 10660751 | Hacohen | May 2020 | B2 |
| 10667908 | Hariton et al. | Jun 2020 | B2 |
| 10667912 | Dixon et al. | Jun 2020 | B2 |
| 10682227 | Hariton et al. | Jun 2020 | B2 |
| 10695173 | Gross et al. | Jun 2020 | B2 |
| 10695177 | Hariton et al. | Jun 2020 | B2 |
| 10702385 | Hacohen | Jul 2020 | B2 |
| 10736742 | Hariton et al. | Aug 2020 | B2 |
| 10758342 | Chau et al. | Sep 2020 | B2 |
| 10779939 | Hariton et al. | Sep 2020 | B2 |
| 10813760 | Metchik et al. | Oct 2020 | B2 |
| 10820998 | Marr et al. | Nov 2020 | B2 |
| 10835377 | Hacohen et al. | Nov 2020 | B2 |
| 10842627 | Delgado et al. | Nov 2020 | B2 |
| 10856972 | Hariton et al. | Dec 2020 | B2 |
| 10856975 | Hariton et al. | Dec 2020 | B2 |
| 10856978 | Straubinger et al. | Dec 2020 | B2 |
| 10874514 | Dixon et al. | Dec 2020 | B2 |
| 10888422 | Hariton et al. | Jan 2021 | B2 |
| 10888425 | Delgado et al. | Jan 2021 | B2 |
| 10888644 | Ratz et al. | Jan 2021 | B2 |
| 10905552 | Dixon et al. | Feb 2021 | B2 |
| 10905554 | Cao | Feb 2021 | B2 |
| 10918481 | Hariton et al. | Feb 2021 | B2 |
| 10918483 | Metchik et al. | Feb 2021 | B2 |
| 10925732 | Delgado et al. | Feb 2021 | B2 |
| 10945843 | Delgado et al. | Mar 2021 | B2 |
| 10945844 | McCann et al. | Mar 2021 | B2 |
| 10952850 | Hariton et al. | Mar 2021 | B2 |
| 10959846 | Marr et al. | Mar 2021 | B2 |
| 10993809 | McCann et al. | May 2021 | B2 |
| 11065114 | Raanani et al. | Jul 2021 | B2 |
| 11083582 | McCann et al. | Aug 2021 | B2 |
| 11135059 | Hammer et al. | Oct 2021 | B2 |
| 11147672 | McCann et al. | Oct 2021 | B2 |
| 11179240 | Delgado et al. | Nov 2021 | B2 |
| 11246704 | Hariton et al. | Feb 2022 | B2 |
| 11291545 | Hacohen | Apr 2022 | B2 |
| 11291546 | Gross et al. | Apr 2022 | B2 |
| 11291547 | Gross et al. | Apr 2022 | B2 |
| 11304806 | Hariton et al. | Apr 2022 | B2 |
| 11389297 | Franklin et al. | Jul 2022 | B2 |
| 20010002445 | Vesely | May 2001 | A1 |
| 20010005787 | Oz et al. | Jun 2001 | A1 |
| 20010021872 | Bailey et al. | Sep 2001 | A1 |
| 20010021874 | Carpentier et al. | Sep 2001 | A1 |
| 20010044656 | Williamson et al. | Nov 2001 | A1 |
| 20010056295 | Solem | Dec 2001 | A1 |
| 20020013571 | Goldfarb et al. | Jan 2002 | A1 |
| 20020022862 | Grafton et al. | Feb 2002 | A1 |
| 20020029080 | Mortier et al. | Mar 2002 | A1 |
| 20020032481 | Gabbay | Mar 2002 | A1 |
| 20020042621 | Liddicoat et al. | Apr 2002 | A1 |
| 20020082525 | Oslund et al. | Jun 2002 | A1 |
| 20020087048 | Brock et al. | Jul 2002 | A1 |
| 20020099436 | Thornton et al. | Jul 2002 | A1 |
| 20020103532 | Langberg et al. | Aug 2002 | A1 |
| 20020151916 | Muramatsu et al. | Oct 2002 | A1 |
| 20020151961 | Lashinski et al. | Oct 2002 | A1 |
| 20020151970 | Garrison et al. | Oct 2002 | A1 |
| 20020169358 | Mortier et al. | Nov 2002 | A1 |
| 20020173841 | Ortiz et al. | Nov 2002 | A1 |
| 20020177894 | Acosta et al. | Nov 2002 | A1 |
| 20020177904 | Huxel et al. | Nov 2002 | A1 |
| 20020198586 | Inoue | Dec 2002 | A1 |
| 20030009236 | Godin | Jan 2003 | A1 |
| 20030018358 | Saadat | Jan 2003 | A1 |
| 20030036791 | Philipp et al. | Feb 2003 | A1 |
| 20030050693 | Quijano et al. | Mar 2003 | A1 |
| 20030050694 | Yang et al. | Mar 2003 | A1 |
| 20030060846 | Egnelov et al. | Mar 2003 | A1 |
| 20030060875 | Wittens | Mar 2003 | A1 |
| 20030069635 | Cartledge | Apr 2003 | A1 |
| 20030074052 | Besselink | Apr 2003 | A1 |
| 20030078465 | Pai et al. | Apr 2003 | A1 |
| 20030078653 | Vesely et al. | Apr 2003 | A1 |
| 20030083742 | Spence et al. | May 2003 | A1 |
| 20030100943 | Bolduc | May 2003 | A1 |
| 20030105519 | Fasol et al. | Jun 2003 | A1 |
| 20030114901 | Loeb et al. | Jun 2003 | A1 |
| 20030120340 | Liska et al. | Jun 2003 | A1 |
| 20030130731 | Vidlund et al. | Jul 2003 | A1 |
| 20030158578 | Pantages et al. | Aug 2003 | A1 |
| 20030167062 | Gambale et al. | Sep 2003 | A1 |
| 20030171760 | Gambale | Sep 2003 | A1 |
| 20030191528 | Quijano et al. | Oct 2003 | A1 |
| 20030199974 | Lee et al. | Oct 2003 | A1 |
| 20030204195 | Keane et al. | Oct 2003 | A1 |
| 20030229350 | Kay | Dec 2003 | A1 |
| 20030229395 | Cox | Dec 2003 | A1 |
| 20030233142 | Morales et al. | Dec 2003 | A1 |
| 20040010272 | Manetakis et al. | Jan 2004 | A1 |
| 20040019377 | Taylor et al. | Jan 2004 | A1 |
| 20040024451 | Johnson et al. | Feb 2004 | A1 |
| 20040030382 | St. Goar et al. | Feb 2004 | A1 |
| 20040039414 | Carley et al. | Feb 2004 | A1 |
| 20040039436 | Spenser | Feb 2004 | A1 |
| 20040039442 | St. Goar et al. | Feb 2004 | A1 |
| 20040049207 | Goldfarb et al. | Mar 2004 | A1 |
| 20040059413 | Argento | Mar 2004 | A1 |
| 20040092962 | Thornton et al. | May 2004 | A1 |
| 20040093060 | Seguin et al. | May 2004 | A1 |
| 20040122448 | Levine | Jun 2004 | A1 |
| 20040122503 | Campbell et al. | Jun 2004 | A1 |
| 20040122514 | Fogarty et al. | Jun 2004 | A1 |
| 20040127982 | Machold et al. | Jul 2004 | A1 |
| 20040127983 | Mortier et al. | Jul 2004 | A1 |
| 20040133220 | Lashinski et al. | Jul 2004 | A1 |
| 20040133267 | Lane | Jul 2004 | A1 |
| 20040133274 | Webler et al. | Jul 2004 | A1 |
| 20040133374 | Kattan | Jul 2004 | A1 |
| 20040138744 | Lashinski et al. | Jul 2004 | A1 |
| 20040138745 | Macoviak et al. | Jul 2004 | A1 |
| 20040143315 | Bruun et al. | Jul 2004 | A1 |
| 20040148019 | Vidlund et al. | Jul 2004 | A1 |
| 20040148020 | Vidlund et al. | Jul 2004 | A1 |
| 20040148021 | Cartledge et al. | Jul 2004 | A1 |
| 20040153146 | Lashinski et al. | Aug 2004 | A1 |
| 20040172046 | Hlavka et al. | Sep 2004 | A1 |
| 20040176788 | Opolski | Sep 2004 | A1 |
| 20040176839 | Huynh et al. | Sep 2004 | A1 |
| 20040181287 | Gellman | Sep 2004 | A1 |
| 20040186558 | Pavcnik et al. | Sep 2004 | A1 |
| 20040186565 | Schreck | Sep 2004 | A1 |
| 20040186566 | Hindrichs et al. | Sep 2004 | A1 |
| 20040210244 | Vargas et al. | Oct 2004 | A1 |
| 20040210304 | Seguin et al. | Oct 2004 | A1 |
| 20040220593 | Greenhalgh | Nov 2004 | A1 |
| 20040225354 | Allen et al. | Nov 2004 | A1 |
| 20040236354 | Seguin | Nov 2004 | A1 |
| 20040236419 | Milo | Nov 2004 | A1 |
| 20040249433 | Freitag | Dec 2004 | A1 |
| 20040249453 | Cartledge et al. | Dec 2004 | A1 |
| 20040260317 | Bloom et al. | Dec 2004 | A1 |
| 20040260389 | Case et al. | Dec 2004 | A1 |
| 20040260393 | Rahdert et al. | Dec 2004 | A1 |
| 20040260394 | Douk et al. | Dec 2004 | A1 |
| 20040267358 | Reitan | Dec 2004 | A1 |
| 20050004668 | Aklog et al. | Jan 2005 | A1 |
| 20050010287 | Macoviak et al. | Jan 2005 | A1 |
| 20050010787 | Tarbouriech | Jan 2005 | A1 |
| 20050016560 | Voughlohn | Jan 2005 | A1 |
| 20050021056 | St. Goar et al. | Jan 2005 | A1 |
| 20050027305 | Shiu et al. | Feb 2005 | A1 |
| 20050027348 | Case et al. | Feb 2005 | A1 |
| 20050038494 | Eidenschink | Feb 2005 | A1 |
| 20050055038 | Kelleher et al. | Mar 2005 | A1 |
| 20050055086 | Stobie | Mar 2005 | A1 |
| 20050055087 | Starksen | Mar 2005 | A1 |
| 20050060030 | Lashinski et al. | Mar 2005 | A1 |
| 20050065601 | Lee et al. | Mar 2005 | A1 |
| 20050070999 | Spence | Mar 2005 | A1 |
| 20050075726 | Svanidze | Apr 2005 | A1 |
| 20050075727 | Wheatley | Apr 2005 | A1 |
| 20050075731 | Artof et al. | Apr 2005 | A1 |
| 20050080430 | Wright et al. | Apr 2005 | A1 |
| 20050080474 | Andreas et al. | Apr 2005 | A1 |
| 20050085900 | Case et al. | Apr 2005 | A1 |
| 20050085903 | Lau | Apr 2005 | A1 |
| 20050090827 | Gedebou | Apr 2005 | A1 |
| 20050096740 | Langberg et al. | May 2005 | A1 |
| 20050107871 | Realyvasquez et al. | May 2005 | A1 |
| 20050119734 | Spence et al. | Jun 2005 | A1 |
| 20050125002 | Baran et al. | Jun 2005 | A1 |
| 20050125011 | Spence et al. | Jun 2005 | A1 |
| 20050131533 | Alfieri et al. | Jun 2005 | A1 |
| 20050137686 | Salahieh et al. | Jun 2005 | A1 |
| 20050137688 | Salahieh et al. | Jun 2005 | A1 |
| 20050137689 | Salahieh et al. | Jun 2005 | A1 |
| 20050137690 | Salahieh et al. | Jun 2005 | A1 |
| 20050137691 | Salahieh et al. | Jun 2005 | A1 |
| 20050137692 | Haug et al. | Jun 2005 | A1 |
| 20050137693 | Haug et al. | Jun 2005 | A1 |
| 20050137695 | Salahieh et al. | Jun 2005 | A1 |
| 20050137697 | Salahieh et al. | Jun 2005 | A1 |
| 20050137699 | Salahieh et al. | Jun 2005 | A1 |
| 20050143809 | Salahieh et al. | Jun 2005 | A1 |
| 20050149160 | McFerran | Jul 2005 | A1 |
| 20050154443 | Linder et al. | Jul 2005 | A1 |
| 20050159728 | Armour et al. | Jul 2005 | A1 |
| 20050171601 | Cosgrove et al. | Aug 2005 | A1 |
| 20050177180 | Kaganov et al. | Aug 2005 | A1 |
| 20050177228 | Solem et al. | Aug 2005 | A1 |
| 20050182483 | Osborne et al. | Aug 2005 | A1 |
| 20050182486 | Gabbay | Aug 2005 | A1 |
| 20050187613 | Bolduc et al. | Aug 2005 | A1 |
| 20050192596 | Jugenheimer et al. | Sep 2005 | A1 |
| 20050197695 | Stacchino et al. | Sep 2005 | A1 |
| 20050197696 | Gomez Duran | Sep 2005 | A1 |
| 20050203549 | Realyvasquez | Sep 2005 | A1 |
| 20050203606 | VanCamp | Sep 2005 | A1 |
| 20050203618 | Sharkawy et al. | Sep 2005 | A1 |
| 20050216039 | Lederman | Sep 2005 | A1 |
| 20050216079 | MaCoviak | Sep 2005 | A1 |
| 20050222665 | Aranyi | Oct 2005 | A1 |
| 20050222678 | Lashinski et al. | Oct 2005 | A1 |
| 20050234508 | Cummins et al. | Oct 2005 | A1 |
| 20050240200 | Bergheim | Oct 2005 | A1 |
| 20050251251 | Cribier | Nov 2005 | A1 |
| 20050256532 | Nayak et al. | Nov 2005 | A1 |
| 20050256566 | Gabbay | Nov 2005 | A1 |
| 20050267478 | Corradi et al. | Dec 2005 | A1 |
| 20050267573 | Macoviak et al. | Dec 2005 | A9 |
| 20050273138 | To et al. | Dec 2005 | A1 |
| 20050288776 | Shaoulian et al. | Dec 2005 | A1 |
| 20050288778 | Shaoulian et al. | Dec 2005 | A1 |
| 20050288781 | Moaddeb et al. | Dec 2005 | A1 |
| 20060004439 | Spenser et al. | Jan 2006 | A1 |
| 20060004442 | Spenser et al. | Jan 2006 | A1 |
| 20060004443 | Liddicoat et al. | Jan 2006 | A1 |
| 20060004469 | Sokel | Jan 2006 | A1 |
| 20060015171 | Armstrong | Jan 2006 | A1 |
| 20060020275 | Goldfarb et al. | Jan 2006 | A1 |
| 20060020326 | Bolduc et al. | Jan 2006 | A9 |
| 20060020327 | Lashinski et al. | Jan 2006 | A1 |
| 20060020333 | Lashinski et al. | Jan 2006 | A1 |
| 20060020336 | Liddicoat | Jan 2006 | A1 |
| 20060025787 | Morales et al. | Feb 2006 | A1 |
| 20060025855 | Lashinski et al. | Feb 2006 | A1 |
| 20060025858 | Alameddine | Feb 2006 | A1 |
| 20060030885 | Hyde | Feb 2006 | A1 |
| 20060041189 | Vancaillie | Feb 2006 | A1 |
| 20060041319 | Taylor et al. | Feb 2006 | A1 |
| 20060052867 | Revuelta et al. | Mar 2006 | A1 |
| 20060052868 | Mortier | Mar 2006 | A1 |
| 20060058871 | Zakay et al. | Mar 2006 | A1 |
| 20060069429 | Spence et al. | Mar 2006 | A1 |
| 20060074486 | Liddicoat et al. | Apr 2006 | A1 |
| 20060085012 | Dolan | Apr 2006 | A1 |
| 20060089627 | Burnett et al. | Apr 2006 | A1 |
| 20060095009 | Lampropoulos et al. | May 2006 | A1 |
| 20060106423 | Weisel et al. | May 2006 | A1 |
| 20060111773 | Rittgers et al. | May 2006 | A1 |
| 20060116750 | Herbert et al. | Jun 2006 | A1 |
| 20060116757 | Lashinski et al. | Jun 2006 | A1 |
| 20060122692 | Gilad et al. | Jun 2006 | A1 |
| 20060129166 | Lavelle | Jun 2006 | A1 |
| 20060135964 | Vesley | Jun 2006 | A1 |
| 20060149280 | Harvine et al. | Jul 2006 | A1 |
| 20060149368 | Spence | Jul 2006 | A1 |
| 20060155357 | Melsheimer | Jul 2006 | A1 |
| 20060161250 | Shaw | Jul 2006 | A1 |
| 20060161265 | Levine et al. | Jul 2006 | A1 |
| 20060047297 | Case | Aug 2006 | A1 |
| 20060178700 | Quinn | Aug 2006 | A1 |
| 20060178740 | Stacchino et al. | Aug 2006 | A1 |
| 20060184203 | Martin et al. | Aug 2006 | A1 |
| 20060184240 | Jimenez et al. | Aug 2006 | A1 |
| 20060184242 | Lichtenstein | Aug 2006 | A1 |
| 20060190036 | Wendel et al. | Aug 2006 | A1 |
| 20060190038 | Carley et al. | Aug 2006 | A1 |
| 20060195134 | Crittenden | Aug 2006 | A1 |
| 20060195183 | Navia et al. | Aug 2006 | A1 |
| 20060195184 | Lane et al. | Aug 2006 | A1 |
| 20060201519 | Frazier et al. | Sep 2006 | A1 |
| 20060212111 | Case et al. | Sep 2006 | A1 |
| 20060216404 | Seyler et al. | Sep 2006 | A1 |
| 20060229708 | Powell et al. | Oct 2006 | A1 |
| 20060241622 | Zergiebel | Oct 2006 | A1 |
| 20060241656 | Starksen et al. | Oct 2006 | A1 |
| 20060241745 | Solem | Oct 2006 | A1 |
| 20060241748 | Lee et al. | Oct 2006 | A1 |
| 20060247680 | Amplatz et al. | Nov 2006 | A1 |
| 20060247763 | Slater | Nov 2006 | A1 |
| 20060253191 | Salahieh et al. | Nov 2006 | A1 |
| 20060259135 | Navia et al. | Nov 2006 | A1 |
| 20060259136 | Nguyen et al. | Nov 2006 | A1 |
| 20060259137 | Artof et al. | Nov 2006 | A1 |
| 20060271166 | Thill et al. | Nov 2006 | A1 |
| 20060271171 | McQuinn et al. | Nov 2006 | A1 |
| 20060271175 | Woolfson | Nov 2006 | A1 |
| 20060282150 | Olson et al. | Dec 2006 | A1 |
| 20060282161 | Huyn et al. | Dec 2006 | A1 |
| 20060287661 | Bolduc et al. | Dec 2006 | A1 |
| 20060287716 | Banbury et al. | Dec 2006 | A1 |
| 20060287719 | Rowe et al. | Dec 2006 | A1 |
| 20070001627 | Lin et al. | Jan 2007 | A1 |
| 20070008018 | Nagashima et al. | Jan 2007 | A1 |
| 20070016286 | Herrmann et al. | Jan 2007 | A1 |
| 20070016287 | Cartledge et al. | Jan 2007 | A1 |
| 20070016288 | Gurskis et al. | Jan 2007 | A1 |
| 20070021781 | Jervis et al. | Jan 2007 | A1 |
| 20070027528 | Agnew | Feb 2007 | A1 |
| 20070027533 | Douk | Feb 2007 | A1 |
| 20070027536 | Mihaljevic et al. | Feb 2007 | A1 |
| 20070027549 | Godin | Feb 2007 | A1 |
| 20070038221 | Fine et al. | Feb 2007 | A1 |
| 20070038293 | St. Goar et al. | Feb 2007 | A1 |
| 20070038295 | Case et al. | Feb 2007 | A1 |
| 20070043435 | Seguin et al. | Feb 2007 | A1 |
| 20070049942 | Hindrichs et al. | Mar 2007 | A1 |
| 20070049970 | Belef et al. | Mar 2007 | A1 |
| 20070051377 | Douk et al. | Mar 2007 | A1 |
| 20070055206 | To et al. | Mar 2007 | A1 |
| 20070055340 | Pryor | Mar 2007 | A1 |
| 20070056346 | Spenser et al. | Mar 2007 | A1 |
| 20070061010 | Hauser et al. | Mar 2007 | A1 |
| 20070066863 | Rafiee et al. | Mar 2007 | A1 |
| 20070078297 | Rafiee et al. | Apr 2007 | A1 |
| 20070078510 | Ryan | Apr 2007 | A1 |
| 20070080188 | Spence et al. | Apr 2007 | A1 |
| 20070083168 | Whiting et al. | Apr 2007 | A1 |
| 20070106328 | Wardle et al. | May 2007 | A1 |
| 20070112359 | Kimura et al. | May 2007 | A1 |
| 20070112422 | Dehdashtian | May 2007 | A1 |
| 20070112425 | Schaller et al. | May 2007 | A1 |
| 20070118151 | Davidson | May 2007 | A1 |
| 20070118154 | Crabtree | May 2007 | A1 |
| 20070118213 | Loulmet | May 2007 | A1 |
| 20070118215 | Moaddeb | May 2007 | A1 |
| 20070142907 | Moaddeb et al. | Jun 2007 | A1 |
| 20070162103 | Case et al. | Jul 2007 | A1 |
| 20070162107 | Haug et al. | Jul 2007 | A1 |
| 20070162111 | Fukamachi et al. | Jul 2007 | A1 |
| 20070173932 | Cali et al. | Jul 2007 | A1 |
| 20070197858 | Goldfarb et al. | Aug 2007 | A1 |
| 20070198077 | Cully et al. | Aug 2007 | A1 |
| 20070198082 | Kapadia et al. | Aug 2007 | A1 |
| 20070198097 | Zegdi | Aug 2007 | A1 |
| 20070208550 | Cao | Sep 2007 | A1 |
| 20070213582 | Zollinger et al. | Sep 2007 | A1 |
| 20070213810 | Newhauser et al. | Sep 2007 | A1 |
| 20070213813 | Von Segesser et al. | Sep 2007 | A1 |
| 20070219558 | Deutsch | Sep 2007 | A1 |
| 20070219630 | Chu | Sep 2007 | A1 |
| 20070225759 | Thommen et al. | Sep 2007 | A1 |
| 20070225760 | Moszner et al. | Sep 2007 | A1 |
| 20070233186 | Meng | Oct 2007 | A1 |
| 20070233237 | Krivoruchko | Oct 2007 | A1 |
| 20070233239 | Navia et al. | Oct 2007 | A1 |
| 20070239208 | Crawford | Oct 2007 | A1 |
| 20070239272 | Navia et al. | Oct 2007 | A1 |
| 20070239273 | Allen | Oct 2007 | A1 |
| 20070244546 | Francis | Oct 2007 | A1 |
| 20070244555 | Rafiee et al. | Oct 2007 | A1 |
| 20070244556 | Rafiee et al. | Oct 2007 | A1 |
| 20070244557 | Rafiee et al. | Oct 2007 | A1 |
| 20070250160 | Rafiee | Oct 2007 | A1 |
| 20070255397 | Ryan et al. | Nov 2007 | A1 |
| 20070255400 | Parravicini et al. | Nov 2007 | A1 |
| 20070270755 | Von Oepen et al. | Nov 2007 | A1 |
| 20070270943 | Solem et al. | Nov 2007 | A1 |
| 20070276437 | Call et al. | Nov 2007 | A1 |
| 20070282375 | Hindrichs et al. | Dec 2007 | A1 |
| 20070282429 | Hauser et al. | Dec 2007 | A1 |
| 20070295172 | Swartz | Dec 2007 | A1 |
| 20070299424 | Cumming et al. | Dec 2007 | A1 |
| 20080004688 | Spenser et al. | Jan 2008 | A1 |
| 20080004697 | Lichtenstein et al. | Jan 2008 | A1 |
| 20080027483 | Cartledge et al. | Jan 2008 | A1 |
| 20080027555 | Hawkins | Jan 2008 | A1 |
| 20080035160 | Woodson et al. | Feb 2008 | A1 |
| 20080039935 | Buch | Feb 2008 | A1 |
| 20080051703 | Thornton et al. | Feb 2008 | A1 |
| 20080058595 | Snoke et al. | Mar 2008 | A1 |
| 20080065011 | Marchand et al. | Mar 2008 | A1 |
| 20080065204 | Mackoviak et al. | Mar 2008 | A1 |
| 20080071361 | Tuval et al. | Mar 2008 | A1 |
| 20080071363 | Tuval et al. | Mar 2008 | A1 |
| 20080071366 | Tuval et al. | Mar 2008 | A1 |
| 20080071369 | Tuval et al. | Mar 2008 | A1 |
| 20080077235 | Kirson | Mar 2008 | A1 |
| 20080082083 | Forde et al. | Apr 2008 | A1 |
| 20080082159 | Tseng et al. | Apr 2008 | A1 |
| 20080082166 | Styrc et al. | Apr 2008 | A1 |
| 20080086138 | Stone et al. | Apr 2008 | A1 |
| 20080086164 | Rowe et al. | Apr 2008 | A1 |
| 20080086203 | Roberts | Apr 2008 | A1 |
| 20080086204 | Rankin | Apr 2008 | A1 |
| 20080091257 | Andreas et al. | Apr 2008 | A1 |
| 20080091261 | Long et al. | Apr 2008 | A1 |
| 20080097523 | Bolduc et al. | Apr 2008 | A1 |
| 20080097595 | Gabbay | Apr 2008 | A1 |
| 20080132989 | Snow et al. | Jun 2008 | A1 |
| 20080140003 | Bei et al. | Jun 2008 | A1 |
| 20080140116 | Bonutti | Jun 2008 | A1 |
| 20080147182 | Righini et al. | Jun 2008 | A1 |
| 20080161910 | Revuelta et al. | Jul 2008 | A1 |
| 20080167705 | Agnew | Jul 2008 | A1 |
| 20080167714 | St. Goar et al. | Jul 2008 | A1 |
| 20080188929 | Schreck | Aug 2008 | A1 |
| 20080195126 | Solem | Aug 2008 | A1 |
| 20080195200 | Vidlund et al. | Aug 2008 | A1 |
| 20080200980 | Robin et al. | Aug 2008 | A1 |
| 20080208265 | Frazier et al. | Aug 2008 | A1 |
| 20080208328 | Antocci et al. | Aug 2008 | A1 |
| 20080208330 | Keranen | Aug 2008 | A1 |
| 20080208332 | Lamphere et al. | Aug 2008 | A1 |
| 20080221672 | Lamphere et al. | Sep 2008 | A1 |
| 20080234814 | Salahieh et al. | Sep 2008 | A1 |
| 20080243245 | Thambar et al. | Oct 2008 | A1 |
| 20080255580 | Hoffman et al. | Oct 2008 | A1 |
| 20080262609 | Gross et al. | Oct 2008 | A1 |
| 20080269879 | Sathe et al. | Oct 2008 | A1 |
| 20080275300 | Rothe et al. | Nov 2008 | A1 |
| 20080275469 | Fanton et al. | Nov 2008 | A1 |
| 20080275551 | Alfieri | Nov 2008 | A1 |
| 20080281411 | Berreklouw | Nov 2008 | A1 |
| 20080288044 | Osborne | Nov 2008 | A1 |
| 20080288062 | Andrieu et al. | Nov 2008 | A1 |
| 20080294234 | Hartley et al. | Nov 2008 | A1 |
| 20080300629 | Surti | Dec 2008 | A1 |
| 20090005863 | Goetz et al. | Jan 2009 | A1 |
| 20090036966 | O'Connor et al. | Feb 2009 | A1 |
| 20090043153 | Zollinger et al. | Feb 2009 | A1 |
| 20090043381 | Macoviak et al. | Feb 2009 | A1 |
| 20090054969 | Salahieh et al. | Feb 2009 | A1 |
| 20090062866 | Jackson | Mar 2009 | A1 |
| 20090076586 | Hauser et al. | Mar 2009 | A1 |
| 20090076600 | Quinn | Mar 2009 | A1 |
| 20090082844 | Zacharias et al. | Mar 2009 | A1 |
| 20090088836 | Bishop et al. | Apr 2009 | A1 |
| 20090088837 | Gillinov et al. | Apr 2009 | A1 |
| 20090099554 | Forster et al. | Apr 2009 | A1 |
| 20090099650 | Bolduc et al. | Apr 2009 | A1 |
| 20090105794 | Ziarno et al. | Apr 2009 | A1 |
| 20090105816 | Olsen et al. | Apr 2009 | A1 |
| 20090112159 | Slattery et al. | Apr 2009 | A1 |
| 20090125098 | Chuter | May 2009 | A1 |
| 20090125102 | Cartledge | May 2009 | A1 |
| 20090149872 | Gross et al. | Jun 2009 | A1 |
| 20090157175 | Benichou | Jun 2009 | A1 |
| 20090163934 | Raschdorf, Jr. et al. | Jun 2009 | A1 |
| 20090177274 | Scorsin et al. | Jun 2009 | A1 |
| 20090171363 | Chocron | Jul 2009 | A1 |
| 20090171439 | Nissl | Jul 2009 | A1 |
| 20090177266 | Powell et al. | Jul 2009 | A1 |
| 20090177277 | Milo | Jul 2009 | A1 |
| 20090177278 | Spence | Jul 2009 | A1 |
| 20090210052 | Forster et al. | Aug 2009 | A1 |
| 20090222081 | Linder et al. | Sep 2009 | A1 |
| 20090240320 | Tuval et al. | Sep 2009 | A1 |
| 20090241656 | Jacquemin | Oct 2009 | A1 |
| 20090248143 | Laham | Oct 2009 | A1 |
| 20090248148 | Shaolian et al. | Oct 2009 | A1 |
| 20090254103 | Deustch | Oct 2009 | A1 |
| 20090259306 | Rowe | Oct 2009 | A1 |
| 20090259307 | Gross et al. | Oct 2009 | A1 |
| 20090264859 | Mas | Oct 2009 | A1 |
| 20090264994 | Saadat | Oct 2009 | A1 |
| 20090264995 | Subramanian | Oct 2009 | A1 |
| 20090276040 | Rowe et al. | Nov 2009 | A1 |
| 20090281619 | Le et al. | Nov 2009 | A1 |
| 20090287299 | Tabor | Nov 2009 | A1 |
| 20090287304 | Dahlgren et al. | Nov 2009 | A1 |
| 20090299409 | Coe et al. | Dec 2009 | A1 |
| 20090299449 | Styrc | Dec 2009 | A1 |
| 20090306768 | Quardi | Dec 2009 | A1 |
| 20090319037 | Rowe et al. | Dec 2009 | A1 |
| 20090326648 | Machold et al. | Dec 2009 | A1 |
| 20100001038 | Levin et al. | Jan 2010 | A1 |
| 20100010538 | Juravic et al. | Jan 2010 | A1 |
| 20100022823 | Goldfarb et al. | Jan 2010 | A1 |
| 20100023117 | Yoganathan et al. | Jan 2010 | A1 |
| 20100023118 | Medlock et al. | Jan 2010 | A1 |
| 20100023120 | Holecek et al. | Jan 2010 | A1 |
| 20100030014 | Ferrazzi | Feb 2010 | A1 |
| 20100036479 | Hill et al. | Feb 2010 | A1 |
| 20100036484 | Hariton | Feb 2010 | A1 |
| 20100042147 | Janovsky et al. | Feb 2010 | A1 |
| 20100049313 | Alon et al. | Feb 2010 | A1 |
| 20100063542 | Van der Burg et al. | Mar 2010 | A1 |
| 20100063550 | Felix et al. | Mar 2010 | A1 |
| 20100063586 | Hasenkam et al. | Mar 2010 | A1 |
| 20100069852 | Kelley | Mar 2010 | A1 |
| 20100076499 | McNamara et al. | Mar 2010 | A1 |
| 20100076548 | Konno | Mar 2010 | A1 |
| 20100082094 | Quadri | Apr 2010 | A1 |
| 20100094248 | Nguyen et al. | Apr 2010 | A1 |
| 20100100167 | Bortlein et al. | Apr 2010 | A1 |
| 20100114180 | Rock | May 2010 | A1 |
| 20100114299 | Ben-Muvhar et al. | May 2010 | A1 |
| 20100121349 | Meier | May 2010 | A1 |
| 20100130992 | Machold et al. | May 2010 | A1 |
| 20100131054 | Tuval et al. | May 2010 | A1 |
| 20100137979 | Tuval et al. | Jun 2010 | A1 |
| 20100152845 | Bloom et al. | Jun 2010 | A1 |
| 20100160958 | Clark | Jun 2010 | A1 |
| 20100161036 | Pintor et al. | Jun 2010 | A1 |
| 20100161041 | Maisano et al. | Jun 2010 | A1 |
| 20100161042 | Maisano et al. | Jun 2010 | A1 |
| 20100161043 | Maisano et al. | Jun 2010 | A1 |
| 20100161047 | Cabiri | Jun 2010 | A1 |
| 20100168845 | Wright | Jul 2010 | A1 |
| 20100174358 | Rabkin et al. | Jul 2010 | A1 |
| 20100174363 | Castro | Jul 2010 | A1 |
| 20100179574 | Longoria et al. | Jul 2010 | A1 |
| 20100179643 | Shalev | Jul 2010 | A1 |
| 20100179648 | Richter et al. | Jul 2010 | A1 |
| 20100179649 | Richter et al. | Jul 2010 | A1 |
| 20100185277 | Braido | Jul 2010 | A1 |
| 20100198347 | Zakay et al. | Aug 2010 | A1 |
| 20100217382 | Chau et al. | Aug 2010 | A1 |
| 20100222810 | DeBeer et al. | Sep 2010 | A1 |
| 20100228285 | Miles et al. | Sep 2010 | A1 |
| 20100234935 | Bashiri et al. | Sep 2010 | A1 |
| 20100234940 | Dolan | Sep 2010 | A1 |
| 20100249908 | Chau et al. | Sep 2010 | A1 |
| 20100249915 | Zhang | Sep 2010 | A1 |
| 20100249917 | Zhang | Sep 2010 | A1 |
| 20100249920 | Bolling et al. | Sep 2010 | A1 |
| 20100256737 | Pollock et al. | Oct 2010 | A1 |
| 20100262232 | Annest | Oct 2010 | A1 |
| 20100262233 | He | Oct 2010 | A1 |
| 20100280603 | Maisano et al. | Nov 2010 | A1 |
| 20100280604 | Zipory et al. | Nov 2010 | A1 |
| 20100280605 | Hammer et al. | Nov 2010 | A1 |
| 20100280606 | Naor | Nov 2010 | A1 |
| 20100286628 | Gross | Nov 2010 | A1 |
| 20100286767 | Zipory et al. | Nov 2010 | A1 |
| 20100305475 | Hinchliffe et al. | Dec 2010 | A1 |
| 20100312333 | Navia et al. | Dec 2010 | A1 |
| 20100324595 | Linder et al. | Dec 2010 | A1 |
| 20100331971 | Keränen et al. | Dec 2010 | A1 |
| 20110004210 | Johnson et al. | Jan 2011 | A1 |
| 20110004227 | Goldfarb et al. | Jan 2011 | A1 |
| 20110004296 | Lutter et al. | Jan 2011 | A1 |
| 20110004298 | Lee et al. | Jan 2011 | A1 |
| 20110004299 | Navia et al. | Jan 2011 | A1 |
| 20110011917 | Loulmet | Jan 2011 | A1 |
| 20110015729 | Jimenez et al. | Jan 2011 | A1 |
| 20110015731 | Carpentier et al. | Jan 2011 | A1 |
| 20110015739 | Cheung et al. | Jan 2011 | A1 |
| 20110021985 | Spargias | Jan 2011 | A1 |
| 20110022165 | Oba et al. | Jan 2011 | A1 |
| 20110178597 | Navia et al. | Jan 2011 | A9 |
| 20110026208 | Otsuro et al. | Feb 2011 | A1 |
| 20110029066 | Gilad et al. | Feb 2011 | A1 |
| 20110029067 | Mcguckin, Jr. et al. | Feb 2011 | A1 |
| 20110029072 | Gabbay | Feb 2011 | A1 |
| 20110035000 | Nieminen et al. | Feb 2011 | A1 |
| 20110040374 | Goetz et al. | Feb 2011 | A1 |
| 20110040375 | Letac et al. | Feb 2011 | A1 |
| 20110046662 | Moszner et al. | Feb 2011 | A1 |
| 20110054466 | Rothstein et al. | Mar 2011 | A1 |
| 20110054596 | Taylor | Mar 2011 | A1 |
| 20110054598 | Johnson | Mar 2011 | A1 |
| 20110066231 | Cartledge et al. | Mar 2011 | A1 |
| 20110066233 | Thornton et al. | Mar 2011 | A1 |
| 20110067770 | Pederson et al. | Mar 2011 | A1 |
| 20110071626 | Wright et al. | Mar 2011 | A1 |
| 20110077730 | Fentster | Mar 2011 | A1 |
| 20110082538 | Dahlgren et al. | Apr 2011 | A1 |
| 20110087146 | Ryan et al. | Apr 2011 | A1 |
| 20110087322 | Letac et al. | Apr 2011 | A1 |
| 20110093002 | Rucker et al. | Apr 2011 | A1 |
| 20110093063 | Schreck | Apr 2011 | A1 |
| 20110098525 | Kermode et al. | Apr 2011 | A1 |
| 20110106245 | Miller et al. | May 2011 | A1 |
| 20110106247 | Miller et al. | May 2011 | A1 |
| 20110112625 | Ben-Muvhar et al. | May 2011 | A1 |
| 20110112632 | Chau et al. | May 2011 | A1 |
| 20110113768 | Bauer et al. | May 2011 | A1 |
| 20110118830 | Liddicoat et al. | May 2011 | A1 |
| 20110118832 | Punjabi | May 2011 | A1 |
| 20110125257 | Seguin et al. | May 2011 | A1 |
| 20110125258 | Centola | May 2011 | A1 |
| 20110137326 | Bachman | Jun 2011 | A1 |
| 20110137397 | Chau et al. | Jun 2011 | A1 |
| 20110137409 | Yang et al. | Jun 2011 | A1 |
| 20110137410 | Hacohen | Jun 2011 | A1 |
| 20110144703 | Krause et al. | Jun 2011 | A1 |
| 20110144742 | Madrid et al. | Jun 2011 | A1 |
| 20110166636 | Rowe | Jul 2011 | A1 |
| 20110166649 | Gross et al. | Jul 2011 | A1 |
| 20110172784 | Richter | Jul 2011 | A1 |
| 20110184510 | Maisano et al. | Jul 2011 | A1 |
| 20110190877 | Lane et al. | Aug 2011 | A1 |
| 20110190879 | Bobo et al. | Aug 2011 | A1 |
| 20110202076 | Richter | Aug 2011 | A1 |
| 20110202130 | Cartledge et al. | Aug 2011 | A1 |
| 20110208283 | Rust | Aug 2011 | A1 |
| 20110208293 | Tabor | Aug 2011 | A1 |
| 20110208298 | Tuval et al. | Aug 2011 | A1 |
| 20110213459 | Garrison et al. | Sep 2011 | A1 |
| 20110213461 | Seguin et al. | Sep 2011 | A1 |
| 20110218619 | Benichou et al. | Sep 2011 | A1 |
| 20110218620 | Meiri et al. | Sep 2011 | A1 |
| 20110224785 | Hacohen | Sep 2011 | A1 |
| 20110230941 | Markus | Sep 2011 | A1 |
| 20110230961 | Langer et al. | Sep 2011 | A1 |
| 20110238088 | Bodluc et al. | Sep 2011 | A1 |
| 20110238094 | Thomas et al. | Sep 2011 | A1 |
| 20110238159 | Guyenot et al. | Sep 2011 | A1 |
| 20110245911 | Quill et al. | Oct 2011 | A1 |
| 20110245917 | Savage et al. | Oct 2011 | A1 |
| 20110251675 | Dwork | Oct 2011 | A1 |
| 20110251676 | Sweeney et al. | Oct 2011 | A1 |
| 20110251678 | Eidenschink et al. | Oct 2011 | A1 |
| 20110251679 | Weimeyer et al. | Oct 2011 | A1 |
| 20110251680 | Tran et al. | Oct 2011 | A1 |
| 20110251682 | Murray, III et al. | Oct 2011 | A1 |
| 20110251683 | Tabor | Oct 2011 | A1 |
| 20110257433 | Walker | Oct 2011 | A1 |
| 20110257633 | Cartledge et al. | Oct 2011 | A1 |
| 20110257721 | Tabor | Oct 2011 | A1 |
| 20110257728 | Kuehn | Oct 2011 | A1 |
| 20110257729 | Spenser et al. | Oct 2011 | A1 |
| 20110257736 | Marquez et al. | Oct 2011 | A1 |
| 20110257737 | Fogarty et al. | Oct 2011 | A1 |
| 20110264191 | Rothstein | Oct 2011 | A1 |
| 20110264196 | Savage et al. | Oct 2011 | A1 |
| 20110264198 | Murray, III et al. | Oct 2011 | A1 |
| 20110264199 | Tran et al. | Oct 2011 | A1 |
| 20110264200 | Tran et al. | Oct 2011 | A1 |
| 20110264201 | Yeung | Oct 2011 | A1 |
| 20110264202 | Murray, III et al. | Oct 2011 | A1 |
| 20110264203 | Dwork et al. | Oct 2011 | A1 |
| 20110264206 | Tabor | Oct 2011 | A1 |
| 20110264208 | Duffy | Oct 2011 | A1 |
| 20110270276 | Rothstein et al. | Nov 2011 | A1 |
| 20110271967 | Mortier et al. | Nov 2011 | A1 |
| 20110276062 | Bolduc | Nov 2011 | A1 |
| 20110282361 | Miller et al. | Nov 2011 | A1 |
| 20110282438 | Drews et al. | Nov 2011 | A1 |
| 20110282439 | Thill et al. | Nov 2011 | A1 |
| 20110282440 | Cao | Nov 2011 | A1 |
| 20110283514 | Fogarty et al. | Nov 2011 | A1 |
| 20110288435 | Christy et al. | Nov 2011 | A1 |
| 20110288632 | White | Nov 2011 | A1 |
| 20110288634 | Tuval et al. | Nov 2011 | A1 |
| 20110288635 | Miller et al. | Nov 2011 | A1 |
| 20110295354 | Bueche et al. | Dec 2011 | A1 |
| 20110295363 | Girard et al. | Dec 2011 | A1 |
| 20110301498 | Maenhout et al. | Dec 2011 | A1 |
| 20110301688 | Dolan | Dec 2011 | A1 |
| 20110301698 | Miller et al. | Dec 2011 | A1 |
| 20110301701 | Padala et al. | Dec 2011 | A1 |
| 20110301702 | Rust et al. | Dec 2011 | A1 |
| 20110306916 | Nitzan et al. | Dec 2011 | A1 |
| 20110307049 | Kao | Dec 2011 | A1 |
| 20110313452 | Carley et al. | Dec 2011 | A1 |
| 20110313515 | Quadri et al. | Dec 2011 | A1 |
| 20110319989 | Lane et al. | Dec 2011 | A1 |
| 20110319991 | Hariton et al. | Dec 2011 | A1 |
| 20120010694 | Lutter et al. | Jan 2012 | A1 |
| 20120016468 | Robin et al. | Jan 2012 | A1 |
| 20120022557 | Cabiri et al. | Jan 2012 | A1 |
| 20120022629 | Perera et al. | Jan 2012 | A1 |
| 20120022633 | Olson et al. | Jan 2012 | A1 |
| 20120022637 | Ben-Movhar et al. | Jan 2012 | A1 |
| 20120022639 | Hacohen et al. | Jan 2012 | A1 |
| 20120022640 | Gross et al. | Jan 2012 | A1 |
| 20120022644 | Reich et al. | Jan 2012 | A1 |
| 20120035703 | Lutter et al. | Feb 2012 | A1 |
| 20120035712 | Maisano et al. | Feb 2012 | A1 |
| 20120035713 | Lutter et al. | Feb 2012 | A1 |
| 20120035722 | Tuval et al. | Feb 2012 | A1 |
| 20120041547 | Duffy et al. | Feb 2012 | A1 |
| 20120041551 | Spenser et al. | Feb 2012 | A1 |
| 20120046738 | Lau et al. | Feb 2012 | A1 |
| 20120046742 | Tuval et al. | Feb 2012 | A1 |
| 20120053676 | Ku et al. | Mar 2012 | A1 |
| 20120053680 | Bolling et al. | Mar 2012 | A1 |
| 20120053682 | Kovalsky et al. | Mar 2012 | A1 |
| 20120053688 | Fogarty et al. | Mar 2012 | A1 |
| 20120059337 | Eilat | Mar 2012 | A1 |
| 20120059454 | Millwee et al. | Mar 2012 | A1 |
| 20120059458 | Buchbinder et al. | Mar 2012 | A1 |
| 20120065464 | Ellis et al. | Mar 2012 | A1 |
| 20120078237 | Wang et al. | Mar 2012 | A1 |
| 20120078353 | Quadri et al. | Mar 2012 | A1 |
| 20120078355 | Zipory et al. | Mar 2012 | A1 |
| 20120078357 | Conklin | Mar 2012 | A1 |
| 20120078359 | Li et al. | Mar 2012 | A1 |
| 20120083832 | Delaloye et al. | Apr 2012 | A1 |
| 20120083839 | Letac et al. | Apr 2012 | A1 |
| 20120083879 | Eberhardt et al. | Apr 2012 | A1 |
| 20120089022 | House et al. | Apr 2012 | A1 |
| 20120089223 | Nguyen et al. | Apr 2012 | A1 |
| 20120095552 | Spence et al. | Apr 2012 | A1 |
| 20120101570 | Tuval et al. | Apr 2012 | A1 |
| 20120101571 | Thambar et al. | Apr 2012 | A1 |
| 20120101572 | Kovalsky et al. | Apr 2012 | A1 |
| 20120109155 | Robinson et al. | May 2012 | A1 |
| 20120123511 | Brown | May 2012 | A1 |
| 20120123529 | Levi | May 2012 | A1 |
| 20120123530 | Carpentier et al. | May 2012 | A1 |
| 20120130473 | Norris et al. | May 2012 | A1 |
| 20120130474 | Buckley | May 2012 | A1 |
| 20120130475 | Shaw | May 2012 | A1 |
| 20120136434 | Carpentier et al. | May 2012 | A1 |
| 20120136436 | Cabiri et al. | May 2012 | A1 |
| 20120143323 | Hasenkam et al. | Jun 2012 | A1 |
| 20120150218 | Sandgren et al. | Jun 2012 | A1 |
| 20120150290 | Gabbay | Jun 2012 | A1 |
| 20120158021 | Morrill | Jun 2012 | A1 |
| 20120165915 | Melsheimer et al. | Jun 2012 | A1 |
| 20120165930 | Gifford, III et al. | Jun 2012 | A1 |
| 20120179086 | Shank et al. | Jul 2012 | A1 |
| 20120179244 | Schankereli et al. | Jul 2012 | A1 |
| 20120191182 | Hauser et al. | Jul 2012 | A1 |
| 20120197292 | Chin-Chen et al. | Aug 2012 | A1 |
| 20120197388 | Khairkhahan et al. | Aug 2012 | A1 |
| 20120215303 | Quadri et al. | Aug 2012 | A1 |
| 20120239142 | Liu et al. | Sep 2012 | A1 |
| 20120245604 | Tegzes | Sep 2012 | A1 |
| 20120271198 | Whittaker et al. | Oct 2012 | A1 |
| 20120277845 | Bowe | Nov 2012 | A1 |
| 20120283757 | Miller et al. | Nov 2012 | A1 |
| 20120283824 | Lutter et al. | Nov 2012 | A1 |
| 20120290062 | McNamara et al. | Nov 2012 | A1 |
| 20120296349 | Smith et al. | Nov 2012 | A1 |
| 20120296360 | Norris et al. | Nov 2012 | A1 |
| 20120296417 | Hill et al. | Nov 2012 | A1 |
| 20120296418 | Bonyuet et al. | Nov 2012 | A1 |
| 20120296419 | Richardson | Nov 2012 | A1 |
| 20120300063 | Majkrzak et al. | Nov 2012 | A1 |
| 20120123531 | Tsukashima et al. | Dec 2012 | A1 |
| 20120310328 | Olson et al. | Dec 2012 | A1 |
| 20120310330 | Buchbinder et al. | Dec 2012 | A1 |
| 20120323313 | Seguin | Dec 2012 | A1 |
| 20120323316 | Chau et al. | Dec 2012 | A1 |
| 20120330408 | Hillukka et al. | Dec 2012 | A1 |
| 20120330410 | Hammer et al. | Dec 2012 | A1 |
| 20120330411 | Gross et al. | Dec 2012 | A1 |
| 20130006347 | McHugo | Jan 2013 | A1 |
| 20130018450 | Hunt | Jan 2013 | A1 |
| 20130018458 | Yohanan | Jan 2013 | A1 |
| 20130023758 | Fabro | Jan 2013 | A1 |
| 20130030519 | Tran et al. | Jan 2013 | A1 |
| 20130030522 | Rowe et al. | Jan 2013 | A1 |
| 20130035759 | Gross et al. | Feb 2013 | A1 |
| 20130041204 | Heilman et al. | Feb 2013 | A1 |
| 20130041451 | Patterson et al. | Feb 2013 | A1 |
| 20130046373 | Cartledge et al. | Feb 2013 | A1 |
| 20130066341 | Ketai et al. | Mar 2013 | A1 |
| 20130066342 | Dell et al. | Mar 2013 | A1 |
| 20130079872 | Gallagher | Mar 2013 | A1 |
| 20130079873 | Migliazza et al. | Mar 2013 | A1 |
| 20130085529 | Housman | Apr 2013 | A1 |
| 20130090724 | Subramanian et al. | Apr 2013 | A1 |
| 20130096673 | Hill et al. | Apr 2013 | A1 |
| 20130116776 | Gross et al. | May 2013 | A1 |
| 20130116779 | Weber | May 2013 | A1 |
| 20130116780 | Miller et al. | May 2013 | A1 |
| 20130123896 | Bloss et al. | May 2013 | A1 |
| 20130123900 | Eblacas et al. | May 2013 | A1 |
| 20130123910 | Cartledge et al. | May 2013 | A1 |
| 20130131791 | Hlavka et al. | May 2013 | A1 |
| 20130131792 | Miller et al. | May 2013 | A1 |
| 20130150945 | Crawford et al. | Jun 2013 | A1 |
| 20130150956 | Yohanan et al. | Jun 2013 | A1 |
| 20130158647 | Norris et al. | Jun 2013 | A1 |
| 20130166017 | Cartledge et al. | Jun 2013 | A1 |
| 20130166022 | Conklin | Jun 2013 | A1 |
| 20130172978 | Vidlund et al. | Jul 2013 | A1 |
| 20130172992 | Gross et al. | Jul 2013 | A1 |
| 20130178930 | Straubinger et al. | Jul 2013 | A1 |
| 20130190857 | Mitra | Jul 2013 | A1 |
| 20130190861 | Chau et al. | Jul 2013 | A1 |
| 20130190863 | Call et al. | Jul 2013 | A1 |
| 20130190866 | Zipory et al. | Jul 2013 | A1 |
| 20130197632 | Kovach et al. | Aug 2013 | A1 |
| 20130204361 | Adams et al. | Aug 2013 | A1 |
| 20130211501 | Buckley et al. | Aug 2013 | A1 |
| 20130211508 | Lane et al. | Aug 2013 | A1 |
| 20130226289 | Shaolian et al. | Aug 2013 | A1 |
| 20130226290 | Yellin et al. | Aug 2013 | A1 |
| 20130231735 | Deem et al. | Sep 2013 | A1 |
| 20130245742 | Norris | Sep 2013 | A1 |
| 20130253643 | Rolando et al. | Sep 2013 | A1 |
| 20130261737 | Costello | Oct 2013 | A1 |
| 20130261738 | Clague et al. | Oct 2013 | A1 |
| 20130268069 | Zakai et al. | Oct 2013 | A1 |
| 20130274870 | Lombardi et al. | Oct 2013 | A1 |
| 20130282059 | Ketai et al. | Oct 2013 | A1 |
| 20130289711 | Liddy et al. | Oct 2013 | A1 |
| 20130289718 | Tsukashima et al. | Oct 2013 | A1 |
| 20130289740 | Liddy et al. | Oct 2013 | A1 |
| 20130297013 | Klima et al. | Nov 2013 | A1 |
| 20130304093 | Serina et al. | Nov 2013 | A1 |
| 20130304197 | Buchbinder et al. | Nov 2013 | A1 |
| 20130304200 | McLean | Nov 2013 | A1 |
| 20130310928 | Morriss et al. | Nov 2013 | A1 |
| 20130325114 | McLean et al. | Dec 2013 | A1 |
| 20130325118 | Cartledge | Dec 2013 | A1 |
| 20130331929 | Mitra et al. | Dec 2013 | A1 |
| 20140000112 | Braido et al. | Jan 2014 | A1 |
| 20140005767 | Glazier et al. | Jan 2014 | A1 |
| 20140005778 | Buchbinder et al. | Jan 2014 | A1 |
| 20140018911 | Zhou et al. | Jan 2014 | A1 |
| 20140018914 | Zipory et al. | Jan 2014 | A1 |
| 20140018915 | Biadillah et al. | Jan 2014 | A1 |
| 20140031928 | Murphy et al. | Jan 2014 | A1 |
| 20140046430 | Shaw | Feb 2014 | A1 |
| 20140052237 | Lane et al. | Feb 2014 | A1 |
| 20140067050 | Costello et al. | Mar 2014 | A1 |
| 20140067054 | Chau et al. | Mar 2014 | A1 |
| 20140081376 | Burkart et al. | Mar 2014 | A1 |
| 20140088368 | Park | Mar 2014 | A1 |
| 20140094826 | Sutherland et al. | Apr 2014 | A1 |
| 20140094903 | Miller et al. | Apr 2014 | A1 |
| 20140094906 | Spence et al. | Apr 2014 | A1 |
| 20140099726 | Heller | Apr 2014 | A1 |
| 20140106951 | Brandon | Apr 2014 | A1 |
| 20140120287 | Jacoby et al. | May 2014 | A1 |
| 20140121749 | Roeder | May 2014 | A1 |
| 20140121763 | Duffy et al. | May 2014 | A1 |
| 20140135799 | Henderson | May 2014 | A1 |
| 20140135894 | Norris et al. | May 2014 | A1 |
| 20140135895 | Andress et al. | May 2014 | A1 |
| 20140142619 | Serina et al. | May 2014 | A1 |
| 20140142681 | Norris | May 2014 | A1 |
| 20140142688 | Duffy et al. | May 2014 | A1 |
| 20140142695 | Gross et al. | May 2014 | A1 |
| 20140148849 | Serina et al. | May 2014 | A1 |
| 20140148891 | Johnson | May 2014 | A1 |
| 20140148898 | Gross et al. | May 2014 | A1 |
| 20140155783 | Starksen et al. | Jun 2014 | A1 |
| 20140163670 | Alon et al. | Jun 2014 | A1 |
| 20140163690 | White | Jun 2014 | A1 |
| 20140172069 | Roeder et al. | Jun 2014 | A1 |
| 20140172077 | Bruchman et al. | Jun 2014 | A1 |
| 20140172082 | Bruchman et al. | Jun 2014 | A1 |
| 20140188108 | Goodine et al. | Jul 2014 | A1 |
| 20140188140 | Meier et al. | Jul 2014 | A1 |
| 20140188210 | Beard et al. | Jul 2014 | A1 |
| 20140188215 | Hlavka et al. | Jul 2014 | A1 |
| 20140188221 | Chung et al. | Jul 2014 | A1 |
| 20140194970 | Chobotov | Jul 2014 | A1 |
| 20140194976 | Starksen et al. | Jul 2014 | A1 |
| 20140194981 | Menk et al. | Jul 2014 | A1 |
| 20140194983 | Kovalsky et al. | Jul 2014 | A1 |
| 20140207231 | Hacohen et al. | Jul 2014 | A1 |
| 20140214157 | Börtlein et al. | Jul 2014 | A1 |
| 20140214159 | Vidlund et al. | Jul 2014 | A1 |
| 20140222136 | Geist et al. | Aug 2014 | A1 |
| 20140222137 | Miller et al. | Aug 2014 | A1 |
| 20140222142 | Kovalsky et al. | Aug 2014 | A1 |
| 20140236287 | Clague et al. | Aug 2014 | A1 |
| 20140236289 | Alkhatib | Aug 2014 | A1 |
| 20140243859 | Robinson | Aug 2014 | A1 |
| 20140243894 | Groothuis et al. | Aug 2014 | A1 |
| 20140243963 | Sheps et al. | Aug 2014 | A1 |
| 20140249622 | Carmi et al. | Sep 2014 | A1 |
| 20140257461 | Robinson et al. | Sep 2014 | A1 |
| 20140257467 | Lane et al. | Sep 2014 | A1 |
| 20140257475 | Gross et al. | Sep 2014 | A1 |
| 20140257476 | Montorfano et al. | Sep 2014 | A1 |
| 20140275757 | Goodwin et al. | Sep 2014 | A1 |
| 20140276648 | Hammer et al. | Sep 2014 | A1 |
| 20140277358 | Slazas | Sep 2014 | A1 |
| 20140277409 | Börtlein et al. | Sep 2014 | A1 |
| 20140277411 | Börtlein et al. | Sep 2014 | A1 |
| 20140277412 | Börtlein et al. | Sep 2014 | A1 |
| 20140277418 | Miller | Sep 2014 | A1 |
| 20140277422 | Ratz et al. | Sep 2014 | A1 |
| 20140277427 | Ratz et al. | Sep 2014 | A1 |
| 20140296962 | Cartledge et al. | Oct 2014 | A1 |
| 20140296969 | Tegels et al. | Oct 2014 | A1 |
| 20140303649 | Nguyen et al. | Oct 2014 | A1 |
| 20140303720 | Sugimoto et al. | Oct 2014 | A1 |
| 20140309661 | Sheps et al. | Oct 2014 | A1 |
| 20140309730 | Alon et al. | Oct 2014 | A1 |
| 20140324164 | Gross et al. | Oct 2014 | A1 |
| 20140329225 | Morin | Nov 2014 | A1 |
| 20140331475 | Duffy et al. | Nov 2014 | A1 |
| 20140336744 | Tani et al. | Nov 2014 | A1 |
| 20140343668 | Zipory et al. | Nov 2014 | A1 |
| 20140343670 | Bakis et al. | Nov 2014 | A1 |
| 20140350662 | Vaturi | Nov 2014 | A1 |
| 20140350670 | Keränen | Nov 2014 | A1 |
| 20140358222 | Gorman, III et al. | Dec 2014 | A1 |
| 20140358224 | Tegels et al. | Dec 2014 | A1 |
| 20140378331 | Morin | Dec 2014 | A1 |
| 20140379006 | Sutherland et al. | Dec 2014 | A1 |
| 20140379065 | Johnson et al. | Dec 2014 | A1 |
| 20140379074 | Spence et al. | Dec 2014 | A1 |
| 20140379076 | Vidlund et al. | Dec 2014 | A1 |
| 20150012087 | Miller et al. | Jan 2015 | A1 |
| 20150018940 | Quill et al. | Jan 2015 | A1 |
| 20150018944 | O'Connor et al. | Jan 2015 | A1 |
| 20150032205 | Matheny | Jan 2015 | A1 |
| 20150045880 | Hacohen | Feb 2015 | A1 |
| 20150045881 | Lim | Feb 2015 | A1 |
| 20150051697 | Spence et al. | Feb 2015 | A1 |
| 20150081014 | Gross et al. | Mar 2015 | A1 |
| 20150094802 | Buchbinder et al. | Apr 2015 | A1 |
| 20150105855 | Cabiri et al. | Apr 2015 | A1 |
| 20150119970 | Nakayama et al. | Apr 2015 | A1 |
| 20150127097 | Neumann et al. | May 2015 | A1 |
| 20150142100 | Morriss et al. | May 2015 | A1 |
| 20150142103 | Vidlund | May 2015 | A1 |
| 20150148894 | Damm et al. | May 2015 | A1 |
| 20150157457 | Hacohen | Jun 2015 | A1 |
| 20150157458 | Thambar et al. | Jun 2015 | A1 |
| 20150164640 | McLean et al. | Jun 2015 | A1 |
| 20150173896 | Richter et al. | Jun 2015 | A1 |
| 20150173897 | Raanani et al. | Jun 2015 | A1 |
| 20150182336 | Zipory et al. | Jul 2015 | A1 |
| 20150196390 | Ma et al. | Jul 2015 | A1 |
| 20150196393 | Vidlund et al. | Jul 2015 | A1 |
| 20150216661 | Hacohen et al. | Aug 2015 | A1 |
| 20150230924 | Miller et al. | Aug 2015 | A1 |
| 20150238313 | Spence et al. | Aug 2015 | A1 |
| 20150245934 | Lombardi et al. | Sep 2015 | A1 |
| 20150250588 | Yang et al. | Sep 2015 | A1 |
| 20150272730 | Melnick et al. | Oct 2015 | A1 |
| 20150272731 | Racchini et al. | Oct 2015 | A1 |
| 20150272734 | Sheps et al. | Oct 2015 | A1 |
| 20150282964 | Beard et al. | Oct 2015 | A1 |
| 20150305903 | Kitaoka | Oct 2015 | A1 |
| 20150320556 | Levi et al. | Nov 2015 | A1 |
| 20150327994 | Morriss et al. | Nov 2015 | A1 |
| 20150328000 | Ratz et al. | Nov 2015 | A1 |
| 20150335429 | Morriss et al. | Nov 2015 | A1 |
| 20150342736 | Rabito et al. | Dec 2015 | A1 |
| 20150351903 | Morriss et al. | Dec 2015 | A1 |
| 20150351904 | Cooper et al. | Dec 2015 | A1 |
| 20150351906 | Hammer et al. | Dec 2015 | A1 |
| 20150359629 | Ganesan et al. | Dec 2015 | A1 |
| 20160030169 | Shahriari | Feb 2016 | A1 |
| 20160030171 | Quijano et al. | Feb 2016 | A1 |
| 20160089482 | Siegenthaler | Mar 2016 | A1 |
| 20160095700 | Righini | Apr 2016 | A1 |
| 20160100939 | Armstrong et al. | Apr 2016 | A1 |
| 20160106539 | Buchbinder et al. | Apr 2016 | A1 |
| 20160113766 | Ganesan et al. | Apr 2016 | A1 |
| 20160113768 | Ganesan et al. | Apr 2016 | A1 |
| 20160125160 | Heneghan et al. | May 2016 | A1 |
| 20160157862 | Hernandez et al. | Jun 2016 | A1 |
| 20160175095 | Dienno et al. | Jun 2016 | A1 |
| 20160200773 | Morin | Jul 2016 | A1 |
| 20160213473 | Hacohen et al. | Jul 2016 | A1 |
| 20160220367 | Barrett | Aug 2016 | A1 |
| 20160228247 | Maimon et al. | Aug 2016 | A1 |
| 20160242902 | Morriss et al. | Aug 2016 | A1 |
| 20160245802 | Morin et al. | Aug 2016 | A1 |
| 20160258939 | Morin et al. | Sep 2016 | A1 |
| 20160266089 | Morin et al. | Sep 2016 | A1 |
| 20160270911 | Ganesan et al. | Sep 2016 | A1 |
| 20160296330 | Hacohen | Oct 2016 | A1 |
| 20160310268 | Oba et al. | Oct 2016 | A1 |
| 20160310274 | Gross et al. | Oct 2016 | A1 |
| 20160317301 | Quadri et al. | Nov 2016 | A1 |
| 20160317305 | Pelled et al. | Nov 2016 | A1 |
| 20160324633 | Gross et al. | Nov 2016 | A1 |
| 20160324635 | Vidlund et al. | Nov 2016 | A1 |
| 20160324640 | Gifford et al. | Nov 2016 | A1 |
| 20160331526 | Schweich et al. | Nov 2016 | A1 |
| 20160331527 | Vidlund et al. | Nov 2016 | A1 |
| 20160338706 | Rowe | Nov 2016 | A1 |
| 20160367360 | Cartledge et al. | Dec 2016 | A1 |
| 20160367368 | Vidlund et al. | Dec 2016 | A1 |
| 20160374801 | Jimenez et al. | Dec 2016 | A1 |
| 20160374802 | Levi et al. | Dec 2016 | A1 |
| 20170042678 | Ganesan et al. | Feb 2017 | A1 |
| 20170049435 | Sauer et al. | Feb 2017 | A1 |
| 20170056166 | Ratz et al. | Mar 2017 | A1 |
| 20170056171 | Cooper et al. | Mar 2017 | A1 |
| 20170065407 | Hacohen et al. | Mar 2017 | A1 |
| 20170065411 | Grundeman et al. | Mar 2017 | A1 |
| 20170074855 | Morin et al. | Mar 2017 | A1 |
| 20170100236 | Robertson et al. | Apr 2017 | A1 |
| 20170128205 | Tamir et al. | May 2017 | A1 |
| 20170135816 | Lashinski et al. | May 2017 | A1 |
| 20170189174 | Braido et al. | Jul 2017 | A1 |
| 20170196688 | Christianson et al. | Jul 2017 | A1 |
| 20170196692 | Kirk et al. | Jul 2017 | A1 |
| 20170209264 | Chau et al. | Jul 2017 | A1 |
| 20170216026 | Quill et al. | Aug 2017 | A1 |
| 20170224323 | Rowe et al. | Aug 2017 | A1 |
| 20170231757 | Gassler | Aug 2017 | A1 |
| 20170231759 | Geist et al. | Aug 2017 | A1 |
| 20170231760 | Lane et al. | Aug 2017 | A1 |
| 20170231766 | Hariton et al. | Aug 2017 | A1 |
| 20170234850 | Morin | Aug 2017 | A1 |
| 20170239048 | Goldfarb et al. | Aug 2017 | A1 |
| 20170252159 | Hacohen et al. | Sep 2017 | A1 |
| 20170266003 | Hammer et al. | Sep 2017 | A1 |
| 20170333183 | Backus | Nov 2017 | A1 |
| 20170333187 | Hariton et al. | Nov 2017 | A1 |
| 20170349940 | Morin et al. | Dec 2017 | A1 |
| 20170360426 | Hacohen et al. | Dec 2017 | A1 |
| 20170367823 | Hariton et al. | Dec 2017 | A1 |
| 20180000580 | Wallace et al. | Jan 2018 | A1 |
| 20180014930 | Hariton et al. | Jan 2018 | A1 |
| 20180014932 | Hammer et al. | Jan 2018 | A1 |
| 20180021129 | Peterson et al. | Jan 2018 | A1 |
| 20180023114 | Morin et al. | Jan 2018 | A1 |
| 20180023115 | Morin et al. | Jan 2018 | A1 |
| 20180028215 | Cohen | Feb 2018 | A1 |
| 20180028311 | Hacohen | Feb 2018 | A1 |
| 20180049873 | Manash et al. | Feb 2018 | A1 |
| 20180055628 | Patel et al. | Mar 2018 | A1 |
| 20180055630 | Patel et al. | Mar 2018 | A1 |
| 20180098850 | Rafiee et al. | Apr 2018 | A1 |
| 20180116790 | Ratz et al. | May 2018 | A1 |
| 20180116843 | Schreck et al. | May 2018 | A1 |
| 20180125644 | Conklin | May 2018 | A1 |
| 20180132999 | Perouse | May 2018 | A1 |
| 20180147059 | Hammer et al. | May 2018 | A1 |
| 20180153687 | Hariton et al. | Jun 2018 | A1 |
| 20180153689 | Maimon et al. | Jun 2018 | A1 |
| 20180153696 | Albitov et al. | Jun 2018 | A1 |
| 20180161159 | Lee et al. | Jun 2018 | A1 |
| 20180177593 | Hariton et al. | Jun 2018 | A1 |
| 20180177594 | Patel et al. | Jun 2018 | A1 |
| 20180185148 | Hariton et al. | Jul 2018 | A1 |
| 20180206983 | Noe et al. | Jul 2018 | A1 |
| 20180214263 | Rolando et al. | Aug 2018 | A1 |
| 20180243086 | Barbarino et al. | Aug 2018 | A1 |
| 20180250126 | O'Connor et al. | Sep 2018 | A1 |
| 20180250147 | Syed | Sep 2018 | A1 |
| 20180271654 | Hariton et al. | Sep 2018 | A1 |
| 20180280136 | Hariton et al. | Oct 2018 | A1 |
| 20180296333 | Dixon et al. | Oct 2018 | A1 |
| 20180296336 | Cooper et al. | Oct 2018 | A1 |
| 20180296341 | Noe et al. | Oct 2018 | A1 |
| 20180325671 | Abunassar et al. | Nov 2018 | A1 |
| 20180344457 | Gross et al. | Dec 2018 | A1 |
| 20180344490 | Fox et al. | Dec 2018 | A1 |
| 20180353294 | Calomeni et al. | Dec 2018 | A1 |
| 20180360457 | Ellis et al. | Dec 2018 | A1 |
| 20190000613 | Delgado et al. | Jan 2019 | A1 |
| 20190015200 | Delgado et al. | Jan 2019 | A1 |
| 20190021852 | Delgado et al. | Jan 2019 | A1 |
| 20190021857 | Hacohen et al. | Jan 2019 | A1 |
| 20190038404 | Iamberger et al. | Feb 2019 | A1 |
| 20190038405 | Iamberger et al. | Feb 2019 | A1 |
| 20190053896 | Adamek-bowers et al. | Feb 2019 | A1 |
| 20190060060 | Chau et al. | Feb 2019 | A1 |
| 20190060068 | Cope et al. | Feb 2019 | A1 |
| 20190060070 | Groothuis et al. | Feb 2019 | A1 |
| 20190069997 | Ratz et al. | Mar 2019 | A1 |
| 20190069998 | Hacohen | Mar 2019 | A1 |
| 20190083248 | Hariton et al. | Mar 2019 | A1 |
| 20190083249 | Hariton et al. | Mar 2019 | A1 |
| 20190083261 | Perszyk et al. | Mar 2019 | A1 |
| 20190105153 | Barash et al. | Apr 2019 | A1 |
| 20190117391 | Humair | Apr 2019 | A1 |
| 20190167423 | Hariton et al. | Jun 2019 | A1 |
| 20190175339 | Vidlund | Jun 2019 | A1 |
| 20190175342 | Hariton et al. | Jun 2019 | A1 |
| 20190183639 | Moore | Jun 2019 | A1 |
| 20190183644 | Hacohen | Jun 2019 | A1 |
| 20190192295 | Spence et al. | Jun 2019 | A1 |
| 20190216602 | Lozonschi | Jul 2019 | A1 |
| 20190231525 | Hariton et al. | Aug 2019 | A1 |
| 20190240010 | Hacohen | Aug 2019 | A1 |
| 20190321172 | Gross et al. | Oct 2019 | A1 |
| 20190336280 | Naor | Nov 2019 | A1 |
| 20190350701 | Adamek-bowers et al. | Nov 2019 | A1 |
| 20190365530 | Hoang et al. | Dec 2019 | A1 |
| 20190388218 | Vidlund et al. | Dec 2019 | A1 |
| 20190388220 | Vidlund et al. | Dec 2019 | A1 |
| 20200000449 | Goldfarb et al. | Jan 2020 | A1 |
| 20200000579 | Manash et al. | Jan 2020 | A1 |
| 20200000580 | Hacohen | Jan 2020 | A1 |
| 20200015964 | Noe et al. | Jan 2020 | A1 |
| 20200030098 | Delgado et al. | Jan 2020 | A1 |
| 20200038181 | Hariton et al. | Feb 2020 | A1 |
| 20200046496 | Hammer et al. | Feb 2020 | A1 |
| 20200054335 | Hernandez et al. | Feb 2020 | A1 |
| 20200060818 | Geist et al. | Feb 2020 | A1 |
| 20200078002 | Hacohen et al. | Mar 2020 | A1 |
| 20200113677 | McCann et al. | Apr 2020 | A1 |
| 20200113689 | McCann et al. | Apr 2020 | A1 |
| 20200113692 | McCann et al. | Apr 2020 | A1 |
| 20200138567 | Marr et al. | May 2020 | A1 |
| 20200146824 | Hammer et al. | May 2020 | A1 |
| 20200163760 | Hariton et al. | May 2020 | A1 |
| 20200163761 | Hariton et al. | May 2020 | A1 |
| 20200205969 | Hacohen | Jul 2020 | A1 |
| 20200214832 | Metchik et al. | Jul 2020 | A1 |
| 20200237512 | McCann et al. | Jul 2020 | A1 |
| 20200246136 | Marr et al. | Aug 2020 | A1 |
| 20200246140 | Hariton et al. | Aug 2020 | A1 |
| 20200253600 | Darabian | Aug 2020 | A1 |
| 20200261094 | Goldfarb et al. | Aug 2020 | A1 |
| 20200306037 | Siegel | Oct 2020 | A1 |
| 20200315786 | Metchik et al. | Oct 2020 | A1 |
| 20200330221 | Hacohen | Oct 2020 | A1 |
| 20200330227 | Hacohen | Oct 2020 | A1 |
| 20200337842 | Metchik et al. | Oct 2020 | A1 |
| 20200360139 | Hammer et al. | Nov 2020 | A1 |
| 20200390548 | Hariton et al. | Dec 2020 | A1 |
| 20210093449 | Hariton et al. | Apr 2021 | A1 |
| 20210106419 | Abunassar | Apr 2021 | A1 |
| 20210113331 | Quadri et al. | Apr 2021 | A1 |
| 20210137680 | Kizuka et al. | May 2021 | A1 |
| 20210145578 | Hariton et al. | May 2021 | A1 |
| 20210196461 | Hariton et al. | Jul 2021 | A1 |
| 20210259835 | Tyler, II et al. | Aug 2021 | A1 |
| 20210330456 | Hacohen et al. | Oct 2021 | A1 |
| 20210361422 | Gross et al. | Nov 2021 | A1 |
| 20210361426 | Hacohen | Nov 2021 | A1 |
| 20210401573 | Gross et al. | Dec 2021 | A1 |
| 20220000612 | Hacohen | Jan 2022 | A1 |
| Number | Date | Country |
|---|---|---|
| 2005107650 | Nov 2005 | AI |
| 2822801 | Aug 2006 | CA |
| 2671966 | Jun 2008 | CA |
| 101653365 | Feb 2010 | CN |
| 103974674 | Aug 2014 | CN |
| 103997990 | Aug 2014 | CN |
| 105324091 | Feb 2016 | CN |
| 0170262 | Feb 1986 | EP |
| 0614342 | Sep 1994 | EP |
| 1006905 | Jun 2000 | EP |
| 0954257 | Aug 2000 | EP |
| 1258437 | Nov 2002 | EP |
| 1264582 | Dec 2002 | EP |
| 0871417 | Oct 2003 | EP |
| 1266641 | Oct 2004 | EP |
| 1034753 | Feb 2005 | EP |
| 1258232 | Jan 2006 | EP |
| 1637092 | Mar 2006 | EP |
| 1990014 | Nov 2008 | EP |
| 1562522 | Dec 2008 | EP |
| 1420723 | Jan 2009 | EP |
| 1903991 | Sep 2009 | EP |
| 1418865 | Oct 2009 | EP |
| 2119399 | Nov 2009 | EP |
| 1531762 | Apr 2010 | EP |
| 1450733 | Feb 2011 | EP |
| 2 446 915 | May 2012 | EP |
| 2088965 | Nov 2012 | EP |
| 1768630 | Jan 2015 | EP |
| 1861045 | Mar 2015 | EP |
| 1465555 | May 2015 | EP |
| 2349124 | Oct 2018 | EP |
| 2739214 | Oct 2018 | EP |
| 3417813 | Dec 2018 | EP |
| 3583922 | Dec 2019 | EP |
| 3270825 | Apr 2020 | EP |
| 2485795 | Sep 2020 | EP |
| 223448 | Dec 2012 | IL |
| S53152790 | Dec 1978 | JP |
| 20010046894 | Jun 2001 | KR |
| 9205093 | Apr 1992 | WO |
| 9310714 | Jun 1993 | WO |
| 9639963 | Dec 1996 | WO |
| 9640344 | Dec 1996 | WO |
| 9701369 | Jan 1997 | WO |
| 9846149 | Oct 1998 | WO |
| 1998043557 | Oct 1998 | WO |
| 1999030647 | Jun 1999 | WO |
| 0022981 | Apr 2000 | WO |
| 2000-047139 | Aug 2000 | WO |
| 0126586 | Apr 2001 | WO |
| 0156457 | Aug 2001 | WO |
| 2001-062189 | Aug 2001 | WO |
| 0182832 | Nov 2001 | WO |
| 02085250 | Oct 2002 | WO |
| 02085251 | Oct 2002 | WO |
| 02085252 | Oct 2002 | WO |
| 2003020179 | Mar 2003 | WO |
| 2003028558 | Apr 2003 | WO |
| 03047467 | Jun 2003 | WO |
| 2003049647 | Jun 2003 | WO |
| 2003105667 | Dec 2003 | WO |
| 2004028399 | Apr 2004 | WO |
| 04103434 | Dec 2004 | WO |
| 2004108191 | Dec 2004 | WO |
| 05021063 | Mar 2005 | WO |
| 05046488 | May 2005 | WO |
| 2005062931 | Jul 2005 | WO |
| 2006007389 | Jan 2006 | WO |
| 2006007401 | Jan 2006 | WO |
| 06012013 | Feb 2006 | WO |
| 06012038 | Feb 2006 | WO |
| 06054930 | May 2006 | WO |
| 2006065212 | Jun 2006 | WO |
| 2006070372 | Jul 2006 | WO |
| 06086434 | Aug 2006 | WO |
| 2006089236 | Aug 2006 | WO |
| 2006091163 | Aug 2006 | WO |
| 06097931 | Sep 2006 | WO |
| 06105084 | Oct 2006 | WO |
| 06116558 | Nov 2006 | WO |
| 2006128193 | Nov 2006 | WO |
| 07011799 | Jan 2007 | WO |
| 2007030063 | Mar 2007 | WO |
| 2007047488 | Apr 2007 | WO |
| 2007059252 | May 2007 | WO |
| 07121314 | Oct 2007 | WO |
| 07136783 | Nov 2007 | WO |
| 07136981 | Nov 2007 | WO |
| 08013915 | Jan 2008 | WO |
| 2008014144 | Jan 2008 | WO |
| 2008029296 | Mar 2008 | WO |
| 2008031103 | Mar 2008 | WO |
| 2008058940 | May 2008 | WO |
| 08068756 | Jun 2008 | WO |
| 2008070797 | Jun 2008 | WO |
| 2008103722 | Aug 2008 | WO |
| 2009026563 | Feb 2009 | WO |
| 09033469 | Mar 2009 | WO |
| 09053497 | Apr 2009 | WO |
| 2009080801 | Jul 2009 | WO |
| 2009091509 | Jul 2009 | WO |
| 2009160631 | Oct 2009 | WO |
| 10004546 | Jan 2010 | WO |
| 2010000454 | Jan 2010 | WO |
| 2010005827 | Jan 2010 | WO |
| 2010006627 | Jan 2010 | WO |
| 2010006905 | Jan 2010 | WO |
| 2010027485 | Mar 2010 | WO |
| 2010037141 | Apr 2010 | WO |
| 2010044851 | Apr 2010 | WO |
| 2010045297 | Apr 2010 | WO |
| 2010057262 | May 2010 | WO |
| 2010073246 | Jul 2010 | WO |
| 2010081033 | Jul 2010 | WO |
| 2010085649 | Jul 2010 | WO |
| 2010121076 | Oct 2010 | WO |
| 2010128502 | Nov 2010 | WO |
| 2010128503 | Nov 2010 | WO |
| 2010150178 | Dec 2010 | WO |
| 2011025972 | Mar 2011 | WO |
| 2011051942 | May 2011 | WO |
| 2011067770 | Jun 2011 | WO |
| 2011069048 | Jun 2011 | WO |
| 2011089401 | Jul 2011 | WO |
| 2011089601 | Jul 2011 | WO |
| 2011106137 | Sep 2011 | WO |
| 2011111047 | Sep 2011 | WO |
| 0187190 | Nov 2011 | WO |
| 2011137531 | Nov 2011 | WO |
| 2011-143263 | Nov 2011 | WO |
| 2011144351 | Nov 2011 | WO |
| 2011148374 | Dec 2011 | WO |
| 2011154942 | Dec 2011 | WO |
| 2012011108 | Jan 2012 | WO |
| 2012014201 | Feb 2012 | WO |
| 2012024428 | Feb 2012 | WO |
| 2012036740 | Mar 2012 | WO |
| 2012048035 | Apr 2012 | WO |
| 2012068541 | May 2012 | WO |
| 2012127309 | Sep 2012 | WO |
| 2012176195 | Dec 2012 | WO |
| 2012177942 | Dec 2012 | WO |
| 2013021374 | Feb 2013 | WO |
| 2013021375 | Feb 2013 | WO |
| 2013021384 | Feb 2013 | WO |
| 2013059747 | Apr 2013 | WO |
| 2013069019 | May 2013 | WO |
| 2013072496 | May 2013 | WO |
| 2013078497 | Jun 2013 | WO |
| 2013088327 | Jun 2013 | WO |
| 2013114214 | Aug 2013 | WO |
| 2013128436 | Sep 2013 | WO |
| 2013175468 | Nov 2013 | WO |
| 2014022124 | Feb 2014 | WO |
| 2014064694 | May 2014 | WO |
| 2014064695 | May 2014 | WO |
| 2014076696 | May 2014 | WO |
| 2014087402 | Jun 2014 | WO |
| 2014115149 | Jul 2014 | WO |
| 2014121280 | Aug 2014 | WO |
| 2014144937 | Sep 2014 | WO |
| 2014145338 | Sep 2014 | WO |
| 2014164364 | Oct 2014 | WO |
| 2014194178 | Dec 2014 | WO |
| 2014195786 | Dec 2014 | WO |
| 2015059699 | Apr 2015 | WO |
| 2015173794 | Nov 2015 | WO |
| 2015191923 | Dec 2015 | WO |
| 2016016899 | Feb 2016 | WO |
| 2016093877 | Jun 2016 | WO |
| 2016125160 | Aug 2016 | WO |
| 2017223486 | Dec 2017 | WO |
| 2018025260 | Feb 2018 | WO |
| 2018025263 | Feb 2018 | WO |
| 2018029680 | Feb 2018 | WO |
| 2018039631 | Mar 2018 | WO |
| 2018106837 | Jun 2018 | WO |
| 2018112429 | Jun 2018 | WO |
| 2018118717 | Jun 2018 | WO |
| 2018131042 | Jul 2018 | WO |
| 2018131043 | Jul 2018 | WO |
| 2019026059 | Feb 2019 | WO |
| 2019027507 | Feb 2019 | WO |
| 2019030753 | Feb 2019 | WO |
| 2019077595 | Apr 2019 | WO |
| 2019116369 | Jun 2019 | WO |
| 2019138400 | Jul 2019 | WO |
| 2019195860 | Oct 2019 | WO |
| 2019202579 | Oct 2019 | WO |
| 2020058972 | Mar 2020 | WO |
| 2020167677 | Aug 2020 | WO |
| 2021156866 | Aug 2021 | WO |
| 2021186424 | Sep 2021 | WO |
| Entry |
|---|
| IPR2021-01051 Preliminary Guidance Patent Owner's Motion to Amend dated Jun. 24, 2022. |
| Ex Parte Quayle dated May 2, 2022, which issued during the prosecution of U.S. Appl. No. 16/879,952. |
| An International Search Report and a Written Opinion both dated May 3, 2022, which issued during the prosecution of Applicant's PCT/IL2021/051433. |
| An Office Action together with an English Summary dated May 7, 2022 which issued during the prosecution of Chinese Patent Application No. 201880058940.2. |
| Notice of Allowance dated May 4, 2022, which issued during the prosecution of U.S. Appl. No. 16/680,739. |
| An Office Action dated Jun. 28, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,969. |
| An Office Action dated Jul. 8, 2022, which issued during the prosecution of U.S. Appl. No. 16/144,054. |
| IPR2021-00383 Final Written Decision dated Jul. 18, 2022. |
| An Office Action dated Apr. 11, 2022, which issued during the prosecution of U.S. Appl. No. 17/473,472. |
| IPR2021-00383 Preliminary Guidance dated Jan. 31, 2022. |
| An Office Action dated Mar. 18, 2022, which issued during the prosecution of U.S. Appl. No. 16/746,489. |
| Notice of Allowance dated Mar. 22, 2022, which issued during the prosecution of U.S. Appl. No. 17/366,711. |
| Notice of Allowance dated Mar. 4, 2022, which issued during the prosecution of U.S. Appl. No. 16/768,909. |
| An Office Action dated Dec. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,969. |
| An Office Action dated Jan. 24, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,466. |
| An Office Action dated Sep. 29, 2022, which issued during the prosecution of U.S. Appl. No. 17/010,886. |
| An Office Action dated Sep. 29, 2022, which issued during the prosecution of U.S. Appl. No. 16/656,790. |
| An Office Action dated Nov. 2, 2022, which issued during the prosecution of U.S. Appl. No. 17/004,693. |
| An Office Action dated Nov. 28, 2022, which issued during the prosecution of U.S. Appl. No. 17/141,853. |
| An Office Action dated Oct. 19, 2022, which issued during the prosecution of U.S. Appl. No. 17/875,589. |
| An Office Action dated Oct. 26, 2022, which issued during the prosecution of U.S. Appl. No. 16/746,489. |
| An Office Action dated Nov. 23. 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An Office Action dated Dec. 31, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An Office Action dated Feb. 6, 2013, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
| Langer F et al., “RING plus STRING: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation,” J Thorac Cardiovasc Surg 133:247-9, Jan. 2007. |
| Langer F et al., “RING+STRING: Successful repair technique for ischemic mitral regurgitation with severe leaflet tethering,” Circulation 120[suppl 1]: S85-S91, Sep. 2009. |
| “Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves”, J Webb et al., Circulation. Apr. 2010; 121: 1848-1857. |
| Jansen, J., Willeke, S., Reul, H. and Rum, G. (1992), Detachable Shape-Memory Sewing Ring for Heart Valves. Artificial Organs, 16:294-297. 1992 (an abstract). |
| Alexander S. Geha, et al., Replacement of degenerated mitral and aortic bioprostheses without explanation Ann Thorac Surg. Jun. 2001; 72:1509-1514. |
| An International Search Report and a Written Opinion both dated Oct. 13, 2011 which issued during the prosecution of Applicant's PCT/IL11/00231. |
| An Office Action dated Jul. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921. |
| An International Search Report and a Written Opinion both dated Dec. 5, 2011, which issued during the prosecution of Applicant's PCT/IL11/00582. |
| An Office Action dated May 29, 2012, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| U.S. Appl. No. 61/555,160, filed Nov. 3, 2011. |
| U.S. Appl. No. 61/525,281, filed Aug. 19, 2011. |
| U.S. Appl. No. 61/537,276, filed Sep. 21, 2011. |
| U.S. Appl. No. 61/515,372, filed Aug. 5, 2011. |
| U.S. Appl. No. 61/492,449, filed Jun. 2, 2011. |
| U.S. Appl. No. 61/588,892, filed Jan. 20, 2012. |
| An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00292. |
| An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00293. |
| An Office Action dated Nov. 28, 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Feb. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| An Office Action dated Feb. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/031,852. |
| An Office Action dated Sep. 19, 2014, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An Intemational Search Report and a Written Opinion both dated Sep. 4, 2014 which issued during the prosecution of Applicant's PCT/IL2014/050087. |
| Invitation to Pay Additional Fees dated Jun. 12, 2014 PCT/IL2014/050087. |
| An Office Action dated Jun. 17, 2014, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Jul. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An Office Action dated May 23, 2014, which issued during the prosecution of U.S. Appl. No. 13/411,814. |
| Dominique Himbert; Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter approaches and outcomes 24 pages Oct. 28, 2013. |
| An International Search Report and a Written Opinion both dated Mar. 17, 2014 which issued during the prosecution of Applicant's PCT/IL2013/050937. |
| An International Preliminary Report on patentabilty dated Dec. 2, 2013, which issued during the prosecution of Applicant's PCT/IL11/00582. |
| An Office Action dated Sep. 12, 2013, which issued during the prosecution of U.S. Appl. No. 13/411,814. |
| An Office Action dated Aug. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An International Preliminary Report on patentabilty dated Sep. 11, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000231. |
| An Office Action dated Jul. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
| An Office Action dated Jan. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921. |
| An Office Action dated Jul. 23, 2013, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Jul. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An Office Action dated Nov. 8, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| An Office Action dated Jun. 4, 2014, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| An Office Action dated Aug. 13, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An Office Action dated Jul. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An Office Action dated Feb. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
| An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00292. |
| An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00293. |
| A Notice of Allowance dated Aug. 15, 2014, which issued during the prosecution of U.S. Appl. No. 13/411,814. |
| An Office Action dated Aug. 14. 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| U.S. Appl. No. 61/283,819, filed Dec. 8, 2009. |
| Notice of Allowance dated Apr. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| U.S. Appl. No. 61/756,034, filed Jan. 24, 2013. |
| U.S. Appl. No. 61/756,049, filed Jan. 24, 2013. |
| An International Preliminary Report on Patentability dated Jan. 31, 2017, which issued during the prosecution of Applicant's PCT/IL2015/050792. |
| U.S. Appl. No. 62/372,861, filed Aug. 10, 2016. |
| Notice of Allowance dated Aug. 13, 2018, which issued during the prosecution of U.S. Appl. No. 15/995,597. |
| Notice of Allowance dated Apr. 20, 2018, which issued during the prosecution of U.S. Appl. No. 15/878,206. |
| An Office Action dated Dec. 10, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| An International Preliminary Report on Patentability dated Jul. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050087. |
| An Office Action dated Nov. 27, 2015, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
| An Office Action dated Jan. 21, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,264. |
| An Office Action dated Jan. 30, 2015, which issued during the prosecution of UK Patent Application No. 1413474.6. |
| An International Search Report and a Written Opinion both dated May 30, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050125. |
| An Office Action dated Sep. 26, 2016, which issued during the prosecution of U.S. Appl. No. 14/761,004. |
| An Office Action dated Jan. 18, 2017, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
| An Office Action dated Feb. 7, 2017, which issued during the prosecution of U.S. Appl. No. 14/689,608. |
| An Office Action dated Feb. 8, 2017, which issued during the prosecution of UK Patent Application No. 1613219.3. |
| An Office Action together dated Feb. 10, 2017: which issued during the prosecution of European Patent Application No. 12821522.5. |
| An International Search Report and a Written Opinion both dated Oct. 27, 2015, which issued during the prosecution of Applicant's PCT/IL2015/050792. |
| European Search Report dated Feb. 18. 2015, which issued during the prosecution of Applicant's European App No. 12821522.5. |
| Saturn Project—a novel solution for transcatheter heart valve replacement specifically designed to address clinical therapeutic needs on mitral valve: Dec. 2016. |
| Righini presentation EuroPCR May 2015 (Saturn)—(downloaded from: https://www.pcronline.com/Cases-resourcesimages/Resources/Course-videos-slides/2015/Cardiovascularinnovation-pipeline-Mitral-and-tricuspid-valve-interventions). |
| An Advisory Action dated Apr. 2, 2018, which issued during the prosecution of U.S. Appl. No. 14/761,004. |
| An Office Action dated Jul. 26, 2018, which issued during the prosecution of U.S. Appl. No. 15/872.501. |
| An Office Action dated May 4, 2018, which issued during the prosecution of U.S. Appl. No. 15/872.501. |
| An Office Action dated Apr. 20, 2018, which issued during the prosecution of U.S. Appl. No. 15/886,517. |
| An Office Action dated Aug. 9, 2018, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
| An Office Action dated Aug. 9, 2018, which issued during the prosecution of U.S. Appl. No. 15/902,403. |
| An Office Action dated Jun. 28, 2018, which issued during the prosecution of U.S. Appl. No. 29/635,658. |
| An Office Action dated Jun. 28, 2018, which issued during the prosecution of U.S. Appl. No. 29/635,661. |
| Georg Lutter, MD, et a1; “Percutaneous Valve Replacement: Current State and Future Prospects”, The Annals of Thoracic Surgery ; vol. 78, pp. 2199-2206, Dec. 2004. |
| An Office Action dated Jun. 6, 2018, which issued during the prosecution of UK Patent Application No. 1720803.4. |
| An International Search Report and a Written Opinion both dated Jun. 20, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050024. |
| An Office Action dated Jun. 18, 2018, which issued during the prosecution of UK Patent Application No. 1800399.6. |
| An Office Action dated Oct. 23, 2017, which issued during the prosecution of U.S. Appl. No. 14/761,004. |
| An Office Action dated Dec. 7, 2017, which issued during the prosecution of U.S. Appl. No. 15/211,791. |
| Interview Summary dated Feb. 8, 2018, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
| An Office Action dated Feb. 7, 2018, which issued during the prosecution of U.S. Appl. No. 15/197,069. |
| An International Search Report and a Written Opinion both dated Nov. 24, 2017, which issued during the prosecution of Applicant's PCT/IL2017/050873. |
| An Office Action dated Jan. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/541,783. |
| An Office Action dated Feb. 2, 2018, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Invitation to pay additional fees dated Jan. 2, 2018, which issued during the prosecution of Applicant's PCT/IL2017/050849. |
| An Invitation to pay additional fees dated Sep. 29, 2017, which issued during the prosecution of Applicant's PCT/IL2017/050873. |
| European Search Report dated Jun. 29, 2017, which issued during the prosecution of Applicant's European App No. 11809374.9. |
| An Invitation to pay additional fees dated Oct. 11, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050725. |
| An Office Action dated Dec. 4, 2018, which issued during the prosecution of U.S. Appl. No. 16/041,059. |
| An Office Action together with the English translation dated Nov. 5, 2018 which issued during the prosecution of Chinese Patent Application No. 201680008328.5. |
| Notice of Allowance dated Sep. 25, 2018, which issued during the prosecution of U.S. Appl. No. 15/188,507. |
| European Search Report dated Sep. 26, 2018 which issued during the prosecution of Applicant's European App No. 18186784.7. |
| An Office Action dated Jun. 30, 2015, which issued during the prosecution of U.S. Appl. No. 14/522,987. |
| Notice of Allowance dated Dec. 13. 2013, which issued during the prosecution of U.S. Appl. No. 13/675,119. |
| An International Preliminary Report on Patentability dated Aug. 8, 2017, which issued during the prosecution of Applicant's PCT/IL2016/050125. |
| An Office Action dated Jan. 17, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
| An Office Action dated Mar. 25, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| An Office Action dated Feb. 25, 2016, which issued during the prosecution of U.S. Appl. No. 14/522,987. |
| An Office Action dated Apr. 13, 2016, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
| An Office Action dated Aug. 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,264. |
| Maisano (2015) TCR presentation re Cardiovalve. |
| Notice of Allowance dated Sep. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541. |
| Notice of Allowance dated May 10, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| Notice of Allowance dated May 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| An International Preliminary Report on Patentability dated May 19, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050937. |
| Dusan Pavcnik, MD, PhD2, et al.; “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement”, Cardiovascular Radiology. Radiology Apr. 1992, vol. 183, pp. 151-154. |
| Notice of Allowance dated Oct. 16, 2013, which issued during the prosecution of U.S. Appl. No. 13/675,119. |
| Notice of Allowance dated Feb. 11. 2015, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| Notice of Allowance dated May 5, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| Notice of Allowance dated Mar. 10, 2015, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
| Notice of Allowance dated Jul 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541. |
| An Office Action dated Mar. 25, 2019, which issued during the prosecution of European Patent Application No. 14710060.6. |
| An International Search Report and a Written Opinion both dated Nov. 9, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050869. |
| An International Search Report and a Written Opinion both dated Dec. 5, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050725. |
| An International Search Report and a Written Opinion both dated Apr. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2019/050142. |
| An International Preliminary Report on Patentability dated Feb. 12, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050873. |
| An Office Action dated Sep. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/460,313. |
| An Office Action dated Nov. 26, 2019, which issued during the prosecution of U.S. Appl. No. 16/532,945. |
| An Office Action dated Aug. 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| An Office Action dated Nov. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
| An Office Action dated Jun. 14, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385. |
| An Office Action dated Oct. 4, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140. |
| An Office Action dated Jun. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/388,038. |
| An International Preliminary Report on Patentability dated Feb. 4, 2020, which issued during the prosecution of Applicant's PCT/IL2018/050725. |
| An International Search Report and a Written Opinion both dated Jan. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051122. |
| An International Search Report and a Written Opinion both dated May 13, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051350. |
| An International Preliminary Report on Patentability dated Feb. 5, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050849. |
| An Office Action dated Oct. 25, 2018, which issued during the prosecution of U.S. Appl. No. 14/761,004. |
| An Office Action dated Mar. 4, 2019, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
| An Office Action dated Jan. 9, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Office Action dated Jan. 30, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
| An Office Action dated Feb. 5, 2019, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
| An Office Action dated May 23, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| An Office Action dated May 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/691,032. |
| An Office Action dated Aug. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559. |
| An Office Action dated Jun. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/682,789. |
| Notice of Allowance dated Jan. 13, 2020, which issued during the prosecution of U.S. Appl. No. 15/956,956. |
| An Office Action dated Jun. 25, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Office Action dated May 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/433,547. |
| U.S. Appl. No. 62/560,384, filed Sep. 19, 2017. |
| U.S. Appl. No. 62/112,343, filed Feb. 5, 2015. |
| An International Preliminary Report on Patentability dated Feb. 11, 2020, which issued during the prosecution of Applicant's PCT/IL2018/050869. |
| An International Preliminary Report on Patentability dated Oct. 20, 2020, which issued during the prosecution of Applicant's PCT/IL2019/050142. |
| An Office Action dated Jan. 6, 2020, which issued during the prosecution of U.S. Appl. No. 16/660,231. |
| An Office Action dated Dec. 31, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140. |
| Notice of Allowance dated Apr. 24, 2019, which issued during the prosecution of U.S. Appl. No. 16/045,059. |
| An Office Action dated Jan. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/284,331. |
| European Search Report dated Mar. 5, 2020 which issued during the prosecution of Applicant's European App No. 17752184.6. |
| European Search Report dated Mar. 4, 2020 which issued during the prosecution of Applicant's European App No. 16706913.7. |
| Notice of Allowance dated Mar. 12, 2020, which issued during the prosecution of U.S. Appl. No. 16/460,313. |
| An Office Action dated Jan. 9, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190. |
| An Office Action dated Jan. 3, 2020, which issued during the prosecution of U.S. Appl. No. 16/678,355. |
| An Office Action dated Feb. 6, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Notice of Allowance dated Jan. 16, 2020, which issued during the prosecution of U.S. Appl. No. 16/532,945. |
| Notice of Allowance dated Aug. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166. |
| Notice of Allowance dated Jul. 27, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166. |
| Notice of Allowance dated Jun. 23, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166. |
| Notice of Allowance dated May 7, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166. |
| Sündermann, Simon H., et al. “Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design.” European Journal of Cardio-Thoracic Surgery 42.4 (2012): e48-e52. |
| An Office Action summarized English translation and Search Report dated Jul. 3, 2020, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
| Serruys, P. W., Piazza, N., Cribier, A., Webb, J., Laborde, J. C., & de Jaegere, P. (Eds.). (2009). Transcatheter aortic valve implantation: tips and tricks to avoid failure. CRC Press.—Screenshots from Google Books downloaded from: https://books.google.co.il/books?id=FLzLBQAAQBAJ&lpg=PA198&ots=soqWrDH-y_&dq=%20%22Edwards%20SAPIEN%22&lr&pg=PA20#v=onepage&q=%22Edwards%20SAPIEN%22&f=false ; Downloaded on Jun. 18, 2020. |
| An International Search Report and a Written Opinion both dated Jun. 24, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051398. |
| An Office Action dated Jul. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Aug. 28, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/132,937. |
| An Office Action dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
| Notice of Allowance dated Aug. 26, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
| An Office Action dated Aug. 7, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Tchetche, D. and Nicolas M. Van Mieghem: “New-generation TAVI devices: description and specifications” EuroIntervention, 2014, No. 10:U90-U100. |
| An Office Action dated Aug. 23, 2019, which issued during the prosecution of U.S. Appl. No. 15/600,190. |
| Symetis S.A.: “ACURATE neo ™ Aortic Bioprosthesis for Implantation using the ACURATE neo ™ TA Transapical Delivery System in Patients with Severe Aortic Stenosis,” Clinical Investigation Plan, Protocol No. 2015-01, Vs. No. 2, 2015:1-76. |
| Notice of Allowance dated Sep. 10, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190. |
| Notice of Allowance dated Sep. 10, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Oct. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Sep. 21, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
| Notice of Allowance dated Oct. 28, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
| Notice of Allowance dated Jan. 16, 2020, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
| An Office Action dated May 11, 2020, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
| An Office Action dated Sep. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
| Notice of Allowance dated Mar. 29, 2017, which issued during the prosecution of U.S. Appl. No. 14/161,921. |
| Agarwal et al. International Cardiology Perspective Functional Tricuspid Regurgitation, Circ Cardiovasc Interv 2009;2;2;565-573 (2009). |
| Alfieri et al., “An effective technique to correct anterior mitral leaflet prolapse,” J Card 14(6):468-470 (1999). |
| Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic Cardiovascular Surgery 122:674-681 (2001). |
| Alfieri, “The edge-to-edge repair of the mitral valve,” [Abstract] 6th Annual NewEra Cardiac Care: Innovation & Technology, Heart Surgery Forum pp. 103. (2000). |
| Alfieri et al. “Novel Suture Device for Beating-Heart Mitral Leaflet Approximation”, Ann Thorac Surg. 2002, 74:1488-1493. |
| Alfieri et al., “The edge to edge technique,” The European Association for Cardio-Thoracic Surgery 14th Annual Meeting Oct. 7-11, Book of Procees. (2000). |
| Amplatzer Cardiac Plug brochure (English pages), AGA Medical Corporation (Plymouth, MN) (copyright 2008-2010, downloaded Jan. 11, 2011). |
| AMPLATZER® Cribriform Occluder. A patient guide to Percutaneous, Transcatheter, Atrial Septal Defect Closuer, AGA Medical Corporation, Apr. 2008. |
| AMPLATZER® Septal Occluder. A patient guide to the Non-Surgical Closuer of the Atrial Septal Defect Using the AMPLATZER Septal Occluder System, AGA Medical Corporation, Apr. 2008. |
| Brennan, Jennifer, 510(k) Summary of safety and effectiveness, Jan. 2008. |
| Dictionary.com definition of “lock”, Jul. 29, 2013. |
| Dang NC et al. “Simplified Placement of Multiple Artificial Mitral Valve Chords,” The Heart Surgery Forum #2005-1005, 8 (3) (2005). |
| Maisano, The double-orifice technique as a standardized approach to treat mitral . . . , European Journal of Cardio-thoracic Surgery 17 (2000) 201-205. |
| “Two dimensional real-time ultrasonic imaging of the heart and great vessels”, Mayo Clin Proc. vol. 53:271-303, 1978. |
| Odell JA et al, “Early Results o4yf a Simplified Method of Mitral Valve Annuloplasty,” Circulation 92: 150-154 (1995). |
| O'Reilly S et al., “Heart valve surgery pushes the envelope,” Medtech Insight 8(3): 73, 99-108 (2006). |
| Swain CP et al., “An endoscopically deliverable tissue-transfixing device for securing biosensors in the gastrointestinal tract,” Gastrointestinal Endoscopy 40(6): 730-734 (1994). |
| An Invitation to pay additional fees dated Jan. 31, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050860. |
| U.S. Appl. No. 62/030,715, filed Jul. 30, 2014. |
| U.S. Appl. No. 62/139,854, filed Mar. 30, 2015. |
| U.S. Appl. No. 61/312,412, filed Mar. 10, 2010. |
| An Invitation to pay additional fees dated Jan. 31, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050861. |
| An International Preliminary Report on Patentability dated Dec. 23, 2013, which issued during the prosecution of Applicant's PCT/IL2012/000250. |
| An International Preliminary Report on Patentability dated Sep. 18, 2007, which issued during the prosecution of Applicant's PCT/IL2006/000342. |
| An International Preliminary Report on Patentability dated Jun. 5, 2012, which issued during the prosecution of Applicant's PCT/IL2010/001024. |
| An International Preliminary Report on Patentability dated Apr. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050861. |
| An International Preliminary Report on Patentability dated Apr. 26, 2016, which issued during the prosecution of Applicant's PCT/IL2014/050914. |
| An International Preliminary Report on Patentability dated Jun. 10, 2009, which issued during the prosecution of Applicant's PCT/IL07/01503. |
| An International Preliminary Report on Patentability dated Dec. 18, 2010, which issued during the prosecution of Applicant's PCT/IL09/00593. |
| An International Preliminary Report on Patentability dated Jun. 29, 2011, which issued during the prosecution of Applicant's PCT/IL2009/001209. |
| Notice of Allowance dated Aug. 18, 2017, which issued during the prosecution of U.S. Appl. No. 14/682,608. |
| Notice of Allowance dated Jul. 6, 2017, which issued during the prosecution of U.S. Appl. No. 14/682,608. |
| Notice of Allowance dated May 22, 2017, which issued during the prosecution of U.S. Appl. No. 14/682,608. |
| An Office Action dated Apr. 21, 2017, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
| An Office Action dated Sep. 29, 2017, which issued during the prosecution of U.S. Appl. No. 15/191,069. |
| An International Preliminary Report on Patentability dated Nov. 9, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000357. |
| An International Preliminary Report on Patentability dated Nov. 9, 2011 which issued during the prosecution of Applicant's PCT/IL2010/000358. |
| An International Preliminary Report on Patentability dated Nov. 27, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000404. |
| An International Preliminary Report on Patentability dated Feb. 4, 2014, which issued during the prosecution of Applicant's PCT/IL2011/000446. |
| An International Preliminary Report on Patentability dated Jan. 29, 2013, which issued during the prosecution of Applicant's PCT/IL2011/000600. |
| An International Preliminary Report on Patentability dated Dec. 23, 2014, which issued during the prosecution of Applicant's PCT/IL2012/050451. |
| A Notice of Allowance dated Jul. 30, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007. |
| An Office Action dated Sep. 29, 2014, which issued during the prosecution of U.S. Appl. No. 13/504,870. |
| An Office Action dated Jan. 13, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013. |
| An Office Action dated Mar. 23, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013. |
| Notice of Allowance dated Mar. 25, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153. |
| An Office Action dated Oct. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/749,153. |
| Notice of Allowance dated May 22, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153. |
| Notice of Allowance dated Aug. 3, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153. |
| An Office Action dated Dec. 19, 2013, which issued during the prosecution of U.S. Appl. No. 14/027,934. |
| An Office Action dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 14/027,934. |
| An Office Action dated Aug. 22, 2014, which issued during the prosecution of U.S. Appl. No. 14/027,934. |
| An Office Action dated Apr. 2, 2015, which issued during the prosecution of U.S. Appl. No. 14/027,934. |
| An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/027,934. |
| An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/084,426. |
| An Office Action dated Mar. 16, 2015, which issued during the prosecution of U.S. Appl. No. 14/084,426. |
| An Office Action dated Jan. 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756. |
| An Office Action dated May 11, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756. |
| Notice of Allowance dated Oct. 20, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954. |
| Notice of Allowance dated Feb. 19, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,192. |
| An Office Action dated Jul. 20, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412. |
| An Office Action dated Mar. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/843,412. |
| A Restriction Requirement dated May 1, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412. |
| A Notice of Allowance dated May 2, 2013, which issued during the prosecution of U.S. Appl. No. 12/843,412. |
| A Restriction Requirement dated Nov. 19, 2012, which issued during the prosecution of U.S. Appl. No. 12/926,673. |
| An Office Action dated Feb. 12, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673. |
| An Office Action dated Oct. 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673. |
| A Notice of Allowance dated Jan. 7, 2014, which issued during the prosecution of U.S. Appl. No. 12/926,673. |
| An Office Action dated Oct. 9, 2013, which issued during the prosecution of U.S. Appl. No. 12/996,954. |
| An Office Action dated Mar. 24, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954. |
| An Office Action dated Oct. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/996,954. |
| Notice of Allowance dated Jul. 7, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954. |
| An Office Action dated Nov. 16, 2018, which issued during the prosecution of U.S. Appl. No. 16/042,028. |
| An International Search Report with Written Opinion both dated Feb. 2, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000600. |
| An International Search Report together with Written Opinion both dated Mar. 30, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001024. |
| An International Search Report and a Written Opinion both dated Feb. 10, 2011, which issued during the prosecution of Applicant's PCT/IL10/00890. |
| An Office Action dated May 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/128,756. |
| An Office Action dated Sep. 6, 2018, which issued during the prosecution of U.S. Appl. No. 15/994,022. |
| An Office Action dated Sep. 7, 2018, which issued during the prosecution of U.S. Appl. No. 15/991,725. |
| An Office Action dated Nov. 26, 2018, which issued during the prosecution of U.S. Appl. No. 16/040,831. |
| An Office Action dated Jul. 11, 2018, which issued during the prosecution of U.S. Appl. No. 15/978,494. |
| An Office Action dated Nov. 23, 2018, which issued during the prosecution of U.S. Appl. No. 16/041,208. |
| An Office Action dated Jun. 15, 2018, which issued during the prosecution of U.S. Appl. No. 15/970,314. |
| An Office Action dated Oct. 12, 2018, which issued during the prosecution of U.S. Appl. No. 15/970,314. |
| An Office Action dated Jul. 26, 2018, which issued during the prosecution of U.S. Appl. No. 15/979,686. |
| An Office Action dated Sep. 10, 2018, which issued during the prosecution of U.S. Appl. No. 16/008,618. |
| An International Preliminary Report on Patentability dated Apr. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050860. |
| An Office Action dated Apr. 22, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559. |
| Notice of Allowance dated Aug. 30, 2019, which issued during the prosecution of U.S. Appl. No. 15/682,789. |
| Notice of Allowance dated Mar. 29, 2019, which issued during the prosecution of U.S. Appl. No. 15/541,783. |
| Dieter RS, “Percutaneous valve repair: Update on mitral regurgitation and endovascular approaches to the mitral valve,” Applications in Imaging, Cardiac Interventions, Supported by an educational grant from Amersham Health pp. 11-14 (2003). |
| An Advisory Action dated Dec. 13, 2013, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Aug. 7, 2015, which issued during the prosecution of U.S. Appl. No. 14/128,756. |
| An Office Action dated May 19, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868. |
| An Office Action dated Sep. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868. |
| An Office Action dated May 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868. |
| A Notice of Allowance dated Sep. 18, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868. |
| Restriction Requirement dated May 5, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868. |
| A Restriction Requirement dated Mar. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/785,717. |
| An Office Action dated Oct. 5, 2020, which issued during the prosecution of Canadian Patent Application No. 2,973,940. |
| An Office Action dated Nov. 30, 2020, which issued during the prosecution of U.S. Appl. No. 16/138,129. |
| An Office Action summarized English translation and Search Report dated Nov. 25, 2020, which issued during the prosecution of Chinese Patent Application No. 201910449820.1. |
| Notice of Allowance dated Nov. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/318,025. |
| An Office Action dated Aug. 2, 2011, which issued during the prosecution of U.S. Appl. No. 12/435,291. |
| Notice of Allowance dated Dec. 7, 2011, which issued during the prosecution of U.S. Appl. No. 12/435,291. |
| An Office Action dated Apr. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512. |
| An Office Action dated Oct. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512. |
| Notice of Allowance dated Apr. 20, 2011, which issued during the prosecution of U.S. Appl. No. 12/484,512. |
| Notice of Allowance dated Mar. 23, 2011, which issued during the prosecution of U.S. Appl. No. 12/484,512. |
| An Office Action dated Jan. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| An Office Action dated Aug. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| An Advisory Action dated Sep. 6, 2012 which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| Notice of Allowance dated Jun. 23, 2014, which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| A Restriction Requirement dated Nov. 14, 2011 which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| Amendment, Terminal Disclaimer and Extension dated Jun. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991. |
| A Restriction Requirement dated Jul. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930. |
| An Office Action dated Apr. 2, 2013, which issued during the prosecution of U.S. Appl. No. 12/785,717. |
| An Office Action dated Dec. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/781,717. |
| An Office Action dated Nov. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/791,026. |
| An Office Action dated May 10, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026. |
| Notice of Allowance dated Nov. 13, 2014, which issued during the prosecution of U.S. Appl. No. 12/791,026. |
| Notice of Allowance dated Dec. 24, 2014, which issued during the prosecution of U.S. Appl. No. 12/791,026. |
| A Restriction Requirement dated Jan. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/791,026. |
| A Restriction Requirement dated Sep. 14, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,192. |
| An Office Action dated Aug. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192. |
| An Office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192. |
| Notice of Allowance dated Nov. 19, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192. |
| A Notice of Allowance dated Jun. 26, 2012, which issued during the prosecution of U.S. Appl. No. 12/608,316. |
| An Office Action dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316. |
| A Restriction Requirement dated Apr. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316. |
| An Office Action dated Jul. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061. |
| An Office Action dated Jan. 23, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061. |
| An Office Action dated Mar. 9, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635. |
| An Office Action dated Nov. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635. |
| A Notice of Allowance dated May 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,635. |
| Restriction Requirement dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/689,635. |
| An Office Action dated May 6, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,693. |
| An Office Action dated Feb. 3, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693. |
| Notice of Allowance dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693. |
| A Restriction Requirement dated Sep. 17, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,693. |
| A Notice of Allowance dated Sep. 3, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693. |
| European Search Report dated Jul. 8, 2016, which issued during the prosecution of Applicant's European App No. 13849843.1. |
| A Supplementary European Search Report dated Dec. 4, 2012, which issued during the prosecution of European Patent Application No. EP 09834225.6. |
| A Supplementary European Search Report dated Mar. 28, 2013, which issued during the prosecution of European Patent Application No. EP 1077 2091.4. |
| Search Report in European Patent Application 10772090.6 dated Jan. 17, 2014. |
| Supplementary European Search Report dated Oct. 23, 2014 which issued during the prosecution of Applicant's European App No. 10826224.7. |
| Notice of Allowance dated May 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090. |
| Notice of Allowance dated Apr. 12, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090. |
| An Office Action dated Jun. 7, 2013 which issued during the prosecution of U.S. Appl. No. 13/141,606. |
| An Office Action dated Jun. 13, 2014, which issued during the prosecution of U.S. Appl. No. 13/141,606. |
| Notice of Allowance dated Sep. 29, 2014, which issued during the prosecution of U.S. Appl. No. 13/141,606. |
| An Office Action dated Feb. 4, 2013 which issued during the prosecution of U.S. Appl. No. 13/141,606. |
| An English translation of an Office Action dated Apr. 23, 2014 which issued during the prosecution of Chinese Patent Application No. 201080059948.4. |
| Communication dated Jul. 25, 2014, issued by the State Intellectual Property Office of the P.R. of China in counterpart Application No. 200980157331.3. |
| An International Search Report and a Written Opinion both dated Jan. 25, 2016, which issued during the prosecution of Applicant's PCT/IL2015/051027. |
| An International Search Report dated May 19, 2011, which issued during the prosecution of Applicant's PCT/IL2011/00064. |
| An International Search Report and a Written Opinion both dated Feb. 22, 2013, which issued during the prosecution of Applicant's PCT/IL201/050451. |
| An International Search Report & Written Opinion both dated Mar. 21, 2014, which issued during the prosecution of Applicant's PCT/IL13/50992. |
| An International Search Report and Written Opinion both dated Apr. 9, 2014, which issued during the prosecution of Applicant's PCT/IL13/50860. |
| An International Search Report and a Written Opinion both dated Apr. 15, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050861. |
| An International Search Report & Written Opinion both dated May 12, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050914. |
| An International Search Report and a Written Opinion both dated May 30, 2007, which issued during the prosecution of Applicant's PCT/IL2006/000342. |
| An International Search Report and a Written Opinion both dated Jun. 10, 2010, which issued during the prosecution of Applicant's PCT/IL09/01209. |
| An International Search Report and a Written Opinion both dated Aug. 17, 2010. which issued during the prosecution of Applicant's PCT/IL10/00357. |
| An International Search Report & Written Opinion both dated Sep. 8, 2009, which issued during the prosecution of Applicant's PCT/IL09/00593. |
| An International Search Report and a Written Opinion both dated Sep. 12, 2008, which issued during the prosecution of Applicant's PCT/IL07/01503. |
| An International Search Report and Written Opinion dated Nov. 8, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000358. |
| An International Search Report and a Written Opinion both dated Nov. 23, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000446. |
| Supplementary European Search Report dated Sep. 25, 2015, which issued during the prosecution of Applicant's European App No. 09794095.1. |
| A Supplementary European Search Report dated Feb. 1, 2011, which issued during the prosecution of European Patent Application No. EP 07849540. |
| An English translation of an Office Action dated Dec. 12, 2013 which issued during the prosecution of Chinese Patent Application No. 200980157331.3. |
| Communication regarding amended claims filed dated Dec. 27, 2012, regarding European App No. 11792047.0. |
| An Office Action dated Mar. 23, 2015, which issued during the prosecution of European Patent Application No. EP 09834225.6. |
| An English translation of an Office Action dated Jul. 17, 2015 which issued during the prosecution of Chinese Patent Application No. 201080059948.4. |
| An English translation of an Office Action dated Dec. 16, 2015 which issued during the prosecution of Chinese Patent Application No. 201080059948.4. |
| Communication from the European Patent Office dated Jun. 11, 2015, which issued during the prosecution of European U.S. Appl. No. 11/811,934. |
| A communication from the European Patent Office dated Sep. 28, 2011 which issued during the prosecution of European Application No. 09834225.6. |
| A communication from the European Patent Office dated Oct. 19, 2012 which issued during the prosecution of European Application No. 11792047.0. |
| An Office Action dated Oct. 23, 2012, which issued during the prosecution of Japanese Patent Application No. 2009-539871. |
| An English Translation of an Office Action dated Nov. 24, 2015, which issued during the prosecution of Israel Patent Application No. 223448. (the relevant part only). |
| Notice of Allowance dated Nov. 17, 2015, which issued during the prosecution of U.S. Appl. No. 14/486,226. |
| Notice of Allowance dated Jan. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/551,951. |
| An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 14/551,951. |
| An Office Action dated Jan. 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100. |
| An Office Action dated May 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100. |
| An International Search Report and a Written Opinion both dated Nov. 14, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000404. |
| An International Search Report and a Written Opinion both dated Dec. 6, 2012 which issued during the prosecution of Applicant's PCT/IL2012/000250. |
| A Notice of Allowance dated Apr. 3, 2013, which issued during the prosecution of U.S. Appl. No. 12/563,930. |
| An Office Action dated Aug. 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930. |
| An Office Action dated Dec. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952. |
| A Restriction Requirement dated Oct. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952. |
| A Notice of Allowance dated May 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,952. |
| An Office Action dated Apr. 1, 2013 which issued during the prosecution of U.S. Appl. No. 13/161,476. |
| An Office Action dated Nov. 21, 2013, which issued during the prosecution of U.S. Appl. No. 13/161,476. |
| An Advisory Action dated Feb. 4, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,476. |
| A Restriction Requirement dated Oct. 25, 2012 which issued during the prosecution of U.S. Appl. No. 13/167,444. |
| An Office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,444. |
| An Office Action dated Aug. 26, 2014 which issued during the prosecution of U.S. Appl. No. 13/167,444. |
| An Office Action dated Aug. 23, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,444. |
| Notice of Allowance dated Nov. 12, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007. |
| Notice of Allowance dated Jan. 7, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,007. |
| An Office Action dated Oct. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,492. |
| A Restriction Requirement dated Nov. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/167,492. |
| An Office Action dated Feb. 14, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,492. |
| Notice of Allowance dated Nov. 7, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,492. |
| An Office Action dated Jun. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,492. |
| Notice of Allowance dated Dec. 9, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,476. |
| Notice of Allowance dated Jan. 22, 2015, which issued during the prosecution of U.S. Appl. No. 13/167,444. |
| An International Preliminary Report on Patentability dated May 1, 2012, which issued during the prosecution of Applicant's PCT/IL2010/000890. |
| An International Preliminary Report on Patentability dated Jun. 9, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050992. |
| U.S. Appl. No. 60/873,075, filed Dec. 5, 2006. |
| U.S. Appl. No. 60/902,146, filed Feb. 16, 2007. |
| An Office Action dated Mar. 29, 2018, which issued during the prosecution of U.S. Appl. No. 15/188,507. |
| Notice of Allowance dated Sep. 17, 2014, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Oct. 1, 2015, which issued during the prosecution of U.S. Appl. No. 14/141,228. |
| A Restriction Requirement dated Jun. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/319,030. |
| An Office Action dated Oct. 14, 2014, which issued during the prosecution of US Appl. No. 13/319,030. |
| An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,030. |
| An Office Action dated May 3, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,030. |
| Notice of Allowance dated Dec. 30, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,030. |
| An Office Action dated Apr. 7, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007. |
| An Office Action dated Apr. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/141,228. |
| An Office Action dated Oct. 5, 2015, which issued during the prosecution of U.S. Appl. No. 14/246,417. |
| An Office Action dated Apr. 7, 2016, which issued during the prosecution of U.S. Appl. No. 14/242,151. |
| An Office Action dated May 23, 2016, which issued during the prosecution of U.S. Appl. No. 14/209,171. |
| An Office Action dated Jul. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417. |
| An Office Action dated Jun. 14, 2016, which issued during the prosecution of U.S. Appl. No. 14/273,155. |
| An Office Action dated Jun. 17, 2016, which issued during the prosecution of U.S. Appl. No. 14/357,040. |
| An Office Action dated Mar. 24, 2015, which issued during the prosecution of U.S. Appl. No. 14/486,226. |
| U.S. Appl. No. 61/001,013, filed Oct. 29, 2007. |
| U.S. Appl. No. 61/132,295, filed Jun. 16, 2008. |
| U.S. Appl. No. 61/265,936, filed Dec. 2, 2009. |
| U.S. Appl. No. 61/283,445, filed Dec. 2, 2009. |
| U.S. Appl. No. 61/207,908, filed Feb. 17, 2009. |
| U.S. Appl. No. 61/733,979, filed Dec. 6, 2012. |
| U.S. Appl. No. 61/717,303, filed Oct. 23, 2012. |
| U.S. Appl. No. 61/820,979, filed May 8, 2013. |
| U.S. Appl. No. 61/745,848, filed Dec. 6, 2012. |
| U.S. Appl. No. 61/555,570, filed Nov. 4, 2011. |
| U.S. Appl. No. 61/557,082, filed Nov. 8, 2011. |
| U.S. Appl. No. 60/662,616, filed Mar. 17, 2005. |
| U.S. Appl. No. 60/700,542, filed Jul. 18, 2005. |
| U.S. Appl. No. 61/782,121, filed Mar. 14, 2013. |
| European Search Report dated Jul. 15, 2016, which issued during the prosecution of Applicant's European App No. 13849947.0. |
| European Search Report dated Nov. 4, 2015, which issued during the prosecution of European Patent Application No. EP 1077 2091.4. |
| Search Report in European Patent Application 10826224.7 dated Nov. 16, 2015. |
| Supplementary European Search Report dated Dec. 23, 2014 which issued during the prosecution of Applicant's European App No. 10834311. |
| Supplementary European Search Report dated Jan. 21, 2014 which issued during the prosecution of Applicant's European App No. 11 78 6226. |
| A Supplementary European Search Report dated Jan. 20, 2015, which issued during the prosecution of European Patent Application No. 12803037.6. |
| Supplementary European Search Report dated Aug. 4, 2014 which issued during the prosecution of Applicant's European App No. 11 81 1934.6. |
| European Search Report dated Jun. 24, 2016, which issued during the prosecution of European Patent Application No. EP 12847363. |
| Supplementary European Search Report dated Apr. 29, 2015, which issued during the prosecution of Applicant's European App No. 14200202. |
| An Office Action dated Dec. 16, 2013, which issued during the prosecution of U.S. Appl. No. 13/666,262. |
| An Office Action dated Dec. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/666,141. |
| Notice of Allowance dated Jun. 25, 2014, which issued during the prosecution of U.S. Appl. No. 13/666,262. |
| A Notice of Allowance dated Feb. 2, 2015, which issued during the prosecution of U.S. Appl. No. 13/504,870. |
| Notice of Allowance dated Aug. 19, 2013, which issued during the prosecution of U.S. Appl. No. 11/908,906. |
| An Office Action dated Jun. 8, 2012, which issued during the prosecution of U.S. Appl. No. 11/908,906. |
| An Office Action dated Dec. 21, 2013, which issued during the prosecution of U.S. Appl. No. 11/908,906. |
| A Restriction Requirement dated Aug. 5, 2011, which issued during the prosecution of U.S. Appl. No. 11/908,906. |
| An Office Action dated Sep. 16, 2009 which issued during the prosecution of U.S. Appl. No. 11/950,930. |
| Notice of Allowance dated Sep. 12, 2014, which issued during the prosecution of U.S. Appl. No. 11/950,930. |
| An Office Action dated Aug. 5, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930. |
| An Office Action dated Feb. 17, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930. |
| A Restriction Requirement dated Apr. 19, 2010 which issued during the prosecution of U.S. Appl. No. 12/341,960. |
| An Office Action dated Sep. 28, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103. |
| An Office Action dated Jun. 13, 2012, which issued during the prosecution of U.S. Appl. No. 12/437,103. |
| A Restriction Requirement dated Jul. 12, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103. |
| Notice of Allowance dated Mar. 6, 2014, which issued during the prosecution of U.S. Appl. No. 12/437,103. |
| Notice of Allowance dated Dec. 20, 2013, which issued during the prosecution of U.S. Appl. No. 12/437,103. |
| Notice of Allowance dated Apr. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/341,960. |
| An Office Action dated Mar. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960. |
| An Office Action dated Aug. 4, 2010, which issued during the prosecution of U.S. Appl. No. 12/341,960. |
| An Interview Summary dated Jul. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960. |
| Notice of Allowance dated Aug. 21, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385. |
| Notice of Allowance dated Oct. 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385. |
| Notice of Allowance dated Dec. 24, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Notice of Allowance dated Oct. 21, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Declaration of Ivan Vesely, Ph.D., in Support of Petition for Inter Partesreview of U.S. Pat. No. 7,563,267—dated May 29, 2019. |
| U.S. Appl. No. 60/128,690, filed Apr. 9, 1999. |
| U.S. Appl. No. 60/613,867, filed Sep. 27, 2004. |
| An Office Action dated Dec. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/144,054. |
| An Office Action dated Feb. 2, 2021, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
| An Office Action dated Jan. 13, 2021, which issued during the prosecution of European Patent Application No. 15751089.2. |
| An Office Action together with an English summary dated Mar. 3, 2021, which issued during the prosecution of Chinese Patent Application No. 201780047391.4. |
| Declaration of Dr. Ivan Vesely, Ph.D. in Support of Petition for Inter Partes Review of U.S. Pat. No. 10,226,341—dated Dec. 17, 2020. |
| Petition for Inter Partes Review of U.S. Pat. No. 10,226,341 and EXHIBITS 1001-1013—dated Dec. 29, 2020. |
| Batista, Randas JV, et al. “Partial left ventriculectomy to treat end-stage heart disease.” The Annals of thoracic surgery 64.3 (1997): 634-638. |
| Beall Jr, Arthur C., et al. “Clinical experience with a dacron velour-covered teflon-disc mitral-valve prosthesis.” The Annals of thoracic surgery 5.5 (1968): 402-410. |
| Kalbacher, D., et al. “1000 MitraClip™ procedures: Lessons learnt from the largest single-centre experience worldwide.” (2019): 3137-3139. |
| Maisano, F., et al. “The edge-to-edge technique: a simplified method to correct mitral insufficiency.” European joumal of cardio-thoracic surgery 13.3 (1998): 240-246. |
| Fucci, C., et al. “Improved results with mitral valve repair using new surgical techniques.” European journal of cardio-thoracic surgery 9.11 (1995): 621-627. |
| Notice of Allowance dated Nov. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559. |
| Mitral Valve Academic Research Consortium. “Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles a Consensus Document from the Mitral Valve Academic Research Consortium.” Journal of the American College of Cardiology 66.3 (2015): 278-307. |
| An Office Action dated Aug. 29, 2018, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Office Action dated May 8, 2018, which issued during the prosecution of U.S. Appl. No. 15/902,403. |
| An Office Action dated May 11, 2018, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
| Notice of Allowance dated Oct. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/886,517. |
| Notice of Allowance dated Jul. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
| Notice of Allowance dated Nov. 16, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Apr. 27, 2020, which issued during the prosecution of U.S. Appl. No. 16/591,330. |
| An Advisory Action dated Jan. 2, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Notice of Allowance dated Oct. 17, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Office Action dated Dec. 31, 2019, which issued during the prosecution of U.S. Appl. No. 16/591,330. |
| Notice of Allowance dated Feb. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/937,216. |
| An Advisory Action dated Nov. 18, 2020, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
| An International Search Report and a Written Opinion both dated Mar. 27, 2018, which issued during the prosecution of Applicant's PCT/IL2017/050849. |
| Notice of Allowance dated Jun. 11, 2021, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
| Notice of Allowance dated Jul. 16, 2021, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
| Patent Trial and Appeal Board Decision Granting Institution in U.S. Pat. No. 10,226,341—Dated Jul. 20, 2021. |
| European Search Report dated Jun. 10, 2021 which issued during the prosecution of Applicant's European App No. 21157988.3. |
| Notice of Allowance dated Nov. 19, 2018, which issued during the prosecution of U.S. Appl. No. 15/197,069. |
| Poirier, Nancy C., et al. “A novel repair for patients with atrioventricular septal defect requiring reoperation for left atrioventricular valve regurgitation.” European journal of cardio-thoracic surgery 18.1 (2000): 54-61. |
| An Office Action dated Mar. 29, 2021, which issued during the prosecution of U.S. Appl. No. 16/738,516. |
| Ando, Tomo, et al. “Iatrogenic ventricular septal defect following transcatheter aortic valve replacement: a systematic review.” Heart, Lung and Circulation 25.10 (2016): 968-974. |
| Urena, Marina, et al. “Transseptal transcatheter mitral valve replacement using balloon-expandable transcatheter heart valves: a step-by-step approach.” JACC: Cardiovascular Interventions 10.19 (2017): 1905-1919. |
| An English summary of an Official Action dated Mar. 29, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
| An International Search Report and a Written Opinion both dated Jan. 28, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051031. |
| An International Preliminary Report on Patentability dated Mar. 9, 2021, which issued during the prosecution of Applicant's PCT/IL2019/051031. |
| An Office Action dated May 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/636,204. |
| Notice of Allowance dated May 17, 2021, which issued during the prosecution of U.S. Appl. No. 16/138,129. |
| Notice of Allowance dated Jun. 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/802,353. |
| An Office Action dated May 12, 2021, which issued during the prosecution of Canadian Patent Application No. 2,973,940. |
| Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021. |
| Declaration of Ivan Vesely, Ph.D. In Support of Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021. |
| Notice of Allowance dated Oct. 30, 2018, which issued during the prosecution of U.S. Appl. No. 15/197,069. |
| An International Search Report and a Written Opinion both dated Jul. 12, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132. |
| Notice of Allowance dated Oct. 3, 2019, which issued during the prosecution of U.S. Appl. No. 15/691,032. |
| An Office Action dated Sep. 6, 2018, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
| Condado, José Antonio, et al. “Percutaneous edge-to-edge mitral valve repair: 2-year follow-up in the first human case.” Catheterization and cardiovascular interventions 67.2 (2006): 323-325. |
| Notice of Allowance dated Mar. 18, 2020, which issued during the prosecution of U.S. Appl. No. 16/284,331. |
| Feldman, Ted, et al. “Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.” Journal of the American College of Cardiology 54.8 (2009): 686-694. |
| Notice of Allowance dated Nov. 21, 2018, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
| Notice of Allowance dated Jul. 3, 2019, which issued during the prosecution of U.S. Appl. No. 15/691,032. |
| IPR2021-00383 Petitioners' Authorized Reply to Patent Owner's Preliminary Response dated May 27, 2021. |
| Exhibit 1014—Transcript of proceedings held May 20, 2021 (Edwards Lifesciences vs. Cardiovalve). |
| Exhibit 1015—Facilitate, Meriam-Webster.com, https://www.merriamwebster.com/dictionary/facilitate (visited May 26, 2021). |
| Patent Owner's Authorized Surreply to Petitioner's Reply to Patent Owner's Preliminary Response dated Jun. 4, 2021(Edwards Lifesciences vs. Cardiovalve). |
| An Invitation to pay additional fees dated May 19, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132. |
| An Office Action dated Aug. 18, 2021, which issued during the prosecution of U.S. Appl. No. 17/210,183. |
| An Office Action dated Sep. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/768,909. |
| An Office Action dated Sep. 15, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,599. |
| Notice of Allowance dated Oct. 14, 2021, which issued during the prosecution of U.S. Appl. No. 16/680,739. |
| An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/331,845. |
| European Search Report dated Oct. 11, 2021 which issued during the prosecution of Applicant's European App No. 21176010.3. |
| Fann, James I., et al. “Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response.” Circulation 110.8 (2004): 988-993. |
| IPR2021-00383 Patent Owner'S Contingent Motion to Amend Under 37 C.F.R. §42.121 dated Oct. 13, 2021. |
| IPR2021-00383 Patent Owner's Response Pursuant to 37 C.F.R. §42.120 dated Oct. 13, 2021. |
| IPR2021-00383 Second Declaration of Dr. Michael Sacks dated Oct. 13, 2021. |
| An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/306,231. |
| Maisano, Francesco, et al. “The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique.” Journal of the American College of Cardiology 58.21 (2011): 2174-2182. |
| An Office Action dated Nov. 6, 2015, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
| An Office Action dated Jan. 26, 2022, which issued during the prosecution of U.S. Appl. No. 16/888,210. |
| IPR2021-00383 Deposition of Dr. Ivan Vesely, dated Sep. 22, 2021. |
| Cardiovalve Exhibit 2009—Percutaneous Mitral Leaflet Repair: MitraClip® Therapy for Mitral Regurgitation (2012). |
| Feldman, Ted, et al. “Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial.” Journal of the American College of Cardiology 46.11 (2005): 2134-2140. |
| An Office Action summarized English translation and Search Report dated Oct. 8, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
| An Office Action dated Nov. 4, 2021, which issued during the prosecution of U.S. Appl. No. 17/366,711. |
| An Office Action summarized English translation and Search Report dated Aug. 12, 2021, which issued during the prosecution of Chinese Patent Application No. 201880058940.2. |
| An Office Action dated Nov. 25, 2021, which issued during the prosecution of European Patent Application No. 18826823.9. |
| IPR2021-01051 Institution decision dated Dec. 10, 2021 |
| Notice of Allowance dated Dec. 7, 2021, which issued during the prosecution of U.S. Appl. No. 17/394,307. |
| Notice of Allowance dated Dec. 6, 2021, which issued during the prosecution of U.S. Appl. No. 16/738,516. |
| Notice of Allowance dated Dec. 29: 2021, which issued during the prosecution of U.S. Appl. No. 17/210,183. |
| IPR2021-00383 Petitioners' Reply to Patent Owner's Response dated Jan. 5, 2022. |
| IPR2021-00383 Petitioners' Opposition to Patent Owner's Contingent Motion to Amend dated Jan. 5, 2022. |
| An Office Action dated Sep. 22, 2021, which issued during the prosecution of European Patent Application No. 20714289.4. |
| Summary of Examination Notice dated Jan. 6, 2022, which issued during the prosecution of Chinese Patent Application No. 201880064313.X. |
| An Office Action dated Jan. 12, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787. |
| Notice of Allowance dated Jun. 20, 2017, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
| Notice of Allowance dated Oct. 20, 2021, which issued during the prosecution of U.S. Appl. No. 16/636,204. |
| Notice of Allowance dated Jan. 31, 2022, which issued during the prosecution of U.S. Appl. No. 17/479,418. |
| An Office Action dated Jan. 13, 2022, which issued during the prosecution of U.S. Appl. No. 17/473,472. |
| An Office Action dated Jul. 27, 2022, which issued during the prosecution of U.S. Appl. No. 16/881,350. |
| An Office Action dated Sep. 21, 2022, which issued during the prosecution of U.S. Appl. No. 16/776,581. |
| An Office Action dated Jul. 20, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787. |
| An Office Action dated Sep. 16, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,466. |
| An Office Action dated Aug. 1, 2022, which issued during the prosecution of European Patent Application No. 18826823.9. |
| European Search Report dated Sep. 6, 2022 which issued during the prosecution of Applicant's European App No. 22161862.2. |
| IPR2021-01051 Petitioners' Reply to Preliminary Guidance dated Aug. 2, 2022. |
| IPR2021-01051 Patent Owner's Sur-Reply To Petitioners' Reply to Preliminary Guidance dated Aug. 23, 2022. |
| An Office Action dated Aug. 5, 2022, which issued during the prosecution of U.S. Appl. No. 16/760,147. |
| An Office Action dated Sep. 8, 2022, which issued during the prosecution of U.S. Appl. No. 16/896,858. |
| European Search Report dated Mar. 20, 2023 which issued during the prosecution of Applicant's European App No. 22204764.9. |
| An Office Action dated Apr. 14, 2023, which issued during the prosecution of U.S. Appl. No. 16/144,054. |
| An Office Action dated May 15, 2023, which issued during the prosecution of U.S. Appl. No. 16/656,790. |
| An Office Action dated May 16, 2023, which issued during the prosecution of U.S. Appl. No. 17/114,771. |
| An Office Action dated May 25, 2023, which issued during the prosecution of U.S. Appl. No. 17/397,235. |
| An Office Action dated Mar. 3, 2023, which issued during the prosecution of European Patent Application No. 17 751 143.3. |
| An Office Action dated Mar. 20, 2023, which issued during the prosecution of U.S. Appl. No. 17/181,722. |
| Number | Date | Country | |
|---|---|---|---|
| 20210393402 A1 | Dec 2021 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61756034 | Jan 2013 | US | |
| 61756049 | Jan 2013 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16802353 | Feb 2020 | US |
| Child | 17466785 | US | |
| Parent | 15872501 | Jan 2018 | US |
| Child | 16802353 | US | |
| Parent | 14763004 | US | |
| Child | 15872501 | US |
